EX-10.1



 Exhibit 10.1 

SECURITIES PURCHASE AGREEMENT 

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 18, 2014, by and among dELiA*s, Inc.,
a Delaware corporation with headquarters located at 50 West 23rd Street, New York, New York 10010 (the “Company”), and each investor identified on the signature pages hereto
(individually, an “Investor” and collectively, the “Investors”). 
 BACKGROUND 

A. The Company and each Investor are executing and delivering this Agreement in reliance upon the exemption from registration afforded by
Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the
“SEC”) under the Securities Act. 
 B. Each Investor, severally and not jointly, wishes to purchase, and the Company wishes
to sell, upon the terms and conditions stated in this Agreement, that number of shares of the Preferred Stock (as hereinafter defined) and that aggregate principal amount of Notes (as hereinafter defined), set forth on such Investor’s signature
page to this Agreement. The Investors hereunder are collectively subscribing for an aggregate of 199,834 shares of Preferred Stock and an aggregate of $24,116,600 in principal amount of Notes for an aggregate subscription amount equal to
$44,100,000. The Notes may become convertible into shares of the Preferred Stock of the Company. 
 C. NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Investors agree as follows: 

ARTICLE I 
 DEFINITIONS 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated: 

“8-K Filing” has the meaning set forth in Section 4.4. 

“10% holder” has the meaning set forth in Section 4.14(a)(viii). 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or
is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act. 

“Agent” has the meaning set forth in Section 3.1(k). 

“Agreement” has the meaning set forth in the Preamble. 

“AST” means American Stock Transfer & Trust Company. 

“Business Day” means any day other than Saturday, Sunday, any day which shall be a federal legal holiday in the United States
or any day on which banking institutions in The State of New York are authorized or required by law or other governmental action to close. 







 “Buyout Transaction” has the meaning set forth in Section 4.12. 

“Certificate of Designation” means the certificate of designation of the Preferred Stock to be filed prior to the Closing by
the Company with the Secretary of State of the State of Delaware substantially in the form of Annex B. 
 “Charter
Amendment” has the meaning set forth in Section 4.5. 
 “Closing” means the closing of the purchase
and sale of the Preferred Stock and the Notes pursuant to Section 2.1. 
 “Closing Date” means the date of the
closing of the purchase and sale of the Preferred Stock and the Notes, subject to satisfaction (or, if applicable, waiver) of the conditions to Closing specified herein. 

“Common Stock” means the common stock of the Company, par value $0.001 per share. 

“Company” has the meaning set forth in the Preamble. 

“Company Counsel” means Troutman Sanders LLP, counsel to the Company. 

“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person
with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability
that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto. 

“Conversion Price” has the meaning set forth in the Certificate of Designation. 

“Convertible Securities” means any stock or securities (other than Options) convertible into or exercisable or exchangeable
for Common Stock. 
 “Conversion Shares” has the meaning set forth in the Certificate of Designation. 

“Covering Shares” has the meaning set forth in Section 4.1(b). 

“Credit Agreement” means that certain credit agreement, dated as of June 14, 2013, by, among others, the Company,
certain wholly-owned subsidiaries of the Company, and Salus, as amended and in effect from time to time. 
 “Deposit
Account” means the deposit account of the Company established by the Company for the purpose of holding the proceeds of the issuance of the Notes during the period provided for in the Purchase Agreement. 

“Disclosure Materials” has the meaning set forth in Section 3.1(h). 

“Disqualification Event” has the meaning set forth in Section 3.1(j). 

“Effective Date” means the date that a Registration Statement is first declared effective by the SEC. 

  
 -2- 








 “Effectiveness Period” has the meaning set forth in Section 6.1(b).

 “Eligible Market” means any of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ
Global Market, the NASDAQ Capital Market or OTC Bulletin Board. 
 “Environmental Laws” has the meaning set forth in
Section 3.1(y). 
 “Event” has the meaning set forth in Section 6.1(e). 

“Event Payments” has the meaning set forth in Section 6.1(e). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Excluded Investors” means the officers and directors, each of their Affiliates, and other Affiliates of the Company. 

“Filing Date” means the date that is forty-five (45) days after the Closing Date or, if such date is not a Business Day,
the next date that is a Business Day. 
 “Flatbush” means Flatbush Watermill LLC. 

“Flatbush Director” has the meaning set forth in Section 4.11(a). 

“GAAP” has the meaning set forth in Section 3.1(h). 

“GECC” means General Electric Capital Corporation. 

“Group” has the meaning set forth in Section 4.12(c). 

“Hazardous Materials” has the meaning set forth in Section 3.1(y). 

“Indebtedness” of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all
obligations issued, undertaken or assumed as the deferred purchase price of property or services (other than trade payables entered into in the ordinary course of business), (C) all reimbursement or payment obligations with respect to letters
of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or
businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness
(even though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in
connection with generally accepted accounting principles, consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for
which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts and contract
rights) owned by any Person, even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or obligations of others
of the kinds referred to in clauses (A) through (G) above. 

  
 -3- 








 “Indemnified Party” has the meaning set forth in Section 6.7(c).

 “Indemnifying Party” has the meaning set forth in Section 6.7(c). 

“Insolvent” has the meaning set forth in Section 3.1(i). 

“Intellectual Property Rights” has the meaning set forth in Section 3.1(s). 

“Investor” has the meaning set forth in the Preamble. 

“Issuer Covered Person” has the meaning set forth in Section 3.1(j). 

“Knowledge” of the Company means with respect to any statement made to the knowledge of the Company, that the statement is
based upon the actual knowledge after due inquiry of any executive officer of the Company as of the date of this Agreement. 
 “Lead
Investor” means Valinor Management, LLC or one or more of its Affiliates (or investment vehicles managed by any such Person). 

“Lead Investor Directors” has the meaning set forth in Section 4.11(a). 

“Letter of Credit Agreement” means that certain letter of credit agreement, dated as of June 14, 2013, among the
Company, certain wholly-owned subsidiaries of the Company and GECC, as amended and in effect from time to time. 
 “Lien”
means any lien, charge, claim, security interest, encumbrance, right of first refusal or other restriction. 
 “Losses”
means any and all losses, claims, damages, liabilities, settlement costs and expenses, including, without limitation, reasonable attorneys’ fees. 

“Material Adverse Effect” means any of (i) a material adverse effect on the results of operations, assets, business,
prospects or financial condition of the Company and the Subsidiaries taken as a whole on a consolidated basis, (ii) an adverse impairment of the Company’s ability to perform its obligations under any of the Transaction Documents or
(iii) an adverse effect on the legality, validity or enforceability of any of the Transaction Documents, provided, that none of the following alone shall be deemed, in and of itself, to constitute a Material Adverse Effect: (y) a change in
the market price or trading volume of the Common Stock or (z) changes in general economic conditions or changes affecting the industry in which the Company operates generally (as opposed to Company-specific changes) so long as such changes do
not have a disproportionate effect on the Company and its Subsidiaries taken as a whole. 
 “Money Laundering Laws” has the
meaning set forth in Section 3.1(cc). 
 “Notes” means, collectively, the convertible notes, dated the date
hereof, issued by the Company to each Purchaser, in the form of Annex A attached hereto. 
 “Options” means
any outstanding rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities. 

  
 -4- 








 “Person” means an individual, a limited liability company, a partnership, a
joint venture, a corporation, a trust, an unincorporated organization, a government or any department or agency thereof and any other legal entity. 

“Preferred Stock” means up to 441,000 shares of the Company’s Series B Convertible Preferred Stock issued hereunder or
pursuant to the Notes and having the rights, preferences and privileges set forth in the Certificate of Designation, in the form of Annex B hereto. 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, a partial proceeding,
such as a deposition), whether commenced or threatened in writing. 
 “Prospectus” means the prospectus included in the
Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A, as amended or supplemented by any
prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to the Prospectus including post-effective amendments, and
all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. 
 “Purchase Rights”
has the meaning set forth in Section 4.13. 
 “Registrable Securities” means the Conversion Shares issued or
issuable pursuant to the Preferred Stock, together with any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing. 

“Registration Statement” means each registration statement required to be filed under Article VI, including (in each
case) the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference
in such registration statement. 
 “Regulation D” has the meaning set forth in the Preamble. 

“Required Effectiveness Date” means the date which is, (i) if there is no review of the Registration Statement by the
SEC, one hundred and twenty (120) days after the Closing Date or, if such date is not a Business Day, the next date that is a Business Day, or, (ii) if there is a review of the Registration Statement by the SEC, one hundred and fifty
(150) days after the date of the Closing Date or, if such date is not a Business Day, the next date that is a Business Day. 

“Rights Agreement” means that certain stockholders rights agreement, dated as of December 19, 2005, between the Company
and AST, as rights agent. 
 “Rule 144,” “Rule 415,” “Rule 424,” and
“Rule 430A” means Rule 144, Rule 415, Rule 424 and Rule 430A, respectively, promulgated by the SEC pursuant to the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation
hereafter adopted by the SEC having substantially the same effect as such Rule. 
 “Sale Number” has the meaning set forth
in Section 6.2(b). 
 “Salus” means Salus Capital Partners, LLC. 

  
 -5- 








 “Salus Consent” has the meaning set forth in Section 2.2(a)(vii).

 “Salus Liens” means liens securing the Company’s and certain of its Subsidiaries’ obligations under the Credit
Agreement. 
 “SEC” has the meaning set forth in the Preamble. 

“SEC Comments” means written comments pertaining solely to Rule 415 which are received by the Company from the SEC, and a
copy of which shall have been provided by the Company to the Investors, to a filed Registration Statement which require the Company to limit the amount of Registrable Securities which may be included therein to a number of Registrable Securities,
which is less than such amount sought to be included thereon as filed with the SEC. 
 “SEC Reports” has the meaning set
forth in Section 3.1(h). 
 “Securities” means the Notes, the Preferred Stock and the Conversion Shares. 

“Securities Act” has the meaning set forth in the Preamble. 

“Short Sales” has the meaning set forth in Section 3.2(i). 

“Stated Value” means $100 per share of Preferred Stock. 

“Stockholder Approval” has the meaning set forth in Section 4.5. 

“Stockholder Approval Date” has the meaning set forth in Section 4.5. 

“Stockholder Meeting” has the meaning set forth in Section 4.5. 

“Subsidiary” means any direct or indirect subsidiary of the Company. 

“Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market (other than the OTC Bulletin
Board), or (ii) if the Common Stock is not listed or quoted on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or
(iii) if the Common Stock is not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by OTC Markets Group Inc. (or any similar organization or agency succeeding to its
functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day. 

“Trading Market” means whichever of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ
Global Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 

“Transaction” has the meaning set forth in Section 3.2(i). 

“Transaction Documents” means this Agreement, the schedules and exhibits attached hereto, the Certificate of Designation, the
Notes, the Transfer Agent Instructions and the amendment to the Rights Agreement. 

  
 -6- 








 “Transfer Agent” means American Stock Transfer & Trust Company, or any
successor transfer agent for the Company. 
 “Transfer Agent Instructions” means, with respect to the Company, the
Irrevocable Transfer Agent Instructions, in the form of Exhibit E, executed by the Company and delivered to and acknowledged in writing by the Transfer Agent. 

“Underwritten Demand Registration Request” has the meaning set forth in Section 6.2(a). 

ARTICLE II 
 PURCHASE AND SALE 

2.1 Closing. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and sell to each
Investor, and each Investor shall, severally and not jointly, purchase from the Company, the number of shares of Preferred Stock and a Note in the original principal amount set forth on such Investor’s signature page to this Agreement. The date
and time of the Closing shall be 11:00 a.m., New York City Time, on the Closing Date. The Closing shall take place at the offices of Company Counsel. 

2.2 Closing Deliveries. 

(a) At the Closing, the Company shall deliver or cause to be delivered to each Investor the following: 

(i) one or more certificates evidencing a number of shares of Preferred Stock set forth on such Investor’s signature page to this
Agreement, registered in the name of such Investor, and evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of Delaware; 

(ii) a Note, duly executed by the Company, in the original principal amount set forth on such Investor’s signature page to this
Agreement. 
 (iii) duly executed Transfer Agent Instructions, acknowledged by the Transfer Agent; 

(iv) duly executed amendment to the Rights Agreement in the form of Exhibit B;  

(v) a legal opinion of Company Counsel, in the form of Exhibit C, executed by such counsel; 

(vi) a certificate of the Secretary or an Assistant Secretary of the Company, dated as of the Closing Date, (a) certifying the
resolutions adopted by the Board of Directors (or a committee thereof) of the Company approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Preferred Stock and the Notes, the Preferred
Stock upon conversion of the Notes in accordance with its terms, and all Common Stock issued upon Conversion of any Preferred Stock, (b) certifying the current versions of the certificate of incorporation and by-laws of the Company, as amended
through the Closing Date, and (c) certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on behalf of the Company; 

  
 -7- 








 (vii) a certificate of the Chief Executive Officer or Chief Financial Officer of the Company,
dated as of the Closing Date, certifying to the fulfillment of the conditions applicable to the Company specified in Section 5.1(a) and (b); and 

(viii) the consent of Salus to the Transaction Documents to the extent required by the Credit Agreement and the acknowledgement by Salus that
the Deposit Account and the proceeds thereof do not constitute “Collateral” (as defined in the Credit Agreement) under the Credit Agreement and further the consent of Salus to the declaration and payment of all future dividends on the
Preferred Stock in accordance with the Certificate of Designation (collectively, the “Salus Consent”). 
 (b) At the
Closing, each Investor shall deliver or cause to be delivered to the Company (i) the aggregate purchase price set forth on such Investor’s signature page to this Agreement in United States dollars and in immediately available funds, by
wire transfer to an account designated in writing to such Investor by the Company for such purpose and (ii) a fully completed and executed copy of Exhibit A to this Agreement. 

ARTICLE III 
 REPRESENTATIONS AND
WARRANTIES 
 3.1 Representations and Warranties of the Company. The Company hereby represents and warrants to the Investors and the
Agent as follows: 
 (a) Subsidiaries. Except as disclosed in Schedule 3.1(a) hereto and other than the Salus Liens,
(1) the Company owns or controls, directly or indirectly, all of the capital stock or comparable equity interests of each Subsidiary free and clear of any Lien and all issued and outstanding shares of capital stock or comparable equity interest
of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights, and (2) the Company owns or controls, directly or indirectly, only the following corporations, partnerships, limited liability
partnerships, limited liability companies, associations or other entities and in the percentages set forth in Schedule 3.1(a): (i) A Merchandise, LLC, a Delaware limited liability company, (ii) dELiA*s Assets Corp., a Delaware
corporation, (iii) DACCS, Inc., an Ohio corporation, (iv) dELiA*s Group Inc., a Delaware corporation, (v) dELiA*s Brand LLC, a Delaware limited liability company, (vi) dELiA*s Operating Company, a Delaware corporation,
(vii) AMG Direct, LLC, a Delaware limited liability company, (viii) dELiA*s Distribution Company, a Delaware corporation, and (ix) dELiA*s Retail Company, a Delaware corporation. 

(b) Organization and Qualification. Each of the Company and the Subsidiaries is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization, with the requisite legal authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation
of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company and each Subsidiary is duly qualified to do business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
 (c) Authorization;
Enforcement. The Company has the requisite corporate authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and 

  
 -8- 








 
otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions
contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and no further consent or action is required to be obtained or taken, as the case may be, by the Company, its Board of Directors
or its stockholders. Each of the Transaction Documents has been (or upon delivery will be) duly executed by the Company and is, or when delivered in accordance with the terms hereof, will constitute, the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law. 
 (d) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby do not, and will not, (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or
other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or
cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party
or by which any property or asset of the Company or any Subsidiary is bound, or affected, except to the extent that such conflict, default, termination, amendment, acceleration or cancellation right would not reasonably be expected to have a
Material Adverse Effect, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or any Subsidiary is subject (including,
assuming the accuracy of the representations and warranties of the Investors set forth in Section 3.2 hereof, federal and state securities laws and regulations and the rules and regulations of any self-regulatory organization to which
the Company or its securities are subject, including all applicable Trading Markets), or by which any property or asset of the Company or any Subsidiary are bound or affected. 

(e) Filings, Consents, and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents other
than (i) the filing of the Certificate of Designation with the applicable authorities of the State of Delaware, (ii) the filing with the SEC of one or more Registration Statements in accordance with the requirements of this Agreement,
(iii) the filing of a Notice of Sale on Form D with the SEC, (iv) filings required by applicable state or blue sky securities laws, (v) the filing of any requisite notices and/or application(s) to the Trading Market for the issuance
and sale of the Securities, (vi) the filings or furnishings required in accordance with Section 4.4 of this Agreement, (vii) such filings and authorizations required in connection with Stockholder Approval, and (viii) the
Salus Consent. Except as otherwise explicitly contemplated Section 4.5 of this Agreement, no approval from the holders of outstanding shares of Common Stock is required by applicable law, the articles of incorporation or bylaws of the
Company or the rules of the Trading Market (that are effective on the Company) in connection with the Company’s issuance and sale of the Securities to the Investors, including, without limitation, the conversion of the Notes and the Preferred
Stock. 
 (f) The Securities. The Preferred Stock is duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents (whether under this Agreement or upon 

  
 -9- 








 
conversion of the Notes), will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and will not be subject to preemptive or similar rights of stockholders (other
than those imposed by the Investors). The Conversion Shares are duly authorized and, when issued following Conversion of the Preferred Stock, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and will not be
subject to preemptive or similar rights of stockholders (other than those imposed by the Investors). The Notes, when duly executed and delivered by the Company, will constitute the legal, valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms. 
 (g) Capitalization. The aggregate number of shares and type of all authorized,
issued and outstanding classes of capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) is set forth in
Schedule 3.1(g) hereto. All outstanding shares of capital stock are duly authorized, validly issued, fully paid and nonassessable and have been issued in compliance in all material respects with all applicable securities laws. Except as
disclosed in Schedule 3.1(g) hereto, the Company did not have outstanding at February 18, 2014 any other Convertible Securities, Options, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or
securities, rights or obligations convertible into or exercisable or exchangeable for, or entered into any agreement giving any Person any right to subscribe for or acquire, any shares of Common Stock, or securities or rights convertible or
exchangeable into shares of Common Stock, with or without consideration. Except as set forth on Schedule 3.1(g) hereto, and except for customary adjustments as a result of stock dividends, stock splits, combinations of shares,
reorganizations, recapitalizations, reclassifications or other similar events, there are no anti-dilution or price adjustment provisions contained in any security issued by the Company (or in any agreement providing rights to security holders) and
the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Investors upon conversion of the Preferred Stock or the Notes) and will not result in a right of
any holder of securities to adjust the exercise, conversion, exchange or reset price under such securities. To the Knowledge of the Company, except as disclosed in the SEC Reports and any Schedules 13D or 13G filed with the SEC pursuant to Rule
13d-1 of the Exchange Act by reporting persons or in Schedule 3.1(g) hereto, no Person or group of related Persons beneficially owns (as determined pursuant to Rule 13d-3 under the Exchange Act), or has the right to acquire, by agreement
with or by obligation binding upon the Company, beneficial ownership in excess of 5% of the outstanding Common Stock. 
 (h) SEC Reports;
Financial Statements. The Company has filed all reports required to be filed by it under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 12 months preceding the date hereof on a timely basis or
has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension and has filed all reports required to be filed by it under the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, for the two years preceding the date hereof. Such reports required to be filed by the Company under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, together with any materials filed
or furnished by the Company under the Exchange Act, whether or not any such reports were required being collectively referred to herein as the “SEC Reports” and, together with this Agreement and the Schedules to this Agreement, the
“Disclosure Materials.” As of their respective dates (or, if amended or superseded by a filing prior to the Closing Date, then on the date of such filing), the SEC Reports filed by the Company complied in all material respects with
the requirements of the Securities Act and the Exchange Act and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed (or, if amended or superseded by a filing prior to the Closing Date, then on the
date of such filing) by the Company, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The financial statements of the Company included in the 

  
 -10- 








 
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing (or, if
amended or superseded by a filing prior to the Closing Date, then on the date of such filing). Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis
during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements, the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP or may be
condensed or summary statements, and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. All material agreements to which the Company or any Subsidiary is a party or to which the property or assets of the Company or any Subsidiary
are subject are included as part of or identified in the SEC Reports, to the extent such agreements are required to be included or identified pursuant to the rules and regulations of the SEC. 

(i) Material Changes; Undisclosed Events, Liabilities or Developments; Solvency. Since the date of the latest audited financial
statements included within the SEC Reports, except as disclosed in the SEC Reports or in Schedule 3.1(i) hereto, (i) there has been no event, occurrence or development that, individually or in the aggregate, has had or that would result
in a Material Adverse Effect, (ii) the Company has not incurred any material liabilities other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company’s financial statements pursuant to GAAP or required to be disclosed in filings made with the SEC, (iii) the Company has not altered its method of accounting or changed its auditors, except as
disclosed in its SEC Reports, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders, in their capacities as such, or purchased, redeemed or made any agreements to purchase or redeem
any shares of its capital stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock-based plans. The Company has not taken any steps to seek protection
pursuant to any bankruptcy law nor does the Company have any Knowledge or reason to believe that its creditors intend to initiate involuntary bankruptcy proceedings or any Knowledge of any fact which would reasonably lead a creditor to do so. The
Company is not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at the applicable Closing, will not be Insolvent (as defined below). For purposes of this Section 3.1(i),
“Insolvent” means (1) the present fair saleable value of the Company’s assets is less than the amount required to pay the Company’s total Indebtedness, (2) the Company is unable to pay its debts and liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured, (3) the Company intends to incur or believes that it will incur debts that would be beyond its ability to pay as such debts mature or (4) the
Company has unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted. 

(j) No Disqualification Events. None of the Company and its predecessors and affiliated issuers, and the directors, executive officers
and other officers of the Company participating in the offering contemplated hereby, the beneficial owners of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, the promoters (as that
term is defined in Rule 405 under the Securities Act), if any, connected with the Company in any capacity at the time of sale, and the Persons, if any, that has been or will be paid (directly or indirectly) remuneration for solicitation of
purchasers in connection with the sale of Securities (each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act
(a “Disqualification Event”). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. There are no matters that would have triggered disqualification
under Rule 506(d)(1) under the Securities Act that occurred before September 23, 2013. 

  
 -11- 








 (k) No General Solicitation; Placement Agent’s Fees. Neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities. The Company shall
be responsible for the payment of any placement agent’s fees, financial advisory fees, or brokers’ commission (other than for persons engaged by any Investor or its investment advisor) relating to or arising out of the issuance of the
Securities pursuant to this Agreement. The Company shall pay, and hold each Investor harmless against, any liability, loss or expense (including, without limitation, reasonable attorney’s fees and out-of-pocket expenses) arising in connection
with any such claim for fees arising out of the issuance of the Securities pursuant to this Agreement. The Company acknowledges that it has engaged Janney Montgomery Scott LLC as its exclusive placement agent (the “Agent”) in
connection with the sale of the Securities. Other than the Agent, the Company has not engaged any placement agent or other agent in connection with the sale of the Securities. 

(l) Private Placement; Investment Company; U.S. Real Property Holding Corporation. Neither the Company nor any of its Affiliates nor,
to the Company’s Knowledge, any Person acting on the Company’s behalf has, directly or indirectly, at any time within the past six months, made any offer or sale of any security or solicitation of any offer to buy any security under
circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with the offer and sale by the Company of the Securities as contemplated hereby or
(ii) cause the offering of the Securities pursuant to the Transaction Documents to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder approval provisions, including, without
limitation, under the rules and regulations of any Trading Market. Assuming the accuracy of the representations and warranties of the Investors set forth in Section 3.2, no registration under the Securities Act is required for the offer
and sale of the Securities by the Company to the Investors as contemplated hereby. The sale and issuance of the Securities hereunder does not contravene the rules and regulations of any Trading Market on which the Common Stock is listed or quoted.
The Company is not required to be registered as, and is not an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company is not required to be registered as a United States real
property holding corporation within the meaning of the Foreign Investment in Real Property Tax Act of 1980. 
 (m) Form S-3
Eligibility. The Company is eligible to register the Conversion Shares for resale by the Investors using Form S-3 promulgated under the Securities Act. 

(n) Listing and Maintenance Requirements. Except as set forth on Schedule 3.1(n), the Company has not, in the twelve months
preceding the date hereof, received notice (written or oral) from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. Except as set forth on Schedule 3.1(n), the Company is in compliance with all such listing and maintenance requirements. 

(o) Registration Rights. Except as set forth on Schedule 3.1(o), the Company has not granted or agreed to grant to any Person
any rights (including “piggy-back” registration rights) to have any securities of the Company registered with the SEC or any other governmental authority that have not expired or been satisfied or waived. 

  
 -12- 








 (p) Application of Takeover Protections. The Company and its Board of Directors have
taken all necessary action, if any, to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s
charter documents or the laws of its state of incorporation that is or could become applicable to any of the Investors as a result of the Investors and the Company fulfilling their obligations or exercising their rights under the Transaction
Documents, including, without limitation, as a result of the Company’s issuance of the Securities (including Common Stock upon conversion) and the Investors’ ownership of the Securities (including Common Stock upon conversion). 

(q) Disclosure. The Company confirms that none of it or any of its officers or directors has provided any of the Investors (other than
Excluded Investors or investors who signed a confidentiality agreement with the Company) or their agents or counsel with any information that constitutes or might constitute material, nonpublic information (other than the existence and terms of the
issuance of Securities, as contemplated by this Agreement). The Company understands and confirms that each of the Investors (other than Excluded Investors or investors who signed a confidentiality agreement with the Company) will rely on the
foregoing representation in effecting transactions in securities of the Company. All disclosure provided by the Company to the Investors regarding the Company and the Subsidiaries, their businesses and the transactions contemplated hereby, including
the Schedules to this Agreement furnished by or on behalf of the Company, are true and correct in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. To the Company’s Knowledge, except for the transactions contemplated by this Agreement, no event or circumstance has occurred or information
exists with respect to the Company or any Subsidiary or their businesses, properties, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not
been so publicly announced or disclosed. The Company acknowledges and agrees that no Investor (other than Excluded Investors) makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those
set forth in the Transaction Documents. 
 (r) Acknowledgment Regarding Investors’ Purchase of Securities. The Company
acknowledges and agrees that each of the Investors, in their capacity as such, is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The
Company further acknowledges that no Investor, in its capacity as such, is acting as a financial advisor or fiduciary of the Company with respect to this Agreement and the transactions contemplated hereby and any advice given by any Investor (other
than Excluded Investors) or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Investors’ purchase of the Securities.
The Company further represents to each Investor that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its advisors and
representatives. 
 (s) Patents and Trademarks. The Company and each Subsidiary owns, or possesses adequate rights or licenses to
use, all material trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property
rights necessary to conduct their respective businesses as now conducted (“Intellectual Property Rights”). None of the Company’s or any Subsidiary’s Intellectual Property Rights have expired or terminated, except as
disclosed in the SEC Reports. Except as set forth in the SEC Reports, and except where such violations or infringements would not have, either individually or in the aggregate, a Material Adverse Effect, (a) there are no rights of third


  
 -13- 








 
parties to any such Intellectual Property Rights; (b) to the Company’s Knowledge, there is no infringement by third parties of any such Intellectual Property Rights; (c) there is
no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging the Company’s and/or its Subsidiaries’ rights in or to any such Intellectual Property Rights; (d) there is no pending
or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights; and (e) there is no pending or, to the Company’s Knowledge, threatened
action, suit, proceeding or claim by others that the Company and/or any Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others, and the Company is unaware of any other fact
which would form a reasonable basis for any such claim. 
 (t) Insurance. The Company and the Subsidiaries are each insured by
insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and/or the Subsidiaries are engaged. Neither the Company nor any Subsidiary has
been refused any insurance coverage sought or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost. 
 (u) Tax
Status. The Company and each Subsidiary (i) has made or filed all applicable United States federal and state income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, and shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision
reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim. None of the Company and the Subsidiaries is a Passive Foreign Investment Company within the meaning of Section 1297 of the Internal Revenue
Code of 1986, as amended. 
 (v) Absence of Litigation. There is no action, suit or proceeding by or before any court or any
governmental body or authority (y) which adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (z) against the Company or any Subsidiary, which action, suit or
proceeding would, if determined adversely, individually or in the aggregate, have a Material Adverse Effect. 
 (w) Employee
Relations. Neither the Company nor any Subsidiary is a party to any collective bargaining agreement or employs any member of a union. The Company’s relations with its employees are as disclosed in the SEC Reports, to the extent required.
Except as disclosed in the SEC Reports, no current executive officer of the Company or any Subsidiary has notified the Company or any Subsidiary that such officer intends to leave the Company or a Subsidiary, as applicable, or otherwise terminate
such officer’s employment with the Company or a Subsidiary, as applicable. To the Knowledge of the Company, no executive officer of the Company or any Subsidiary is in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement, non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer does not subject the Company or any Subsidiary to
any liability with respect to any of the foregoing matters. 

  
 -14- 








 (x) Labor Matters. The Company and each Subsidiary is in compliance in all material
respects with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where failure to be in compliance would not,
either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. 
 (y) Environmental Laws.
The Company and each Subsidiary (i) is in compliance in all material respects with any and all Environmental Laws (as hereinafter defined), (ii) has received all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses and (iii) is in compliance in all material respects with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and
(iii), the failure to so comply has had or would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term “Environmental Laws” means all federal, state, local or foreign laws relating to
pollution or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations issued, entered, promulgated or approved thereunder. 
 (z) Title to Assets. Except as set forth on Schedule
3.1(z), neither the Company nor any Subsidiary owns real property. The Company and each Subsidiary has good and marketable title in all personal property owned by them that is material to the business of the Company and each Subsidiary, in each
case free and clear of all Liens, except for the Salus Liens and Liens that do not, individually or in the aggregate, have or result in a Material Adverse Effect. Any real property and facilities held under lease by the Company or any Subsidiary is
held by it under valid, subsisting and enforceable leases of which the Company and each Subsidiary is in material compliance 
 (aa)
Sarbanes-Oxley Act. The Company is in compliance in all material respects with applicable requirements of the Sarbanes-Oxley Act of 2002 and applicable rules and regulations promulgated by the SEC thereunder. The Company maintains disclosure
controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act). 
 (bb) Foreign Corrupt
Practices. Neither the Company nor any Subsidiary nor, to the Knowledge of the Company, any director, officer, agent, employee or other Person acting on behalf of the Company or any Subsidiary has, in the course of its actions for, or on behalf
of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee or to any foreign or domestic political parties or campaigns from corporate funds; (iii) violated or is in violation in any material respect of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as
amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee. 

(cc) Money Laundering Laws. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any applicable governmental agency (collectively,
the 

  
 -15- 








 
“Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company and/or any
Subsidiary with respect to the Money Laundering Laws is pending or, to the Company’s Knowledge, threatened. 
 (dd) Internal
Accounting Control. Each of the Company and the Subsidiaries maintain effective internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. 

(ee) Compliance. Neither the Company nor any of its Subsidiaries (i) is in default under or in violation of (and no event has
occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any of its Subsidiaries under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been
waived), (ii) is in violation of any order of any court, arbitrator or governmental body having jurisdiction over the Company or its properties or assets, or (iii) is in violation of, or in receipt of written notice that it is in violation
of, any statute, rule or regulation of any governmental authority applicable to the Company, except in the case of (i) would not, individually or in the aggregate, have a Material Adverse Effect. 

(ff) Shell Company Status. The Company is not, and has not been for the last three years, an issuer identified in, or subject to, Rule
144(i) promulgated under the Securities Act. 
 (gg) Notices from Trading Market. Except for the letter referenced on Schedule
3.1(n) (a copy of which has been provided to the Investors), the Company has not received any other letters, correspondence or other notices furnished by the Trading Market(s) in the preceding twelve (12) months in connection with any
deficiencies, breaches or other violations of any rule or regulation applicable to such Trading Market(s). 
 3.2 Representations and
Warranties of the Investors. Each Investor hereby, as to itself only and for no other Investor, represents and warrants to the Company as follows: 

(a) Organization; Authority. Such Investor that is an entity is duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization with the requisite corporate, partnership or other power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The purchase by such Investor that is an entity of the Securities hereunder has been duly authorized by all necessary corporate, partnership or other action on the part of such Investor. Such Investor that is an individual
has the capacity to enter into this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by such Investor and constitutes the valid and binding obligation of such Investor, enforceable
against it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law. 
 (b) No Public Sale or Distribution. Such Investor is acquiring the Securities in the ordinary course of business for its own
account and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under the Securities Act or 

  
 -16- 








 
under an exemption from such registration and in compliance with applicable federal and state securities laws, and such Investor does not have a present arrangement to effect any distribution of
the Securities to or through any person or entity; provided, however, that by making the representations herein, such Investor does not agree to hold any of the Securities for any minimum or other specific term and reserves the right
to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act. 

(c) Investor Status. At the time such Investor was offered the Securities, it was, and at the date hereof it is, an “accredited
investor” as defined in Rule 501(a) under the Securities Act or a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Such Investor is not a registered broker dealer registered under Section 15(a)
of the Exchange Act, or a member of the Financial Industry Regulatory Authority, Inc. or an entity engaged in the business of being a broker dealer. Except as otherwise disclosed in writing to the Company on Exhibit A-2 (attached hereto) on
or prior to the date of this Agreement, such Investor is not affiliated with any broker dealer registered under Section 15(a) of the Exchange Act, or a member of the Financial Industry Regulatory Authority, Inc. or an entity engaged in the
business of being a broker dealer. 
 (d) General Solicitation. Such Investor is not purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media, broadcast over television or radio, disseminated over the Internet or presented at any seminar or any other general
solicitation or general advertisement. 
 (e) Experience of Such Investor. Such Investor, either alone or together with its
representatives has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of
such investment. Such Investor understands that it must bear the economic risk of this investment in the Securities indefinitely, and is able to bear such risk and is able to afford a complete loss of such investment. 

(f) Access to Information. Such Investor acknowledges that it has reviewed the Disclosure Materials and has been afforded: (i) the
opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the
Securities; (ii) access to information about the Company and each Subsidiary and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Neither such
inquiries nor any other investigation conducted by or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely on the truth, accuracy and completeness of the Disclosure Materials
and the Company’s representations and warranties contained in the Transaction Documents. Such Investor acknowledges receipt of copies of the SEC Reports. 

(g) No Governmental Review. Such Investor understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the
Securities. 

  
 -17- 








 (h) No Conflicts. The execution, delivery and performance by such Investor of this
Agreement and the consummation by such Investor of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of such Investor that is an entity or (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Investor is a party,
or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Investor, except in the case of clauses (ii) and (iii) above, for such that are
not material and do not otherwise affect the ability of such Investor to consummate the transactions contemplated hereby. 
 (i)
Prohibited Transactions; Confidentiality. No Investor, directly or indirectly, and no Person acting on behalf of or pursuant to any understanding with any Investor, has engaged in any purchases or sales in the securities, including
derivatives, of the Company (including, without limitation, any Short Sales (a “Transaction”) involving any of the Company’s securities) since the time that such Investor was first contacted by the Company, the Agent or any
other Person regarding the investment in the Company contemplated by the Transaction Documents. Such Investor covenants that neither it nor any Person acting on its behalf or pursuant to any understanding with such Investor will engage, directly or
indirectly, in any Transactions in the securities of the Company (including Short Sales) prior to the time the transactions contemplated by this Agreement are publicly disclosed. “Short Sales” include, without limitation, all
“short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, derivatives and similar
arrangements (including on a total return basis), and sales and other transactions through non-U.S. broker-dealers or foreign regulated brokers. 

(j) Restricted Securities. The Investors understand that the Securities are characterized as “restricted securities” under
the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the
Securities Act only in certain limited circumstances. 
 (k) Legends. It is understood that, except as provided in
Section 4.1(b) of this Agreement, certificates evidencing the Securities will bear the legend set forth in Section 4.1(b). 

(l) No Legal, Tax or Investment Advice. Such Investor understands that nothing in this Agreement or any other materials presented by or
on behalf of the Company to the Investor in connection with the purchase of the Securities constitutes legal, tax or investment advice. Such Investor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed
necessary or appropriate in connection with its purchase of the Securities. Such Investor understands that the Agent has acted solely as the agent of the Company in this placement of the Securities, and that the Agent makes no representation or
warranty with regard to the merits of this transaction or as to the accuracy of any information such Investor may have received in connection therewith. Such Investor acknowledges that he has not relied on any information or advice furnished by or
on behalf of the Agent. 

  
 -18- 








 ARTICLE IV 

OTHER AGREEMENTS OF THE PARTIES 

4.1 Transfer Restrictions. 

(a) Each of the Investors covenants that the Securities will only be disposed of pursuant to an effective registration statement under, and in
compliance with the requirements of, the Securities Act or pursuant to an available exemption from the registration requirements of the Securities Act, and in compliance with any applicable state securities laws. In connection with any transfer of
Securities other than pursuant to an effective registration statement or to the Company, the Company may require the transferor to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall
be reasonably satisfactory to the Company, to the effect that such transfer does not require registration under the Securities Act. Notwithstanding the foregoing, the Company hereby consents to and agrees to register on the books of the Company and
with its Transfer Agent, without any such legal opinion, except to the extent that the transfer agent requests such legal opinion, any transfer of Securities by an Investor to an Affiliate of such Investor, provided that the transferee certifies to
the Company that it is an “accredited investor” as defined in Rule 501(a) under the Securities Act. 
 (b) The Investors agree to
the imprinting, until no longer required by this Section 4.1(b), of the following legend on any certificate evidencing any of the Securities: 

THESE SECURITIES [AND THE SECURITIES ISSUABLE UPON CONVERSION OF THESE SECURITIES] HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE
SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. 

Certificates evidencing the Securities shall not be required to contain such legend or any other legend (i) following any sale of such Securities
pursuant to a registration statement (including the Registration Statement) covering the resale of such Securities that is effective under the Securities Act, (ii) following any sale of such Securities pursuant to Rule 144 if the holder
provides the Company with a legal opinion (and the documents upon which the legal opinion is based) reasonably acceptable to the Company to the effect that the Securities can be sold under Rule 144, (iii) if the Securities are eligible for sale
under Rule 144(b) without the requirement that adequate current public information exists with respect to the Company, or (iv) if the holder provides the Company with a legal opinion (and the documents upon which the legal opinion is based)
reasonably acceptable to the Company to the effect that the legend is not required under applicable requirements of the Securities Act (including controlling judicial interpretations and pronouncements issued by the Staff of the SEC). Following the
date that a legend may be removed pursuant to clauses (i) through (iv) above, the Company will no later than three Trading Days following the delivery by an Investor to the Company or the Transfer Agent (if delivery is made to the Transfer
Agent a copy shall be contemporaneously delivered to the Company) of (a) a legended certificate representing such Securities (and, in the case of a requested transfer, endorsed or with stock powers attached, signatures guaranteed, and otherwise
in form necessary to affect transfer), and (b) an opinion of counsel to the extent required by Section 4.1(a), deliver or 

  
 -19- 








 
cause to be delivered to such Investor a certificate representing such Securities that is free from all restrictive and other legends. The Company may not make any notation on its records or give
instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section. 
 If within three Trading Days
after receipt by the Company or its Transfer Agent of a legended certificate and the other documents as specified in clauses (a) and (b) of the paragraph immediately above, the Company shall fail to cause to be issued and delivered to such
Investor a certificate representing such Securities that is free from all restrictive and other legends, and if on or after such Trading Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Investor of shares of Common Stock that the Investor anticipated receiving from the Company without any restrictive legend (the “Covering Shares”), then the Company shall, (1) within three Trading
Days after the Investor’s request, pay cash to the Investor in an amount equal to the excess (if any) of the Investor’s total purchase price (including brokerage commissions, if any) for the Covering Shares, over the product of
(A) the number of Covering Shares, times (B) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including brokerage commissions, if any) and (2) deliver to the Investor the Securities
that would have been issued had the Company timely complied with its delivery obligations hereunder. 
 (c) The Company will not object to
and shall permit (except as prohibited by law) an Investor to pledge or grant a security interest in some or all of the Securities in connection with a bona fide margin agreement with a registered broker-dealer or grant a security interest in some
or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement, and if required under the terms of such
arrangement, the Company will not object to and shall permit (except as prohibited by law) such Investor to transfer pledged or secured Securities to the pledgees or secured parties. Except as required by law, such a pledge or transfer would not be
subject to approval of the Company, no legal opinion of the pledgee, secured party or pledgor shall be required in connection therewith (but such legal opinion shall be required in connection with a subsequent transfer or foreclosure following
default by the purchaser transferee of the pledge), and no notice shall be required of such pledge. Each Investor acknowledges that the Company shall not be responsible for any pledges relating to, or the grant of any security interest in, any of
the Securities or for any agreement, understanding or arrangement between any Investor and its pledgee or secured party. At the appropriate Investor’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or
secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of Selling Stockholders thereunder. Provided that the Company is in compliance with the terms of this Section 4.1(c), the Company’s indemnification obligations pursuant
to Section 6.7 shall not extend to any Proceeding or Losses arising out of or related to this Section 4.1(c). 
 4.2
Furnishing of Information. Until the date that any Investor owning Securities may sell all of them under Rule 144 of the Securities Act (or any successor provision) without volume limitations and without the requirement that there be adequate
current public information with regards to the Company, the Company covenants to use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act. The Company further covenants that it will take such further action as any holder of Securities may reasonably request to satisfy the provisions of this
Section 4.2. 
 4.3 Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that
no Affiliate thereof shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any 

  
 -20- 








 
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the
Securities Act of the sale of the Securities to the Investors or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market. 

4.4 Securities Laws Disclosure; Publicity. The Company shall, at or before 9:00 a.m., New York time, on or prior to the second Trading
Day following execution of this Agreement, issue a press release disclosing all material terms of the transactions contemplated hereby. On or prior to the second Trading Day following execution of this Agreement, the Company shall file a Current
Report on Form 8-K with the SEC (the “8-K Filing”) describing the terms of the transactions contemplated by the Transaction Documents and including as exhibits to such Current Report on Form 8-K the material Transaction Documents
(including this Agreement and the schedules hereto, and the names, and addresses of the Investors and the number of shares of Preferred Stock and the original principal amount of Notes respectively purchased), in the form required by the Exchange
Act. Thereafter, the Company shall timely file any filings and notices required by the SEC or applicable law with respect to the transactions contemplated hereby and provide copies thereof to the Investors promptly after filing. Except as herein
provided, neither the Company nor any Subsidiary shall publicly disclose the name of any Investor, or include the name of any Investor in any press release without the prior written consent of such Investor (which consent shall not be unreasonably
withheld or delayed), unless otherwise required by law, regulatory authority or Trading Market. Neither the Company nor any Subsidiary shall, nor shall any of their respective officers, directors, employees and agents, provide any Investor with any
material nonpublic information regarding the Company or any Subsidiary from and after the issuance of the above referenced press release without the express written consent of such Investor. 

4.5 Stockholder Approval. The Company shall use commercially reasonable efforts to provide each stockholder entitled to vote at the
next annual meeting or at a special meeting of stockholders of the Company (the “Stockholder Meeting”) a proxy statement soliciting each such stockholder’s affirmative vote at the Stockholder Meeting for approval of an
amendment (the “Charter Amendment”) to the certificate of incorporation of the Company to increase the number of authorized and unissued shares of Common Stock by an amount not less than the maximum number of Conversion Shares
(x) issuable as of the Closing Date upon conversion of the shares of Preferred Stock and (y) issuable thereafter upon conversion of shares of Preferred Stock issuable upon conversion of the Notes (such affirmative approval being referred
to herein as the “Stockholder Approval”, and the date such Stockholder Approval is obtained, the “Stockholder Approval Date”), and the Company shall use its commercially reasonable efforts to solicit its
stockholders’ approval of the Charter Amendment and shall cause the Board of Directors of the Company to recommend to the stockholders that they approve the Charter Amendment. The Company shall use its commercially reasonable efforts to cause
the Stockholder Meeting to be promptly called and held not later than the one hundred and twentieth (120th) day following the Closing Date. Each Investor agrees to vote all shares of Common
Stock it beneficially owns on the record date applicable to the Stockholder Meeting that are eligible to vote in favor of the Charter Amendment. 

4.6 Use of Proceeds. The Company will use the net proceeds from the sale of the Preferred Stock to repay the outstanding amounts under
its existing Credit Agreement and for working capital and general corporate purposes. Until such time as all of the Notes have been repaid in full (or have been automatically converted, in full, in accordance with their terms), the proceeds from the
sale of the Notes will be placed in an interest bearing account with JPMorgan Chase Bank, N.A. and the Company shall not use or withdraw such proceeds or grant any Person (other than the Lead Investor, in its capacity as collateral agent for the
Investors) any right, title or interest in or to the proceeds, which proceeds shall secure the obligations of the Company under the Notes. After such date as all of the Notes have been automatically converted, in full, in accordance with their
terms, the Company will use the net proceeds from the sale of the Notes to repay the outstanding amounts under the existing Credit Agreement and for working capital and general corporate purposes. 

  
 -21- 








 4.7 Register. The Company shall maintain at its principal executive offices (or such other
office or agency of the Company as it may designate by notice to each holder of Securities), a register for the Preferred Stock and the Notes in which the Company shall record the name and address of the Person in whose name the Preferred Stock and
the Notes have been issued (including the name and address of each transferee), the principal amount of the Notes, the aggregate number of shares of Preferred Stock held by such Person and the number of Conversion Shares issuable upon conversion of
shares of Preferred Stock held by such Person. The Company shall keep the register open and available at all times during business hours for inspection of any Investor or its legal representatives. 

4.8 Salus Consent. The Company shall take all action required to cause the Salus Consent to become effective at or prior to the
Closing. 
 4.9 Williams Act Filings. Within two (2) Business Days following the Closing Date, the Lead Investor shall
file an amendment to its Schedule 13G converting such Schedule 13G to a Schedule 13D, report the entry into this Agreement and its obligations hereunder and append or incorporate by reference this Agreement as an exhibit thereto. The Lead Investor
shall provide to the Company a reasonable opportunity to review and comment on such amendment in advance of filing, and shall consider in good faith the reasonable and timely comments of the Company. 

4.10 Listing of Common Stock; Trading Market Violations. 

(a) The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which
it is currently listed. 
 (b) Notwithstanding Section 4.10(a), if by July 30, 2014, the Company has not met the Nasdaq
listing requirements relating to minimum bid price (which is the subject to the letter referred to in Schedule 3.1(n)), then the Company will use its best efforts to effect, no later than November 27, 2014, a reverse stock split to regain
compliance with the Nasdaq listing requirements relating to minimum bid price. 
 4.11 Board Nominations. 

(a) On or prior to the Closing Date, the Board of Directors of the Company shall take all necessary action to: (1) increase the size of
the Board by three (3) directors to a total of eight (8) directors; and (2) subject to the last sentence of this Section 4.11(a), appoint each of (A)(i) Seth Cohen and (ii) an individual designated by the Lead
Investor who is not an employee of the Lead Investor or its Affiliates and is approved by the Chief Executive Officer of the Company (collectively the “Lead Investor Directors”) and (B) an individual designated by Flatbush (the
“Flatbush Director”), in each case effective as of the Closing Date. The Company and the Lead Investor intend that the individual appointed to the Board pursuant to subclause (a)(2)(A)(ii) above will be an individual who possesses
information technology, internet and social media marketing or other experience relevant to the Company’s present or presently anticipated operations. Each of the Lead Investor Directors and the Flatbush Director appointed pursuant to this
Section 4.11(a) shall, subject to Section 4.11(e), continue to hold office until the next annual or special meeting of the stockholders at which the election of directors is to be considered, subject, however, to prior death,
resignation, retirement, disqualification or termination of term of office as provided in Section 4.11(c). As long as a Lead Investor Director is on the Board, the Lead Investor agrees to vote all eligible shares of Common Stock or
Preferred Stock it beneficially owns for the election of the Flatbush Director at each meeting of the Company’s stockholders at which the election of the Flatbush Director is to be considered, and as long as a Flatbush


  
 -22- 








 
Director is on the Board, Flatbush agrees to vote all eligible shares of Common Stock or Preferred Stock it beneficially owns for the election of each Lead Investor Director at each meeting of
the Company’s stockholders at which the election of a Lead Investor Director is to be considered. Each of the Lead Investor Directors and the Flatbush Director, prior to being appointed or nominated for election to the Board of Directors of the
Company, shall consent to, and undergo a background check, the results of which shall be reasonably acceptable to both the Lead Investor, Flatbush and the Company, and execute and deliver to the Company such agreements, questionnaires and other
documents as the Company customarily requires from new nominees for directorships, copies of which have previously been provided to the Lead Investor and Flatbush. 

(b) At each meeting of the Company’s stockholders at which the election of directors is to be considered, the Board and the Nominating and
Corporate Governance Committee of the Board shall, subject to Section 4.11(e), nominate each of the Lead Investor Directors and the Flatbush Director designated by the Lead Investor and Flatbush, respectively, for election to the Board.
The Company agrees to recommend that the Company’s stockholders vote, and shall solicit proxies, in favor of the election of each of the Lead Investor Directors and the Flatbush Director at such meeting and otherwise support each of the Lead
Investor Directors and the Flatbush Director for election in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees. 

(c) In the event of a vacancy on the Board resulting from the death, disqualification, resignation, retirement or termination of term of office
of a Lead Investor Director or the Flatbush Director, then, subject to Section 4.11(e), the Board and the Nominating and Corporate Governance Committee of the Board shall fill such vacancy with a Person nominated by the Lead
Investor or Flatbush, as the case may be, to serve until the next annual or special meeting of the stockholders at which the election of directors is to be considered (and at such meeting, such Person, or another Person designated by the Lead
Investor or Flatbush, as the case may be, will be elected to the Board in the manner set forth in Section 4.11(b)). To the extent the death, disqualification, resignation, retirement or termination is of a Lead Investor Director elected
pursuant to Section 4.11(a)(2)(A)(ii), the vacancy shall be filled by a individual meeting the requirements of Section 4.11(a)(2)(A)(ii) and the last sentence of Section 4.11(a). 

(d) By the Closing Date, each of the Lead Investor Directors and the Flatbush Director shall review the Company’s certificate of
incorporation and bylaws, as well as the Code of Business Conduct and Policy Regarding Shareholder Communications with the Board of Directors and agree to abide by the provisions thereof during their service as directors of the Company. Each of the
Lead Investor and Flatbush acknowledges that United States and other applicable securities laws may prohibit any Persons who have material, nonpublic information concerning the Company from purchasing or selling securities of the Company or from
communicating such information to any Person under circumstances in which it is reasonably foreseeable that such Person is likely to purchase or sell such securities in reliance upon such information. 

(e) Notwithstanding the foregoing, the right of each of the Lead Investor and Flatbush to nominate the Lead Investor Directors and the Flatbush
Director, as the case may be, shall at all times be subject to applicable rules and published guidance of the Nasdaq Stock Market, including, but not limited to, Nasdaq Rule 5640 (or any successor rule). The Lead Investor will continue to have the
right to nominate two members of the Board of Directors of the Company only for so long as it is permitted do so under Nasdaq Rule 5640. Once the Lead Investor’s beneficial ownership (determined in accordance with Rule 13D-3 under the Exchange
Act) decreases to an amount that would only allow the Lead Investor to nominate one director under Nasdaq Rule 5640, it will only have the right to nominate one director and the Lead Investor Director who is not Seth Cohen will resign
contemporaneously therewith. Flatbush will continue to have the right to nominate one member of the Board of Directors of the Company only for so 

  
 -23- 








 
long as it is permitted do so under Nasdaq Rule 5640. Each of the Lead Investor’s and Flatbush’s right to nominate directors shall cease once Lead Investor’s and Flatbush’s,
as the case may be, beneficial ownership (determined in accordance with Rule 13D-3 under the Exchange Act) is less than 5% and the remaining Lead Investor Director and the Flatbush Director, as the case may be, will resign contemporaneously
therewith. 
 (f) For as long as Flatbush has the right to designate a Person to be a director pursuant to Section 4.11, Flatbush
may also designate a Person to act as an observer to the Board of Directors, and such Person shall have the right to receive notice of and to act as an observer in all meetings of the Board of Directors and receive copies of all information
furnished by the Company to members of the Board of Directors. 
 (g) In the event that any Lead Investor Director or the Flatbush Director
nominated by the Lead Investor and Flatbush, respectively, hereunder fails to be elected to the Board of Directors of the Company at any meeting of the Company’s stockholders at which the election of directors is to be considered, the Company
shall permit each such Lead Investor Director or the Flatbush Director, as the case may be, who so fails to be elected to act as an observer to the Board of Directors, and such Person shall have the right to receive notice of and to act as an
observer in all meetings of the Board of Directors and receive copies of all information furnished by the Company to members of the Board of Directors until such Person (or its successor designated by the Lead Investor or the Flatbush Director, as
the case may be) is (re)elected to the Board of Directors. 
 4.12 Standstill. 

(a) Except as specifically permitted or contemplated by this Agreement, so long as a Lead Investor Director is a member of the Board of
Directors of the Company, the Lead Investor agrees that it will not, and it will cause each of its Affiliates not to, directly or indirectly: 

(i) Acquire, offer to acquire or agree to acquire, alone or in concert with any other individual or entity, by purchase, tender offer,
exchange offer, agreement or business combination or any other manner, beneficial ownership of any additional securities of the Company; provided, however, that (i) this restriction shall not apply to any securities received by the Lead
Investor pursuant to this Agreement, on conversion of the Notes or Preferred Stock, upon exercise of any preemptive rights, or pursuant to stock splits, dividends, reorganizations, reclassifications, recapitalizations, or similar corporate actions,
and (ii) nothing herein shall be construed to prevent the Lead Investor from at any time acquiring, offering or agree to acquire any additional securities of the Company to the extent that, following such acquisition, the Lead Investor will not
beneficially own (determined in accordance with Rule 13D-3 under the Exchange Act) in excess of 19.99% of the outstanding shares of Common Stock. 

(ii) Submit any stockholder proposal (pursuant to Rule 14a-8 promulgated by the SEC under the Exchange Act or otherwise) or any notice of
nomination or other business for consideration at a stockholder meeting or written consent in lieu thereof, or nominate any candidate for election to the Board or oppose the directors nominated by the Board, other than as expressly permitted by this
Agreement. 
 (iii) Other than any Group formed pursuant to Section 4.11(a), form, join in or in any other way participate in a
“partnership, limited partnership, syndicate or other group” within the meaning of Section 13(d)(3) of the Exchange Act (a “Group”) with respect to the Common Stock or Preferred Stock or deposit any shares of Common
Stock or Preferred Stock in a voting trust or similar arrangement or subject any shares of Common Stock to any voting agreement or pooling arrangement, solicit proxies or written consents of stockholders, or otherwise conduct any nonbinding
referendum with 

  
 -24- 








 
respect to Common Stock or Preferred Stock, or make, or in any way participate in, any “solicitation” of any “proxy” within the meaning of Rule 14a-1 promulgated by the SEC
under the Exchange Act to vote, or advise, encourage or influence any Person with respect to voting, any shares of Common Stock or Preferred Stock with respect to any matter, or become a “participant” in any contested
“solicitation” for the election of directors with respect to the Company (as such terms are defined or used under the Exchange Act and the rules promulgated by the SEC thereunder), other than a “solicitation” or acting as a
“participant” in support of all of the nominees of the Board at any meeting of the Company’s stockholders at which the election of directors is to be considered. 

(iv) Seek, in any capacity other than as a member of the Board, to call, or to request the calling of, a special meeting of the stockholders
of the Company, or seek to make, or make, a stockholder proposal at any meeting of the stockholders of the Company or make a request for a list of the Company’s stockholders (or otherwise induce, encourage or assist any other Person to initiate
or pursue such a proposal or request) or otherwise acting alone, or in concert with others, seek to control or influence the governance or policies of the Company, except as a member of the Board or otherwise as expressly permitted or contemplated
by this Agreement; provided, however, that the foregoing shall not prohibit the Lead Investor or its Affiliates from (A) making statements contemplated by Rule 14a-1(l)(2)(iv)(B) under the Exchange Act to the extent applicable to holders of
interests in the Lead Investor, and by Rule 14a-1(l)(2)(iv)(C) to the extent relating to the foregoing statements), (B) engaging in discussions with other stockholders (so long as the Lead Investor or its Affiliates does not initiate such
discussions and such discussions are in compliance with the terms and conditions hereof) with respect to any transaction that has been publicly announced by the Company involving a recapitalization of the Company, or a material acquisition,
disposition or sale of assets or a business by the Company, or a change of control of the Company, (C) voting as it sees fit on any matter other than with respect to the election of directors as provided in Section 4.10(f), or
(D) privately contacting the Board or management of the Company to express its views regarding Company matters so long as such contact or communication (1) will not require or result in an amendment to or other public disclosure in
connection with the Schedule 13G or Schedule 13D filed by the Lead Investor or any of its Affiliates with respect to the Company and (2) does not unduly interfere with management’s duties and responsibilities or the day-to-day operation of
the Company’s business and affairs. 
 (v) Effect or seek to effect, in any capacity other than as a member of the Board (including,
without limitation, by entering into any discussions, negotiations, agreements or understandings with any third person), offer or propose (whether publicly or otherwise) to effect, or cause or participate in, or in any way assist or facilitate any
other person to effect or seek, offer or propose (whether publicly or otherwise) to effect or cause or participate in (A) any acquisition of any material assets or businesses of the Company or any of its subsidiaries, or any sale, lease,
exchange, pledge, mortgage, or transfer thereof (including through any arrangement having substantially the same economic or other effect as a sale, lease, exchange, pledge, mortgage, or transfer or assets), (B) any tender offer or exchange
offer, merger, acquisition or other business combination involving the Company or any of its subsidiaries, or (C) any recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with respect to the Company or
any of its subsidiaries. 
 (vi) Publicly disclose, or cause or facilitate the public disclosure (including, without limitation, the filing
of any document or report with the SEC or any other governmental agency or any disclosure to any journalist, member of the media or securities analyst) of, any intent, purpose, plan or proposal to obtain any waiver, or consent under, or any
amendment of, any of the provisions of Sections 4.10 or 4.11 of this Agreement, or otherwise seek (in any manner that would require public disclosure by any of the members of the Lead Investor or its Affiliates) to obtain any waiver, consent under,
or amendment of, any provision of this Agreement. 

  
 -25- 








 (vii) Publicly disparage any member of the Board or management of the Company; provided that
this provision shall not apply to compelled testimony, either by legal process, subpoena or otherwise, or to communications that are required by an applicable legal obligation and are subject to contractual provisions providing for confidential
disclosure. 
 (viii) Enter into any arrangements, understandings or agreements (whether written or oral) with, or advise, finance, cause,
solicit, induce, assist or encourage, any other Person that engages, or offers or proposes to engage, in any of the foregoing. 

(ix) Take, cause, solicit, induce or assist others to take any action inconsistent with any of the foregoing. 

(b) Except as specifically permitted or contemplated by this Agreement, so long as a Flatbush Director is a member of the Board of Directors of
the Company, Flatbush agrees that it will not, and it will cause each of its Affiliates not to, directly or indirectly: 
 (i) Acquire,
offer to acquire or agree to acquire, alone or in concert with any other individual or entity, by purchase, tender offer, exchange offer, agreement or business combination or any other manner, beneficial ownership of any additional securities of the
Company; provided, however, that (i) this restriction shall not apply to any securities received by the Flatbush pursuant to this Agreement, on conversion of the Notes or Preferred Stock, upon exercise of any preemptive rights, or pursuant to
stock splits, dividends, reorganizations, reclassifications, recapitalizations, or similar corporate actions and (ii) nothing herein shall be construed to prevent Flatbush from at any time acquiring, offering or agree to acquire any additional
securities of the Company to the extent that, following such acquisition, Flatbush will not beneficially own (determined in accordance with Rule 13D-3 under the Exchange Act) in excess of 19.99% of the outstanding shares of Common Stock. 

(ii) Submit any stockholder proposal (pursuant to Rule 14a-8 promulgated by the SEC under the Exchange Act or otherwise) or any notice of
nomination or other business for consideration at a stockholder meeting or written consent in lieu thereof, or nominate any candidate for election to the Board or oppose the directors nominated by the Board, other than as expressly permitted by this
Agreement. 
 (iii) Other than any Group formed pursuant to Section 4.11(a), form, join in or in any other way participate in a
Group with respect to the Common Stock or Preferred Stock or deposit any shares of Common Stock or Preferred Stock in a voting trust or similar arrangement or subject any shares of Common Stock to any voting agreement or pooling arrangement, solicit
proxies or written consents of stockholders, or otherwise conduct any nonbinding referendum with respect to Common Stock or Preferred Stock, or make, or in any way participate in, any “solicitation” of any “proxy” within the
meaning of Rule 14a-1 promulgated by the SEC under the Exchange Act to vote, or advise, encourage or influence any Person with respect to voting, any shares of Common Stock or Preferred Stock with respect to any matter, or become a
“participant” in any contested “solicitation” for the election of directors with respect to the Company (as such terms are defined or used under the Exchange Act and the rules promulgated by the SEC thereunder), other than a
“solicitation” or acting as a “participant” in support of all of the nominees of the Board at any meeting of the Company’s stockholders at which the election of directors is to be considered. 

(iv) Seek, in any capacity other than as a member of the Board, to call, or to request the calling of, a special meeting of the stockholders
of the Company, or seek to make, or make, a stockholder proposal at any meeting of the stockholders of the Company or make a request for a list of the Company’s stockholders (or otherwise induce, encourage or assist any other Person to initiate
or pursue 

  
 -26- 








 
such a proposal or request) or otherwise acting alone, or in concert with others, seek to control or influence the governance or policies of the Company, except as a member of the Board or
otherwise as expressly permitted or contemplated by this Agreement; provided, however, that the foregoing shall not prohibit Flatbush or its Affiliates from (A) making statements contemplated by Rule 14a-1(l)(2)(iv)(B) under the Exchange Act to
the extent applicable to holders of interests in Flatbush, and by Rule 14a-1(l)(2)(iv)(C) to the extent relating to the foregoing statements), (B) engaging in discussions with other stockholders (so long as Flatbush or its Affiliates does not
initiate such discussions and such discussions are in compliance with the terms and conditions hereof) with respect to any transaction that has been publicly announced by the Company involving a recapitalization of the Company, or a material
acquisition, disposition or sale of assets or a business by the Company, or a change of control of the Company, (C) voting as it sees fit on any matter other than with respect to the election of directors as provided in Section 4.10(f), or
(D) privately contacting the Board or management of the Company to express its views regarding Company matters so long as such contact or communication (1) will not require or result in an amendment to or other public disclosure in
connection with the Schedule 13G or Schedule 13D filed by Flatbush or any of its Affiliates with respect to the Company and (2) does not unduly interfere with management’s duties and responsibilities or the day-to-day operation of the
Company’s business and affair. 
 (v) Effect or seek to effect, in any capacity other than as a member of the Board (including, without
limitation, by entering into any discussions, negotiations, agreements or understandings with any third person), offer or propose (whether publicly or otherwise) to effect, or cause or participate in, or in any way assist or facilitate any other
person to effect or seek, offer or propose (whether publicly or otherwise) to effect or cause or participate in (A) any acquisition of any material assets or businesses of the Company or any of its subsidiaries, or any sale, lease, exchange,
pledge, mortgage, or transfer thereof (including through any arrangement having substantially the same economic or other effect as a sale, lease, exchange, pledge, mortgage, or transfer or assets), (B) any tender offer or exchange offer,
merger, acquisition or other business combination involving the Company or any of its subsidiaries, or (C) any recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with respect to the Company or any of
its subsidiaries. 
 (vi) Publicly disclose, or cause or facilitate the public disclosure (including, without limitation, the filing of any
document or report with the SEC or any other governmental agency or any disclosure to any journalist, member of the media or securities analyst) of, any intent, purpose, plan or proposal to obtain any waiver, or consent under, or any amendment of,
any of the provisions of Sections 4.10 or 4.11 of this Agreement, or otherwise seek (in any manner that would require public disclosure by any of the members of Flatbush or its Affiliates) to obtain any waiver, consent under, or amendment of, any
provision of this Agreement. 
 (vii) Publicly disparage any member of the Board or management of the Company; provided that this provision
shall not apply to compelled testimony, either by legal process, subpoena or otherwise, or to communications that are required by an applicable legal obligation and are subject to contractual provisions providing for confidential disclosure. 

(viii) Enter into any arrangements, understandings or agreements (whether written or oral) with, or advise, finance, cause, solicit, induce,
assist or encourage, any other Person that engages, or offers or proposes to engage, in any of the foregoing. 
 (ix) Take, cause, solicit,
induce or assist others to take any action inconsistent with any of the foregoing. 
 Notwithstanding the foregoing, the provisions of this Section
4.12 shall terminate on the date that (A) the Company publicly announces that it plans to pursue a tender offer, merger, sale of all or substantially all of the 

  
 -27- 








 
Company’s assets or any similar transaction involving the Company and its Subsidiaries taken as a whole (a “Buyout Transaction”); (B) the Board of Directors
approves, recommends or accepts a Buyout Transaction proposed by any Person or Group or (C) any Person or Group, other than the Lead Investor or Flatbush or their respective Affiliates or a Group of which the Lead Investor, Flatbush or
their respective Affiliates are a part, acquires beneficial ownership measured by voting power of more than 20% of the issued and outstanding Common Stock. In addition, any waiver by the Company of the provisions of this
Section 4.12 with respect to the Lead Investor shall be deemed an identical waiver with respect to Flatbush, and any waiver by the Company of the provisions of this Section 4.12 with respect to Flatbush shall be deemed an identical
waiver with respect to the Lead Investor. In addition, each of the Company, the Lead Investor and Flatbush agree and acknowledge that each of Lead Investor and Flatbush makes investments in, and has investments made in them by, companies
and other Persons in the ordinary course of its business and, as a result of such investments, such companies and other Persons may be deemed to be an Affiliates of such Purchaser or otherwise associated with such Purchaser, that certain of such
companies and Persons that may be deemed to be affiliated or associated with such Purchaser represent large institutions over which such Purchaser has no control or investment discretion and that the terms of
this Section 4.12 shall not apply to such companies or Persons. 
 4.13 Preemptive Rights. If at any time the
Company grants, issues or sells any Common Stock or any other Convertible Securities or Options to any Person (the “Purchase Rights”), then each Investor shall be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which shall result in such Investor retaining the same proportionate share of the Common Stock on a fully-diluted as-converted basis as prior to the grant, issuance or sale; provided that this Section 4.13
shall not apply to (a) the issuance of shares of Common Stock or Options to employees, consultants, officers, or directors of the Company pursuant to any stock or option plan or other arrangement duly adopted for such purpose by a majority of
the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose or (b) any offering and sale of the Company’s securities registered under the Securities
Act. 
 4.14 Restrictive Covenants. 

(a) Except as specifically permitted or contemplated by this Agreement, so long as the Lead Investor or Flatbush, as the case may be,
beneficially owns (determined in accordance with Rule 13D-3 under the Exchange Act) at least ten percent (10%) of the Common Stock (on an as-converted basis), the Company shall not, without the prior written consent of the Lead Investor and/or
Flatbush, as the case may be, take any of the following actions or engage in any of the following transactions: 
 (i) if all accrued
dividends on the Preferred Stock shall not have been paid in full, declare or pay dividends on, or repurchase or redeem, any shares of capital stock of the Company; except for repurchases or deemed repurchases in connection with net or cashless
exercise of Options and issuances under the Rights Agreement. 
 (ii) authorize, create or issue any class or series of capital stock of
the Company that ranks senior to or in parity with the Preferred Stock, including any additional Preferred Stock; 
 (iii) commence any
voluntary liquidation, bankruptcy, dissolution, recapitalization, reorganization or assignment to their creditors, or any similar transaction; 

(iv) create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, other than indebtedness under or as
permitted under the Credit Agreement and the Letter of Credit Agreement and further any amendment to such agreements which has the effect of restricting the payment of dividends on the Series B Preferred Stock; 

  
 -28- 








 (v) create, incur, assume or suffer to exist liens on any of its present or future property or
assets, other than liens under or as permitted under the Credit Agreement and the Letter of Credit Agreement; 
 (vi) increase the size of
the number of directors comprising the entire board of directors to more than 9 members; 
 (vii) amend, alter or repeal of any provision
of the certificate of incorporation or bylaws of the Company that materially and adversely affects the rights, preferences, privileges or voting powers of the Preferred Stock; provided, that the Charter Amendment, as well as an incremental
increase in the number of authorized shares of Common Stock to be used, inter alia, in respect of the Company’s present or future compensation plans, shall not require the consent of the Lead Investor; 

(viii) enter into any transaction (other than compensation arrangements with directors, officers and employees in the ordinary course of
business) with any person or entity whose beneficial ownership (determined in accordance with Rule 13D-3 under the Exchange Act) of the Company’s voting securities is at least 10% (each, a “10% Holder”) or a director of the
Company, except for the performance of obligations pursuant to the terms of any agreement to which the Company is a party as of the Closing, as such agreement may be amended or replaced from time to time; provided, any such amendment or
replacement will be permitted (a) to the extent that its terms are not more disadvantageous to the Company than the terms of the agreement in effect as of the Closing (unless such amendment or replacement is permitted pursuant to subclause
(b)), or (b) unless the terms of such transaction are similar to the terms that could be obtained through arms-length negotiations with parties that are not 10% Holders or directors of the Company. The Company acknowledges that any affiliate
transaction not subject to this Section 4.14(viii) must be submitted to and approved by the Board; or 
 (ix) remove or replace Tracy
Gardner as chief executive officer of the Company for reasons other than cause, resignation, death or disability. 
 (b) Except as
specifically permitted or contemplated by this Agreement, so long as the Lead Investor or Flatbush, as the case may be, beneficially owns (determined in accordance with Rule 13D-3 under the Exchange) at least fifteen percent (15%) or more of
the Common Stock (on an as-converted basis), the Company shall not, without the prior written consent of the Lead Investor and/or Flatbush, as the case may be, take any of the following actions or engage in any of the following transactions: 

(i) a sale of all or substantially all of the assets of the Company; 

(ii) a merger or consolidation of the Company; 

(iii) a recapitalization or reorganization of the Company involving consideration in excess of $25,000,000; or 

(iv) agree to any of the foregoing; 

provided, that if all the members of the Board of Directors of the Company other than the Lead Investor Directors and the Flatbush Director approve any
of the foregoing actions, the Lead Investor’s or Flatbush’s prior written consent shall not be required. 
 4.15 Control
Agreement. The Company shall abide by the terms of the Blocked Account Control Agreement, dated as of February 18, 2014, by and among the Company, the Lead Investor, and JPMorgan Chase Bank, N.A. 

  
 -29- 








 ARTICLE V 

CONDITIONS 
 5.1 Conditions
Precedent to the Obligations of the Investors. The obligation of each Investor to acquire the Securities at the Closing is subject to the satisfaction or waiver by such Investor, at or before the Closing, of each of the following conditions:

 (a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct
in all material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the date when made and as of the
Closing as though made on and as of such date (except for representations and warranties that speak as of a specific date, which shall be true and correct as of such specific date); and 

(b) Performance. The Company and each other Investor shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing. 

(c) Salus Consent. The Salus Consent shall have been received. 

(d) Rights Agreement Amendment. The Company and AST shall have entered into an amendment to the Rights Agreement to permit each of the
Lead Investor and Flatbush to purchase the Securities under the Transaction Documents and convert the Preferred Stock into Common Stock in accordance with its terms; provided that following the Closing Date, none of the Lead Investor or Flatbush
shall beneficially own (determined in accordance with Rule 13D-3 under the Exchange Act) more than 19.99% of the outstanding shares of Common Stock. 

(e) Participation by Management. Tracy Gardner shall have made an aggregate investment in the Company pursuant to this Agreement equal
to at least $200,000. 
 (f) Minimum Proceeds. The Company shall have received minimum proceeds under this Agreement equal to at
least $25,000,000 (net after all fees and expenses incurred in connection with this transaction). 
 (g) No Suspensions of Trading in
Common Stock; Listing. Trading in the Common Stock shall not have been suspended by the SEC or any Trading Market (except for any suspensions of trading of not more than one Trading Day solely to permit dissemination of material information
regarding the Company) at any time since the date of execution of this Agreement, and the Common Stock shall have been at all times since such date listed for trading on a Trading Market. 

(h) Absence of Litigation. No action, suit or proceeding by or before any court or any governmental body or authority, against the
Company or any Subsidiary or pertaining to the transactions contemplated by this Agreement or their consummation, shall have been instituted on or before the Closing Date, which action, suit or proceeding would, if determined adversely, have a
Material Adverse Effect. 
 (i) Company Deliverables. The Company shall have delivered the deliverables specified in
Section 2.2(a) of this Agreement. 

  
 -30- 








 5.2 Conditions Precedent to the Obligations of the Company. The obligation of the Company
to sell the Securities at the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions: 

(a) Representations and Warranties. The representations and warranties of the Investors contained herein shall be true and correct in
all material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the date when made and as of the Closing
Date as though made on and as of such date (except for representations and warranties that speak as of a specific date, which shall be true and correct as of such specific date); and 

(b) Performance. The Investors shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Investors at or prior to the Closing. 

(c) Investor Deliverables. The Investors shall have delivered the deliverables specified in Section 2.2(b) of this
Agreement. 
 ARTICLE VI 

REGISTRATION RIGHTS 
 6.1
Required Registration Statement. 
 (a) As promptly as possible, and in any event on or prior to the Filing Date, the Company shall
prepare and file with the SEC a Registration Statement covering the resale of all Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415. The Registration Statement shall be on Form S-3 (except if the Company is
not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance with the Securities Act and the Exchange Act) and shall contain (except if otherwise
directed by the Investors or requested by the SEC) the “Plan of Distribution” in substantially the form attached hereto as Exhibit C. 

(b) The Company shall use its commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC as
promptly as possible after the filing thereof, but in any event prior to the Required Effectiveness Date, and shall use its commercially reasonable efforts to keep the Registration Statement continuously effective under the Securities Act until the
date that all Conversion Shares covered by such Registration Statement have been sold or can be sold publicly under Rule 144 without volume limitations by the holders of the Registrable Securities (the “Effectiveness Period”). Upon
notification by the SEC that a Registration Statement will not be reviewed or is no longer subject to further review and comments, the Company shall request acceleration of such Registration Statement within five (5) Trading Days after receipt
of such notice and request that it become effective no later than 4:00 p.m. New York City time on the Effective Date and file a prospectus supplement for any Registration Statement, whether or not required under Rule 424 (or otherwise), by 9:00 a.m.
New York City time the day after the Effective Date. 
 (c) If the Company receives SEC Comments to a Registration Statement filed pursuant
to Section 6.1(a), the Company shall be obligated to use its commercially reasonable efforts to advocate with the 

  
 -31- 








 
SEC for the registration of all of the Registrable Securities requested to be included in the Registration Statement in accordance with applicable SEC guidance. If it is determined by the Company
that all of the Registrable Securities requested to be included in a Registration Statement cannot be included due to the SEC Comments, then the Company shall use its commercially reasonable efforts to prepare and file as expeditiously as
practicable, such number of additional Registration Statements as may be necessary in order to ensure that all Registrable Securities are covered by an existing and effective Registration Statement. Any cutbacks of Registrable Securities from a
Registration Statement filed pursuant to Section 6.1(a), due to SEC Comments shall be applied to the Investors pro rata in accordance with the number of such Registrable Securities sought to be included in such Registration Statement by
reference to the number of such Purchaser’s Registrable Securities relative to all outstanding Registrable Securities. 
 (d) The
Company shall notify the Investors in writing promptly (and in any event within two Trading Days) after receiving notification from the SEC that the Registration Statement has been declared effective. 

(e) Should an Event (as defined below) occur, then, upon the occurrence of such Event, and on every monthly anniversary thereof until the
applicable Event is cured, the Company shall pay to each Investor an amount in cash, as liquidated damages and not as a penalty, equal to one percent (1.0%) of the purchase price paid by such Investor for the Securities purchased under this
Agreement; provided, however, that the total amount of payments pursuant to this Section 6.1(e) shall not exceed, when aggregated with all such payments paid to all Investors under this Section 6.1(e), five percent
(5%) of the aggregate purchase price of the Securities purchased pursuant to this Agreement. The payments to which an Investor shall be entitled pursuant to this Section 6.1(e) are referred to herein as “Event
Payments.” Any Event Payments payable pursuant to the terms hereof shall be made no later than three (3) Business Days following the occurrence of the Event or on the monthly anniversary of such Event and shall apply on a pro rated
basis for any portion of a month prior to the cure of an Event. In the event the Company fails to make Event Payments in a timely manner, such Event Payments shall bear interest at the rate of one percent (1.0%) per month (prorated for partial
months) until paid in full. All pro rated calculations made pursuant to this paragraph shall be based upon the actual number of days in such pro rated month. Notwithstanding the foregoing, the maximum payment to an Investor associated with all
Events in the aggregate shall not exceed (i) in any 30-day period, an aggregate of 1.0% of the purchase price paid by such Investor for its Securities and (ii) 5.0% of the purchase paid by such Investor for its Securities. 

For such purposes, each of the following shall constitute an “Event”: (i) the Registration Statement required to be
filed by Section 6.1(a) is not filed on or prior to the Filing Date; (ii) the Registration Statement required to be filed by Section 6.1(a) is not declared effective on or prior to the Required Effectiveness Date; or
(iii) the Registration Statement required to be effective ceases for any reason to be effective at any time prior to the expiration of its Effectiveness Period for more than 20 consecutive Trading Days in any twelve month period. 

(f) The Company shall not, from the date hereof until the Effective Date of the Registration Statement, prepare and file with the SEC a
registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than any registration statement or post-effective amendment to a registration statement (or
supplement thereto) relating to the Company’s employee benefit plans registered on Form S-8. 
 (g) Neither the Company nor any of its
security holders (other than the Investors in such capacity pursuant hereto) may include securities of the Company in the Registration Statement required to be filed under Section 6.1(a) other than the Registrable Securities. 

  
 -32- 








 6.2 Demand Registration. 

(a) Each of the Lead Investor and Flatbush may make one written demand for registration under the Securities Act of an underwritten offering
of all or part of the Registrable Securities held by the Investors (a “Underwritten Demand Registration Request”); provided that the Lead Investor or Flatbush, as the case may be, and the Company reasonably believe that the gross
proceeds to the Investors will be at least $5,000,000. Upon receipt of an Underwritten Demand Registration Request, the Company shall promptly (but in no event later than five (5) Business Days following receipt thereof) deliver notice of such
request to all other holders of Registrable Securities who shall then have three (3) Business Days from the date such notice is given to notify the Company in writing of their desire to be included in such registration. The Company shall use
its commercially reasonable efforts to cause each Registration Statement required to be filed under this Section 6.2(a) to be declared effective under the Securities Act as soon as possible but, in any event, no later than One Hundred and Fifty
(150) days after the Company received the Underwritten Demand Registration Request. Upon notification by the SEC that a Registration Statement will not be reviewed or is no longer subject to further review and comments, the Company shall
request acceleration of such Registration Statement within five (5) Trading Days after receipt of such notice and request that it become effective on 4:00 p.m. New York City time on the Effective Date and file a prospectus supplement for any
Registration Statement, whether or not required under Rule 424 (or otherwise), by 9:00 a.m. New York City time the day after the Effective Date. The Company shall not be obligated to effect more than two registrations under this
Section 6.2(a) in respect of Registrable Securities. 
 (b) If in any requested registration made pursuant to
Section 6.2(a) hereof the lead managing underwriter of such offering advises the Company that, in its view, the number of securities requested to be included in such registration by the Investors or any other Persons, including those
shares of Common Stock requested by the Company to be included in such registration, exceeds the largest number (the “Sale Number”) that can be sold in an orderly manner in such offering within a price range acceptable to the
Investors, the Company shall use its best efforts to include in such registration: 
 (i) first, all Registrable Securities requested to be
included in such registration by the Investors; provided, however, that, if the number of such Registrable Securities exceeds the Sale Number, the number of such Registrable Securities (not to exceed the Sale Number) to be included in such
registration shall be allocated on a pro rata basis among all Investors requesting that Registrable Securities be included in such registration, based on the number of Registrable Securities then owned by each such Investor requesting inclusion in
relation to the number of Registrable Securities owned by all Investors requesting inclusion; and 
 (ii) second, to the extent that the
number of securities to be included pursuant to clause (i) of this Section 6.2(b) is less than the Sale Number, any other securities that the Investors propose to register, up to the Sale Number; and 

(iii) third, to the extent that the number of securities to be included pursuant to clauses (i) and (ii) of this
Section 6.2(b) is less than the Sale Number, any securities that the Company proposes to register for its own account and any securities that any other Person proposes to register, up to the Sale Number. 

If, as a result of the proration provisions of this Section 6.2, any Investor shall not be entitled to include all Registrable Securities in a
registration that such Investor has requested be included, such Investor may elect to withdraw its request to include Registrable Securities in such registration or may reduce the number requested to be included; provided, however, that
(A) such request must be made in writing prior to the earlier of the 

  
 -33- 








 
execution of the underwriting agreement or the execution of the custody agreement with respect to such registration and (B) such withdrawal shall be irrevocable and, after making such
withdrawal, such Investor shall no longer have any right to include Registrable Securities in the registration as to which such withdrawal was made. 

(c) The lead managing underwriter to be used in connection with such registration shall be selected by the Lead Investor or Flatbush, as the
case may be. 
 (d) The Company shall (together with all Investors selling Registrable Securities) enter into an underwriting agreement in
customary form with the lead managing Underwriter selected pursuant to Section 6.2(c) above, and each Investor participating in such underwritten offering 

6.3 Effectiveness of Registration Statement. Notwithstanding anything in this Agreement to the contrary, the Company may, by written
notice to the Investors, suspend sales under a Registration Statement after the Effective Date thereof and/or require that the Investors immediately cease the sale of shares of Common Stock pursuant thereto and/or defer the filing of any subsequent
Registration Statement if the Board of Directors determines in good faith, by appropriate resolutions, that, the disclosure of material non-public information concerning the Company (A) would be materially detrimental to the Company (other than
as relating solely to the price of the Common Stock) to maintain a Registration Statement at such time or (B) it is in the best interests of the Company to suspend sales under such registration at such time. Upon receipt of such notice, each
Investor shall immediately discontinue any sales of Registrable Securities pursuant to such registration until such Investor is advised in writing by the Company that the current Prospectus or amended Prospectus, as applicable, may be used. In no
event, however, shall this right be exercised to suspend sales beyond the period during which (in the good faith determination of the Company’s Board of Directors) the failure to require such suspension would be materially detrimental to the
Company. The Company’s rights under this Section 6.3 may be exercised for a period of no more than 20 Trading Days at a time and not more than three times in any twelve-month period. Immediately after the end of any suspension
period under this Section 6.3, the Company shall take all necessary actions (including filing any required supplemental prospectus) to restore the effectiveness of the applicable Registration Statement and the ability of the Investors to
publicly resell their Registrable Securities pursuant to such effective Registration Statement. 
 6.4 Registration Procedures. In
connection with the Company’s registration obligations under Sections 6.1 and 6.2, the Company shall: 
 (a) Not less than three
Trading Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement thereto, furnish via email to those Investors who have supplied the Company with email addresses copies of all such documents and
correspondence proposed to be filed, which documents (other than any document that is incorporated or deemed to be incorporated by reference therein) will be subject to the review of such Investors. The Company shall reflect in each such document
when so filed with the SEC such comments regarding the Investors and the plan of distribution as the Investors may reasonably and promptly propose no later than two Trading Days after the Investors have been so furnished with copies of such
documents as aforesaid. 
 (b) (i) Subject to Section 6.3, prepare and file with the SEC such amendments, including
post-effective amendments, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep the Registration Statement continuously effective, as to the applicable Registrable Securities for the
Effectiveness Period and prepare and file with the SEC such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities; (ii) cause the related Prospectus to be amended or
supplemented by any required Prospectus supplement, and as so 

  
 -34- 








 
supplemented or amended to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably possible, and in any event within 15 Trading Days (except to the extent that the Company
reasonably requires additional time to respond to accounting comments), to any comments received from the SEC with respect to the Registration Statement or any amendment thereto; and (iv) comply in all material respects with the provisions of
the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by the Registration Statement during the applicable period in accordance with the intended methods of disposition by the Investors thereof
set forth in the Registration Statement as so amended or in such Prospectus as so supplemented. 
 (c) Notify the Investors as promptly as
reasonably possible, and (if requested by the Investors) confirm such notice in writing no later than two Trading Days thereafter, of any of the following events: (i) the SEC notifies the Company whether there will be a “review” of
any Registration Statement; (ii) the SEC comments in writing on any Registration Statement; (iii) any Registration Statement or any post-effective amendment is declared effective; (iv) the SEC or any other Federal or state
governmental authority requests any amendment or supplement to any Registration Statement or Prospectus or requests additional information related thereto; (v) the SEC issues any stop order suspending the effectiveness of any Registration
Statement or initiates any Proceedings for that purpose; (vi) the Company receives notice of any suspension of the qualification or exemption from qualification of any Registrable Securities for sale in any jurisdiction, or the initiation or
threat of any Proceeding for such purpose; or (vii) the financial statements included in any Registration Statement become ineligible for inclusion therein or any Registration Statement or Prospectus or other document contains any untrue
statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. 

(d) Use its commercially reasonable efforts to avoid the issuance of or, if issued, obtain the withdrawal of (i) any order suspending
the effectiveness of any Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, as soon as possible. 

(e) If requested by an Investor, provide such Investor without charge, at least one conformed copy of each Registration Statement and each
amendment thereto, including financial statements and schedules, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the SEC.

 (f) Promptly deliver to each Investor, without charge, as many copies of the Prospectus or Prospectuses (including each form of
prospectus) and each amendment or supplement thereto as such Persons may reasonably request. The Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Investors in connection with the
offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto to the extent permitted by federal and state securities laws and regulations. 

(g) (i) In the time and manner required by each Trading Market, prepare and file with such Trading Market an additional shares listing
application covering all of the Registrable Securities; (ii) take all steps necessary to cause such Conversion Shares to be approved for listing on each Trading Market as soon as possible thereafter; (iii) provide to each Investor evidence
of such listing; and (iv) during the Effectiveness Period, maintain the listing of such Conversion Shares on each such Trading Market or another Eligible Market. 

  
 -35- 








 (h) Prior to any public offering of Registrable Securities, use its commercially reasonable
efforts to register or qualify or cooperate with the selling Investors in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities
or Blue Sky laws of such jurisdictions within the United States as any Investor requests in writing, to keep each such registration or qualification (or exemption therefrom) effective for so long as required, but not to exceed the duration of the
Effectiveness Period, and to do any and all other acts or things reasonably necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by a Registration Statement; provided, however,
that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in
respect of doing business in any jurisdiction in which it is not otherwise so subject. 
 (i) Cooperate with the Investors to facilitate the
timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by this Agreement and under law, of
all restrictive legends, and to enable such certificates to be in such denominations and registered in such names as any such Investors may reasonably request. 

(j) Upon the occurrence of any event described in Section 6.4(c)(vii), as promptly as reasonably possible, prepare a supplement or
amendment, including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as
thereafter delivered, neither the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading. 
 (k) Cooperate with any reasonable due diligence investigation undertaken
by the Investors in connection with the sale of Registrable Securities, including, without limitation, by making available documents and information; provided that the Company will not deliver or make available to any Investor material, nonpublic
information unless such Investor requests in advance in writing to receive material, nonpublic information and agrees to keep such information confidential. 

(l) Comply with all rules and regulations of the SEC applicable to the registration of the securities. 

(m) It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect
to the Registrable Securities of any particular Investor that such Investor furnish to the Company the information specified in Exhibits A-1, A-2 and A-3 hereto and such other information regarding itself, the Registrable Securities and other shares
of Common Stock held by it and the intended method of disposition of the Registrable Securities held by it (if different from the Plan of Distribution set forth on Exhibit D hereto) as shall be reasonably required to effect the registration
of such Registrable Securities and shall complete and execute such documents in connection with such registration as the Company may reasonably request. 

(n) The Company shall comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange Act, including,
without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Investors in writing if, at any time
during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result 

  
 -36- 








 
thereof, the Investors are required to make available a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to
facilitate the registration of the Registrable Securities hereunder. 
 6.5 Registration Expenses – Registration Required by
Section 6.1. The Company shall pay all fees and expenses incurred by the Company in connection with (and incident to) the performance of its obligations under Section 6.1 of this Agreement by the Company, including without
limitation (a) all registration and filing fees and expenses, including without limitation those related to filings with the SEC, any Trading Market and in connection with applicable state securities or Blue Sky laws, (b) printing expenses
(including without limitation expenses of printing certificates for Registrable Securities), (c) messenger, telephone and delivery expenses, (d) fees and disbursements of counsel for the Company, (e) fees and expenses of all other
Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement, and (f) all listing fees to be paid by the Company to the Trading Market. The Company shall also pay reasonable
attorneys’ fees and expenses incurred in connection with the legal review of the Registration Statement filed pursuant to Section 6.1 on behalf of the Investors to one counsel designated by the Investors in an amount not to exceed
$5,000. 
 6.6 Registration Expenses – Registration Required by Section 6.2. The Investors participating in any
registration pursuant to Section 6.2 of this Agreement shall pay 50% of all fees and expenses incurred by the Company in connection with (and incident to) the performance of its obligations under Section 6.2 of this Agreement
by the Company (pro rata among the participating Investors based on the number of Registrable Securities included in such registration by such participating Investors), including without limitation (a) all registration and filing fees and
expenses, including without limitation those related to filings with the SEC, any Trading Market and in connection with applicable state securities or Blue Sky laws, (b) printing expenses (including without limitation expenses of printing
certificates for Registrable Securities), (c) messenger, telephone and delivery expenses, (d) fees and disbursements of counsel for the Company, the underwriter and the Investors, (e) fees and expenses of all other non-Affiliated
Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, fees and expenses payable to the underwriter engaged by the Company and the Company’s
accountants), and (f) all listing fees to be paid by the Company to the Trading Market; provided, however, the Investors shall not be responsible for any allocation of internal expenses of the Company (including salaries and expenses of the
Company’s officers and employees); and provided further that the Company shall only be required to pay expenses up to $250,000. Notwithstanding the foregoing, to the extent the Company or any Person (other than the Investors) include securities
in any registration pursuant to Section 6.2 of this Agreement, the Company or such Persons, as applicable, shall bear their pro rata share of such expenses based on the number of securities held by the Company or such Persons to be
included in such registration compared to the total number of securities to be included in such registration. 
 6.7 Indemnification

 (a) Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Investor, the officers, directors, partners, members, agents and employees of each of them, each Person who controls any such Investor (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act)
and the officers, directors, partners, members, agents and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all Losses, as incurred, arising out of or relating to (i) any
misrepresentation or breach of any representation or warranty made by the Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (ii) any breach of any covenant, agreement or
obligation of the Company contained in the Transaction Documents or any 

  
 -37- 








 
other certificate, instrument or document contemplated hereby or thereby, (iii) any cause of action, suit or claim brought or made against such Indemnified Party (as defined in
Section 6.7 (c) below) by a third party (including for these purposes a derivative action brought on behalf of the Company), arising out of or resulting from (x) the execution, delivery, performance or enforcement of the
Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (y) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the
Securities, or (z) the status of Indemnified Party as holder of the Securities (unless, and only to the extent that, such action, suit or claim is based upon a breach of such Investor’s representations, warranties or covenants under the
Transaction Documents or any conduct by such Investor that constitutes fraud, gross negligence or willful misconduct) or (iv) any untrue or alleged untrue statement of a material fact contained in the Registration Statement, any Prospectus or
any form of Company prospectus or in any amendment or supplement thereto or in any Company preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that (A) such
untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon information regarding such Investor furnished in writing to the Company by such Investor for use therein, or to the extent that such information
relates to such Investor or such Investor’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved by such Investor in writing expressly for use in the Registration Statement, or (B) with respect
to any prospectus, if the untrue statement or omission of material fact contained in such prospectus was corrected on a timely basis in the prospectus, as then amended or supplemented, if such corrected prospectus was timely made available by the
Company to the Investor, and the Investor seeking indemnity hereunder was advised in writing not to use the incorrect prospectus prior to the use giving rise to Losses. 

(b) Indemnification by Investors. Each Investor shall, severally and not jointly, indemnify and hold harmless the Company and its
directors, officers, agents and employees to the fullest extent permitted by applicable law, from and against all Losses (as determined by a court of competent jurisdiction in a final judgment not subject to appeal or review) arising solely out of
any untrue statement of a material fact contained in the Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto, or arising out of or relating to any omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, but only to the extent that
(i) such untrue statements or omissions are based solely upon information regarding such Investor furnished to the Company by such Investor in writing expressly for use therein, or (ii) such information relates to such Investor or such
Investor’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Investor expressly for use in the Registration Statement (it being understood that the information provided by the
Investor to the Company in (A) Exhibits A-1, A-2 and A-3 and the Plan of Distribution set forth on Exhibit D, as the same may be modified by such Investor or (B) in writing constitutes information
reviewed and expressly approved by such Investor in writing expressly for use in the Registration Statement), such Prospectus or such form of prospectus or in any amendment or supplement thereto. In no event shall the liability of any selling
Investor hereunder be greater in amount than the dollar amount of the net proceeds received by such Investor upon the sale of the Registrable Securities giving rise to such indemnification obligation. 

(c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense
thereof, including the employment of counsel 

  
 -38- 








 
reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give
such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not
subject to appeal or further review) that such failure shall have proximately and materially adversely prejudiced the Indemnifying Party. 

An Indemnified Party shall have the right to employ separate counsel (including local counsel) in any such Proceeding and to participate in
the defense thereof, but the fees and expenses of such counsel (including local counsel) shall be at the expense of such Indemnified Party or Parties unless: (i) the Indemnifying Party has agreed in writing to pay such fees and expenses; or
(ii) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel (including local counsel) reasonably satisfactory to such Indemnified Party in any such Proceeding; or (iii) the named
parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same
counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel (including local counsel) at the expense of
the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of separate counsel (including local counsel) shall be at the expense of the Indemnifying Party). It shall be
understood, however, that the Indemnifying Party shall not, in connection with any one such Proceeding (including separate Proceedings that have been or will be consolidated before a single judge) be liable for the fees and expenses of more than one
separate firm of attorneys at any time for all Indemnified Parties, which firm shall be appointed by a majority of the Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its
written consent, which consent shall not be unreasonably withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is
a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding. 

All reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within 20 Trading Days of written notice thereof to the Indemnifying Party (regardless of
whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder; provided, that the Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to the extent
it is finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder). 
 (d) Contribution.
If a claim for indemnification under Section 6.7(a) or (b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party,
shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified
Party, and the parties’ relative intent, Knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a 

  
 -39- 








 
party as a result of any Losses shall be deemed to include, subject to the limitations set forth in Section 6.7(c), any reasonable attorneys’ or other reasonable fees or expenses
incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.

 The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 6.7(d) were
determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this
Section 6.7(d), no Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Investor from the sale of the Registrable Securities subject to the
Proceeding exceed the amount of any damages that such Investor has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 

The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties. 
 6.8 Dispositions. Each Investor agrees that it will comply with the prospectus delivery requirements of
the Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to the Registration Statement and shall sell its Registrable Securities in accordance with the Plan of Distribution set forth in the Prospectus. Each
Investor further agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Sections 6.4(c)(v), (vi) or (vii), such Investor will discontinue disposition of such
Registrable Securities under the Registration Statement until such Investor is advised in writing by the Company that the use of the Prospectus, or amended Prospectus, as applicable, may be resumed. The Company may provide appropriate stop orders to
enforce the provisions of this paragraph. Each Investor, severally and not jointly with the other Investors, agrees that the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is
predicated upon the Company’s reliance that the Investor will comply with the provisions of this subsection. Both the Company and the Transfer Agent, and their respective directors, officers, employees and agents, may rely on this subsection.

 6.9 Piggy-Back Registrations. If at any time during the Effectiveness Period there is not an effective Registration Statement
covering all of the Registrable Securities and the Company shall determine to prepare and file with the SEC a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity
securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity
securities issuable in connection with stock option or other employee benefit plans, then the Company shall send to each Investor not then eligible to sell all of their Registrable Securities under Rule 144 in a three-month period, written notice of
such determination and if, within ten days after receipt of such notice, any such Investor shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such Investor requests to
be registered. Notwithstanding the foregoing, in the event that, in connection with any underwritten public offering, the managing underwriter(s) thereof shall impose a limitation on the number of shares of Common Stock which may be included in the
Registration Statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such Registration Statement
only such limited portion of the Registrable Securities with respect to which such Investor has requested inclusion hereunder as the underwriter shall permit; provided, however, that (i) the Company shall not exclude any
Registrable 

  
 -40- 








 
Securities unless the Company has first excluded all outstanding securities, the holders of which are not contractually entitled to inclusion of such securities in such Registration Statement or
are not contractually entitled to pro rata inclusion with the Registrable Securities and (ii) after giving effect to the immediately preceding proviso, any such exclusion of Registrable Securities shall be made pro rata among the Investors
seeking to include Registrable Securities and the holders of other securities having the contractual right to inclusion of their securities in such Registration Statement by reason of demand registration rights, in proportion to the number of
Registrable Securities or other securities, as applicable, sought to be included by each such Investor or other holder. If an offering in connection with which an Investor is entitled to registration under this Section 6.9 is an
underwritten offering, then each Investor whose Registrable Securities are included in such Registration Statement shall, unless otherwise agreed by the Company, offer and sell such Registrable Securities in an underwritten offering using the same
underwriter or underwriters and, subject to the provisions of this Agreement, on the same terms and conditions as other shares of Common Stock included in such underwritten offering and shall enter into an underwriting agreement in a form and
substance reasonably satisfactory to the Company and the underwriter or underwriters. 
 ARTICLE VII 

MISCELLANEOUS 
 7.1
Termination. This Agreement may be terminated by the Company or any Investor (as to itself only), by written notice to the other parties, if the Closing has not been consummated by the fifth Trading Day following the date of this Agreement;
provided that no such termination will affect the right of any party to sue for any breach by the other party (or parties). 
 7.2 Fees
and Expenses. The Company shall reimburse Lead Investor for all out-of-pocket costs and expenses (including, without limitation, as applicable, all legal fees) incurred by it in connection with this Agreement (including the related term sheet)
and the transactions contemplated by this Agreement in an amount not to exceed $50,000. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and
other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and
duties levied in connection with the sale and issuance of the applicable Securities. 
 7.3 Entire Agreement. The Transaction
Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. At or after the Closing, and without further consideration, the Company will execute and deliver to the Investors such further documents as may be
reasonably requested in order to give practical effect to the intention of the parties under the Transaction Documents. 
 7.4
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice
or communication is delivered via facsimile or email at the facsimile number or email address specified in this Section prior to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile or email at the facsimile number or email address specified in this Section on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the Trading
Day following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses, facsimile numbers and email addresses for such notices
and communications are those set forth on the signature pages hereof, or such other address or facsimile number as may be designated in writing hereafter, in the same manner, by any such Person. 

  
 -41- 








 7.5 Amendments; Waivers. No provision of this Agreement may be waived or amended except in
a written instrument signed, in the case of an amendment, by the Company and each of the Investors or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission
of any party to exercise any right hereunder in any manner impair the exercise of any such right. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights
of Investors under Article VI may be given by (i) in the case of Section 6.1, Investors holding at least a majority of the Registrable Securities to which such waiver or consent relates (which majority must include the
Lead Investor and Flatbush) or (ii) in the case of Section 6.2, the Lead Investor or Flatbush, as applicable. 
 7.6
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 
 7.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the
prior written consent of the Investors. Any Investor may assign its rights under this Agreement to any Person to whom such Investor assigns or transfers any Securities, provided (i) such transferor agrees in writing with the transferee or
assignee to assign such rights, and a copy of such agreement is furnished to the Company after such assignment, (ii) the Company is furnished with written notice of (x) the name and address of such transferee or assignee and (y) the
Registrable Securities with respect to which such registration rights are being transferred or assigned, (iii) following such transfer or assignment, the further disposition of such securities by the transferee or assignee is restricted under
the Securities Act and applicable state securities laws, (iv) such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions hereof that apply to the “Investors” and (v) such transfer
shall have been made in accordance with the applicable requirements of this Agreement and with all laws applicable thereto. 
 7.8 No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
except that each Indemnified Party is an intended third party beneficiary of Section 6.7 and (in each case) may enforce the provisions of such Section directly against the parties with obligations thereunder. 

7.9 Governing Law; Venue; Waiver of Jury Trial. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE
STATE OF NEW YORK WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THAT WOULD DEFER TO THE LAW OF ANOTHER JURISDICTION. THE COMPANY AND INVESTORS HEREBY IRREVOCABLY SUBMIT TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE
CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR ANY INVESTOR HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE
ENFORCEMENT OF ANY OF THE TRANSACTION 

  
 -42- 








 
DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR ANY INVESTOR, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY
THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF
PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND INVESTORS HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY. 

7.10 Survival. The representations and warranties, agreements and covenants contained herein shall survive the Closing. 

7.11 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or email attachment, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or
email-attached signature page were an original thereof. 
 7.12 Severability. If any provision of this Agreement is held to be
invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable
provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 

7.13 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) the Transaction Documents, whenever any Investor exercises a right, election, demand or option owed to such Investor by the Company under a Transaction Document and the Company does not timely perform its related obligations within
the periods therein provided, then, prior to the performance by the Company of the Company’s related obligation, such Investor may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future actions and rights. 
 7.14 Replacement of Securities.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution
therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and
an agreement to indemnify and hold harmless the Company for any losses in connection therewith. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance
of such replacement Securities. 
 7.15 Remedies. In addition to being entitled to exercise all rights provided herein or granted by
law, including recovery of damages, each of the Investors and the Company will be entitled to seek specific 

  
 -43- 








 
performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the
foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary restraining order) the defense that a remedy at law would be adequate. 

7.16 Payment Set Aside. To the extent that the Company makes a payment or payments to any Investor hereunder or any Investor enforces
or exercises its rights hereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company by a trustee, receiver or any other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not
occurred. 
 7.17 Adjustments in Share Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution
payable in shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring after the
date hereof, each reference in any Transaction Document to a number of shares or a price per share shall be amended to appropriately account for such event. 

7.18 Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under any Transaction Document are
several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Transaction Documents. The decision of each Investor to purchase
Securities pursuant to this Agreement has been made by such Investor independently of any other Investor and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of the Company which may have been made or given by any other Investor or by any agent or employee of any other Investor, and no Investor or any of its agents or
employees shall have any liability to any other Investor (or any other person) relating to or arising from any such information, materials, statements or opinions. Nothing contained herein or in any Transaction Document, and no action taken by any
Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with
respect to such obligations or the transactions contemplated by the Transaction Document. Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no other
Investor will be acting as agent of such Investor in connection with monitoring its investment hereunder. Each Investor shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any Proceeding for such purpose. 

[SIGNATURE PAGES TO FOLLOW] 

  
 -44- 








 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above. 
  

			
	dELiA*s, INC.
		
	By:	 	 /s/ David J. Dick

	Name:	 	David J. Dick
	Title:	 	Chief Financial Officer


  

			
	Address for Notice:
	
	dELiA*s, Inc.
	50 West 23rd Street
	New York, New York 10010
	Tel: (212) 590-6204
	Fax: (212) 590-6310
	Attn: General Counsel
	
	With a copy to:
	
	Troutman Sanders LLP
	The Chrysler Building
	405 Lexington Avenue
	New York, New York 10174
	Tel: (212) 704-6000
	Fax: (212) 704-6288
	Attn: William D. Freedman, Esq.


 COMPANY SIGNATURE PAGE 







 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Cooper Creek Partners LLC



  

			
	By:	 	 /s/ John McCleary

		 	Name: John McCleary
		 	Title: Chief Financial Officer


  

			
	Address:	 	  

	
	  

	
	  




 

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  




 

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 

  







 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Cooper Creek Partners (Master) Ltd.



  

			
	By:	 	 /s/ John McCleary

		 	Name: John McCleary
		 	Title: Chief Financial Officer


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Crosslane & Co.



  

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Crossledge & Co.



  

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President 


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 

  







 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Daybreak & Co.



  

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 

  







 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Deerhaven Fund, L.P.



  

			
	By:	 	 /s/ Glenn Tongue

		 	Name: Glenn Tongue
		 	Title: Managing Partner


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 FW2, LP



  

			
	By:	 	 /s/ Joshua M. Schwartz

		 	Name: Joshua M. Schwartz
		 	Title: Managing Member, general partner


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 FW3, LP



  

			
	By:	 	 /s/ Joshua M. Schwartz

		 	Name: Joshua M. Schwartz
		 	Title: Managing Member, general partner


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Lake Coral & Co.



  

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Leon G. Cooperman



  

			
	By:	 	 /s/ David Bloom

		 	Name: David Bloom
		 	Title: Attorney-in-Fact


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Prendel LLC



  

			
	By:	 	 /s/ Michael Zimmerman

		 	Name: Michael Zimmerman
		 	Title: Managing Member


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 

  







 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	 Name of Investor:

	
	 Morris Goldfarb & Arlene Goldfarb JTWROS



  

			
	By:	 	 /s/ Morris Goldfarb

		 	Name:
		 	Title:


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Oven & Co.



  

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 P.A.W. Small Cap Partners, L.P.



  

			
	By:	 	 /s/ Peter A. Wright

		 	Name: Peter A. Wright
		 	Title: C.I.O. and General Partner


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Splash & Co.




 

			
	By:	 	 /s/ Robert K. Benson

		 	Name: Robert K. Benson
		 	Title: Senior Vice President


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Tiger Global Investments, LP



  

			
	By:	 	 /s/ Charles P. Coleman III

		 	Name: Charles P. Coleman III
		 	Title: Managing Member of the General Partner


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Tracy Gardner



  

			
	By:	 	 /s/ Tracy Gardner

		 	Name:
		 	Title:


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the principal
amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Valinor Capital Partners, L.P.



  

			
	By:	 	 /s/ Fola Adamolekun

		 	Name: Fola Adamolekun
		 	Title: General Counsel


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Investor Signature Page 

By its execution and delivery of this signature page, the undersigned Investor hereby joins in and agrees to be bound by the terms and
conditions of the Securities Purchase Agreement dated as of February 18, 2014 (the “Purchase Agreement”) by and among dELiA*s, Inc. and the Investors (as defined therein), as to the number of shares of Preferred Stock and the
principal amount of the Note set forth below, and authorizes this signature page to be attached to the Purchase Agreement or counterparts thereof. 
  

	
	Name of Investor:
	
	 Valinor Capital Partners Offshore Master Fund, L.P.



  

			
	By:	 	 /s/ Fola Adamolekun

		 	Name: Fola Adamolekun
		 	Title: General Counsel


  

			
	Address:	 	  

	
	  

	
	  



  

			
	Telephone No.:	 	  

		
	Facsimile No.:	 	  

		
	Email Address:	 	  



  

			
	Number of shares of Preferred Stock:
		
	  
	 	


  

	
	Principal Amount of Notes: $            
	
	Aggregate Purchase Price: $            









 Delivery Instructions (if different than above): 

 

					
	c/o:	 	  
	 	


					
			
	Address:	 	  
	 	
			
		 	  
	 	


					
			
	Telephone No.:	 	  
	 	
			
	Facsimile No. :	 	  
	 	


					
			
	Other Special Instructions:	 	  
	 	

 Annexes: 
  

	 	A.	Form of Notes 

  

	 	B	Form of Designation of Preferred Stock 

 Exhibits: 

 

	 	A	Instruction Sheet for Investors 

  

	 	B	Amendment to Rights Agreement 

  

	 	C	Opinion of Company Corporate Counsel 

  

	 	D	Plan of Distribution 

  

	 	E	Company Transfer Agent Instructions 








 Annex A 

Form of Secured Convertible Note 







 THESE SECURITIES (AND THE SECURITIES ISSUABLE UPON CONVERSION OF THESE SECURITIES) HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE
SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THESE SECURITIES MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE, INCLUDING SECTION 3 HEREOF. 

dELiA*s, Inc. 

SECURED CONVERTIBLE NOTE 

 

			
	Issuance Date: February 18, 2014	  	Original Principal Amount: U.S. $[            ]        

 Note No.:              

FOR VALUE RECEIVED, dELiA*s, Inc., a Delaware corporation (the “Company”), hereby promises to pay to
[                    ] or its registered assigns (“Holder”) the amount set out above as the Original Principal Amount (as reduced in
connection with the automatic conversion of this Note, the “Principal”) on the Maturity Date and to pay interest (“Interest”) on any outstanding Principal at the Interest Rate (as defined below) from the date set
out above as the Issuance Date (the “Issuance Date”) until the same is paid in full on the Maturity Date or otherwise (in each case in accordance with the terms hereof). Upon payment in full of all Principal and Interest payable
hereunder (or upon conversion of this Note (as defined below) in accordance with Section 3 hereof), this Note shall be surrendered to the Company for cancellation. This Secured Convertible Note (including all Secured Convertible Notes issued in
exchange, transfer or replacement hereof, this “Note”) is one of an issue of Secured Convertible Notes issued pursuant to the Purchase Agreement (as defined below) on the Issuance Date (collectively, the “Notes” and
such other Secured Convertible Notes, the “Other Notes”). Certain capitalized terms used herein are defined in Section 25. 

1. PAYMENTS OF PRINCIPAL. On the Maturity Date, the Company shall pay to the Holder an amount in cash representing all outstanding
Principal and all accrued and unpaid Interest. Any such payment shall be applied pro rata to the Note and the Other Notes in accordance with the respective Principal amounts thereof. The Company may not prepay any portion of the outstanding
Principal. 
 2. INTEREST; INTEREST RATE. Interest on this Note shall (i) accrue at the Interest Rate, (ii) commence
accruing on the Issuance Date, (iii) be computed on the basis of a 365-day year for the actual number of days elapsed, and (iv) be payable in cash to the Holder on the Maturity Date; provided that Interest shall not be payable to the
Holder under this Note if Stockholder Approval is obtained. From 







 
and after the occurrence and during the continuance of any Event of Default, the applicable Interest Rate shall automatically be increased by two percent (2%) per annum above the Interest
Rate otherwise applicable in accordance with the terms hereof (the “Default Rate”). In the event that such Event of Default is subsequently cured, the adjustment referred to in the preceding sentence shall cease to be effective as
of the date of such cure. 
 3. CONVERSION. This Note shall be convertible into validly issued, fully paid and non-assessable shares
of Preferred Stock (as defined below), on the terms and conditions set forth in this Section 3. 
 (a) Automatic Conversion. If
at any time after the Issuance Date and prior to the Maturity Date, the Company obtains Stockholder Approval, then the outstanding Principal amount of this Note automatically shall convert into shares of Preferred Stock at the Conversion Price (as
defined below) as of 12:00 noon, New York City time, on the Stockholder Approval Date; provided that such conversion shall not occur if an Event of Default has occurred and is continuing on the Stockholder Approval Date. If an Event of Default that
occurred prior to the Stockholder Approval Date and was continuing on the Stockholder Approval Date is subsequently cured prior to the earlier to occur of (i) the Maturity Date and (ii) the acceleration of this Note by the Holder, then the
Note shall automatically convert into shares of Preferred Stock at the Conversion Price as of 12:00 noon, New York City time on the date of such cure. The Company shall not issue any fraction of a share of Preferred Stock upon any conversion. If the
issuance would result in the issuance of a fraction of a share of Preferred Stock, the Company shall round such fraction of a share of Preferred Stock up to the nearest whole share. Except as provided in this Section 3(a), this Note shall not
be convertible into shares of Preferred Stock. 
 (b) Conversion Rate. The number of shares of Preferred Stock issuable upon
conversion of this Note shall be determined by dividing (x) the outstanding Principal amount of this Note as of 12:00 noon, New York City time, on the Conversion Date by (y) the Conversion Price. 

(c) Mechanics of Conversion. The Company shall notify the Holder of the automatic conversion in writing within one (1) Trading Day
after the Conversion Date. Within three (3) Trading Days after the Conversion Date, the Company shall cause the Transfer Agent to issue, and the Company shall deliver, to the address of such Holder set forth in the Purchase Agreement or to such
address as specified by the Holder in writing to the Company at least two (2) Business Days prior to the Conversion Date, a certificate, registered in the name of the Holder or its designee, for the number of Conversion Shares to which the
Holder shall be entitled. 
 4. GRANT OF SECURITY INTEREST. As collateral security for the Obligations, the Company hereby grants to
Valinor Management, LLC, on behalf of the investment vehicles that it manages and who are holders of the Notes and on behalf of all of the holders of the Other Notes (in such capacity, the “Lead Investor”), a continuing, first
priority security interest in the Deposit Account, all funds therein, and all cash and non-cash proceeds thereof (collectively, the “Collateral”). The security interest in the Collateral shall remain in effect until all of the
Obligations to the holders of the Notes are fully paid and satisfied. 
 5. RIGHTS UPON EVENT OF DEFAULT. 

(a) Event of Default. Each of the following events shall constitute an “Event of Default”: 

(i) the Company’s failure to pay to the Holder any amount of Principal or Interest when and as due under this Note and the
continuation of such failure for a period of at least five (5) Trading Days; 

  
 2 








 (ii) the commencement by the Company of a voluntary case or proceeding under any
applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated as bankrupt or insolvent, or the consent by it to the entry of a decree, order, judgment or other
similar document in respect of the Company in an involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy or insolvency case or
proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment of or taking
possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the execution
of a composition of debts, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any such action; 

(iii) the commencement against the Company by a third party of bankruptcy, insolvency, reorganization or liquidation
proceedings or other similar proceedings for the relief of debtors and the same shall not be dismissed within sixty (60) days of their initiation; 

(iv) any representation or warranty made by the Company in Section 3.1 of the Purchase Agreement shall prove to be
incorrect as of the time it was made and all such incorrect representations and warranties made by the Company shall, when taken together in the aggregate, result in a Material Adverse Effect; 

(v) the Company shall (i) merge with any Person, other than a merger with any subsidiary of the Company in which the
Company is the surviving corporation, (ii) sell all or substantially all of its assets to any Person or entity, or (iii) sell any equity interests of the Company if, after giving effect to such sale of equity interests of the Company, any
person or group (as such term is defined in Section 13(d) of the Securities Exchange Act of 1934, as amended), would own more than 50% of the issued and outstanding equity interests of the Company; or 

(vi) the Company shall breach any of the covenants set forth in this Note or in the Purchase Agreement. 

Upon the occurrence of an Event of Default with respect to this Note or any Other Note, the Company shall promptly deliver written notice
thereof via facsimile and overnight courier (with next day delivery specified) (an “Event of Default Notice”) to each Holder. 

(b) If an Event of Default specified in Sections 5(a)(i), 5(a)(iv), 5(a)(v) or 5(a)(vi) occurs, then the Holder may, by written notice to the
Company, declare this Note to be forthwith due and payable, as to Principal and all accrued Interest, whereupon this Note shall become forthwith due and payable, without presentment, demand, protest or other notice of any kind, all of which are
hereby expressly waived by the Company. If any Event of Default specified in Sections 5(a)(ii) or (iii) occurs, the Principal of and accrued Interest on this Note shall automatically forthwith become due and payable without presentment,
demand, protest or notice of any kind, all of which are hereby expressly waived by the Company. 

  
 3 








 (c) If any Event of Default shall have occurred and be continuing: 

(i) The Lead Investor, on behalf of the holders of the Notes, may exercise in respect of the Collateral all of the rights and
remedies of a secured party upon default under the Uniform Commercial Code and under applicable law. Any surplus of the Collateral held by the Lead Investor remaining after the payment in full in cash of all of the Obligations shall be paid over to
whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct. 
 (ii) In
the event that the proceeds of any such sale, collection or realization are insufficient to pay the Obligations, the Company shall be liable for the deficiency, together with interest thereon at the Default Rate. 

(iii) The Lead Investor shall not be required to marshal any present or future collateral security (including, but not limited
to, the Collateral) for, or other assurances of payment of, the Obligations or any of them or to resort to such collateral security or other assurances of payment in any particular order, and all of the Lead Investor’s rights hereunder and in
respect of such collateral security and other assurances of payment shall be cumulative and in addition to all other rights, however existing or arising. To the extent that the Company lawfully may, the Company hereby agrees that it will not invoke
any law relating to the marshaling of collateral which might cause delay in or impede the enforcement of the Lead Investor’s rights under this Agreement or under any other instrument creating or evidencing any of the Obligations or under which
any of the Obligations is outstanding or by which any of the Obligations is secured or payment thereof is otherwise assured, and, to the extent that it lawfully may, the Company hereby irrevocably waives the benefits of all such laws. 

(iv) Upon the indefeasible payment in full of the Obligations, (i) the security interests created hereby shall terminate
and all rights to the Collateral shall revert to the Company, and (ii) the Investors will, upon the Company’s request and at the Company’s expense, (A) return to the Company such of the Collateral as shall not have been sold or
otherwise disposed of or applied pursuant to the terms hereof, and (B) execute and deliver to the Company such documents as the Company shall reasonably request to evidence such termination, all without any representation, warranty or recourse
whatsoever. Notwithstanding the foregoing, the Obligations shall continue to be effective or shall be reinstated, as the case may be, if at any time payment and performance of the Obligations, or any part thereof, is, pursuant to applicable law,
rescinded or reduced in amount, or must otherwise be restored or returned, whether as a “voidable preference,” “fraudulent conveyance,” or otherwise, all as though such payment or performance had not been made. In the event that
any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned 

(d) If any Event of Default occurs and is continuing, the Holder may pursue any available remedy to collect the payment of Principal and
Interest or to enforce the performance of any provision of this Note. If an Event of Default occurs and is continuing, the holder of this Note may proceed to protect and enforce its rights by an action at law, suit in equity or other appropriate
proceeding. No course of dealing and no delay on the part of the holder of this Note in exercising any right, power or remedy shall operate as a waiver thereof or otherwise prejudice such holder’s rights, powers or remedies. No right, power or
remedy conferred by this Note upon the holder hereof shall be exclusive of any other right, power or remedy referred to herein or now or hereafter available at law, in equity, by statute or otherwise. 

  
 4 








 6. ADJUSTMENTS. Upon conversion of this Note, the Holder shall receive the benefit of any
adjustments made to the conversion price of the Preferred Stock pursuant to Section 8 of the certificate of designation of the Preferred Stock that occurred prior to Conversion Date. 

7. NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its certificate of
incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Note, and will at all times in good faith carry out all of the provisions of this Note and take all action as may be required to protect the rights of the Holder of this Note. 

8. RESERVATION OF AUTHORIZED SHARES. Subject to the receipt of Stockholder Approval, the Company shall reserve out of its authorized
and unissued Preferred Stock and Common Stock, and for so long as any of the Notes are outstanding the Company shall take all action necessary to reserve and keep available out of its authorized and unissued Preferred Stock and Common Stock, a
number of shares of Preferred Stock and Common Stock equal to the maximum number of shares of Preferred Stock and Common Stock issuable upon conversion of the Note and the conversion of the Conversion Shares issuable pursuant to the Notes
(determined without taking into account any limitations on the conversion of the Notes set forth therein). If at any time the number of authorized but unissued shares of Preferred Stock and/or Common Stock shall not be sufficient to effect the
conversion of the entire outstanding principal amount of the Notes or the conversion of the Conversion Shares, as applicable, without limitation of such other remedies as shall be available to the Holder of this Note, the Company will use its
commercially reasonably efforts to take such corporate action as may, in the opinion of counsel, be necessary to increase its authorized but unissued shares of Preferred Stock and/or Common Stock to such number of shares as shall be sufficient for
such purposes. 
 9. VOTING RIGHTS. The Holder shall have no voting rights as the holder of this Note, except as required by law
(including, but not limited to, the Delaware General Corporation Law). 
 10. COVENANTS. Until all of the Notes have been converted,
redeemed or otherwise satisfied in accordance with their terms: 
 (a) Rank. All payments due under this Note shall
rank pari passu with all Other Notes. 
 (b) Preservation of Existence, Etc. The Company shall maintain and
preserve its existence, rights and privileges. 
 (c) Incurrence of Indebtedness. Except as set forth in the Purchase
Agreement, the Company shall not (y) create, incur, assume, suffer to exist or otherwise become or remain liable with respect to, any indebtedness for borrowed money other than pursuant to the Credit Agreement or (z) grant any Lien (as
defined in the Purchase Agreement) on the assets of the Company or its subsidiaries; provided, however, that the foregoing restriction shall not, subject to Section 10(e)(ii) of this Note, in any way, apply to, prohibit or otherwise restrict
(i) the Salus Liens (as defined in the Purchase Agreement) or (ii) any other Liens that are permitted under the Credit Agreement. 

(d) Deposit Account Control Agreement. Prior to or at the Closing, the Company will cause the bank or financial
institution at which the Deposit Account shall be maintained to enter into with the Company and the Lead Investor a deposit account control agreement in form 

  
 5 








 
and substance acceptable to the Lead Investor (such acceptance not to be unreasonably withheld or delayed). The Lead Investor will promptly comment on the form of deposit account control
agreement. 
 (e) Use of Proceeds of Deposit Account Control Agreement. For so long as the Notes are outstanding, the
Company shall not (i) use or withdraw any of the proceeds in the Deposit Account (except for an amount equal to the Principal amount of the Notes so converted into Common Stock in accordance with the terms of the Notes) or (ii) grant any
Lien on or any Person (other than Lead Investor, on behalf of the holders of the Notes) any interest in the Deposit Account or the proceeds thereof. 

11. AMENDING THE TERMS OF THIS NOTE. The prior written consent of the Holder shall be required for any change or amendment to this
Note. 
 12. TRANSFER. This Note may be offered, sold, assigned or transferred by the Holder in whole or in part, subject only to the
provisions of the restrictive legend set forth at the top of the first page of this Note; provided that, so long as no Event of Default has occurred and is continuing, any such sale, assignment or transfer shall be subject to the prior
written consent of the Company, which consent shall not be unreasonably withheld, delayed or conditioned; provided, further, that any partial offer, sale, assignment or transfer of this Note shall be in a principal amount not less than
$250,000. 
 13. REISSUANCE OF THIS NOTE. 

(a) Transfer. If this Note is to be transferred as permitted under Section 12 above, the Holder shall surrender
this Note to the Company along with a duly executed copy of the transfer instrument attached hereto as Exhibit A, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note (in accordance with Section 13(c)),
registered as the Holder may request, representing the outstanding Principal being transferred by the Holder and, if less than the entire outstanding Principal is being transferred, a new Note (in accordance with Section 13(c)) to the Holder
representing the outstanding Principal not being transferred. 
 (b) Lost, Stolen or Mutilated Note. Upon receipt by
the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Note (as to which a written certification and the indemnification contemplated below shall suffice as such evidence), and, in the
case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Note, the Company shall execute and deliver
to the Holder a new Note (in accordance with Section 13(c)) representing the outstanding Principal. 
 (c) Issuance
of New Notes. Whenever the Company is required to issue a new Note pursuant to the terms of this Note, such new Note (i) shall be of like tenor with this Note, (ii) shall represent, as indicated on the face of such new Note, the
Principal remaining outstanding, (iii) shall have an issuance date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have the same rights and conditions as this Note, and
(v) shall represent accrued and unpaid Interest on the Principal and Interest of this Note, from the Issuance Date. 
 14. REMEDIES,
CHARACTERIZATIONS, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note at law or in equity (including a decree of specific
performance and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and 

  
 6 








 
consequential damages for any failure by the Company to comply with the terms of this Note. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm
to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an
injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to
enable the Holder to confirm the Company’s compliance with the terms and conditions of this Note (including, without limitation, compliance with Section 10). 

15. CONSTRUCTION; HEADINGS. This Note shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed
against any Person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of, or affect the interpretation of, this Note. Terms used in this Note but defined in the Purchase Agreement shall have the
meanings ascribed to such terms on the Issuance Date in the Purchase Agreement unless otherwise consented to in writing by the Holder. 

16. FAILURE OR INDULGENCE NOT WAIVER. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it
is in writing and signed by an authorized representative of the waiving party. 
 17. NOTICES; CURRENCY; PAYMENTS. 

(a) Notices. Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice
shall be given in accordance with Section 7 of the Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Note, including in reasonable detail a description of such action and
the reason therefore. 
 (b) Currency. All principal, interest and other amounts, if any, owing under this Note or any
Transaction Document that, in accordance with their terms, are paid in cash, shall be paid in United States Dollars (“U.S. Dollars”). 

(c) Payments. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Note, unless
otherwise expressly set forth herein, such payment shall be made in lawful money of the United States of America by (i) wire transfer of immediately available funds to such Person according to wire transfer instructions previously provided to
the Company in writing or (ii) a certified check drawn on the account of the Company and sent via overnight courier service to such Person at such address as previously provided to the Company in writing. Whenever any amount expressed to be due
by the terms of this Note is due on any day which is not a Business Day, the same shall instead be due on the next succeeding day which is a Business Day. 

18. CANCELLATION. After all Principal and accrued Interest at any time owed on this Note have been paid in full (or upon conversion of
this Note in accordance with Section 3 hereof, together with payment of any Interest due and owing upon conversion in accordance with Section 3 hereof), this Note shall automatically be deemed canceled, shall be surrendered to the Company
for cancellation and shall not be reissued. 

  
 7 








 19. WAIVER OF NOTICE. To the extent permitted by law, the Company hereby irrevocably
waives demand, notice, presentment, protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Note. 

20. SEVERABILITY. If any provision of this Note is held to be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Note shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing,
shall incorporate such substitute provision in this Note. 
 21. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THAT WOULD DEFER TO THE LAW OF ANOTHER JURISDICTION. THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMIT TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE
AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR THE HOLDER HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN
(INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR THE HOLDER, ANY CLAIM THAT IT IS NOT PERSONALLY
SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. THE COMPANY AND THE HOLDER EACH HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION
OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE
GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND THE HOLDER HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY.

 22. MAXIMUM PAYMENTS. Nothing contained herein shall be deemed to establish or require the payment of a rate of interest or other
charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be credited
against amounts owed by the Company to the Holder and, if there shall remain any excess after such application, such excess shall be refunded to the Company 

23. APPOINTMENT OF LEAD INVESTOR. 

(a) Appointment. The Holder hereby designates Lead Investor to act as agent (“Agent”) for the holders
of the Notes with respect to any and all actions taken by the Lead Investor, on behalf of the holders of the Notes and the other Transaction Documents with respect to the Collateral (including under Section 4 and Section 5(c) hereof). The
Holder hereby irrevocably authorizes Lead Investor to take such action on its behalf with respect to the Collateral under the provisions of this Agreement and the other Loan Documents and to exercise such powers and to perform such duties hereunder
and thereunder as are specifically delegated to or required of Lead Investor by the terms hereof and thereof and such other powers as are 

  
 8 








 
reasonably incidental thereto and Lead Investor shall hold all Collateral, payments of principal and interest, fees, charges and collections received pursuant to the Transaction Documents in its
capacity as Agent (and not in its individual capacity as a holder of a Note), for the ratable benefit of the holders of the Notes in proportion to the aggregate amounts then due and owing to the holders under the Notes. Agent may perform any of its
duties hereunder by or through its agents or employees. As to any matters not expressly provided for by the Transaction Documents, Agent shall not be required to exercise any discretion or take any action, but shall be required to act or to refrain
from acting (and shall be fully protected in so acting or refraining from acting) upon the instructions of the Required Holders, and such instructions shall be binding; provided, however, that Agent shall not be required to take any
action which exposes Agent to liability or which is contrary to this Agreement or the other Transaction Documents or applicable law unless Agent is furnished with an indemnification reasonably satisfactory to Agent with respect thereto. 

(b) Nature of Duties. Agent shall have no duties or responsibilities except those expressly set forth in the Notes. None
of Agent or any of its officers, directors, partners, employees or agents shall be (i) liable for any action taken or omitted by them as such hereunder or in connection herewith, unless caused by its gross negligence or willful misconduct (as
determined by a court of competent jurisdiction in a final non-appealable judgment), or (ii) responsible in any manner for any recitals, statements, representations or warranties made by the Company contained in any of the Transaction Documents
or for any failure of the Company to perform its obligations under any of the Transaction Documents. Agent shall not be under any obligation to any holder of the Notes to ascertain or to inquire as to the observance or performance of any of the
agreements contained in, or conditions of, the Transaction Documents, or to inspect the properties, books or records of the Company. The duties of Agent shall be mechanical and administrative in nature; Agent shall not by reason of the Transaction
Documents have a fiduciary relationship in respect of the Holder or any other holder of the Notes; and nothing herein, expressed or implied, is intended to or shall be so construed as to impose upon Agent any obligations in respect of the
Transaction Documents except as expressly set forth herein. 
 (c) Lack of Reliance on Agent and Resignation. Agent
shall not be required to make any inquiry concerning either the performance or observance of any of the terms, provisions or conditions of the Transaction Documents or existence of any Event of Default. Agent may resign on thirty
(30) days’ written notice to each of the holders of the Notes and the Company and upon such resignation, the Required Holders will promptly designate a successor Agent. Any such successor Agent shall succeed to the rights, powers and
duties of Agent, and the term “Agent” shall mean such successor agent effective upon its appointment, and the former Agent’s rights, powers and duties as Agent shall be terminated, without any other or further act or deed on the part
of such former Agent. After any Agent’s resignation as Agent, the provisions of this Section 23 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Agent. 

(d) Certain Rights of Agent. If Agent shall request instructions from the holders of the Notes with respect to any act
or action (including failure to act) in connection with the Notes or with respect to the Collateral, Agent shall be entitled to refrain from such act or taking such action unless and until Agent shall have received instructions from the Required
Holders; and Agent shall not incur liability to any Person by reason of so refraining. Without limiting the foregoing, the holders of the Notes shall not have any right of action whatsoever against Agent as a result of its acting or refraining from
acting hereunder in accordance with the instructions of the Required Holders. 

  
 9 








 (e) Reliance. Agent shall be entitled to rely, and shall be fully
protected in relying, upon any note, writing, resolution, notice, statement, certificate, telex, teletype or telecopier message, cablegram, email, order or other document or telephone message believed by it to be genuine and correct and to have been
signed, sent or made by the proper person or entity, and, with respect to all legal matters pertaining to the Notes and the other Transaction Documents and its duties hereunder, upon advice of counsel selected by it. Agent may employ agents and
attorneys-in-fact and shall not be liable for the default or misconduct of any such agents or attorneys-in-fact selected by Agent with reasonable care. 

(f) Notice of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of any Event of Default
hereunder, unless Agent has received written notice from a holder of the Notes or the Company referring to the Notes, describing such Event of Default and stating that such notice is a “notice of default”. Agent shall take such action with
respect to such Event of Default in respect of the Collateral as shall be reasonably directed by the Required Holders; provided, that, unless and until Agent shall have received such directions, Agent may (but shall not be obligated to) take
such action, or refrain from taking such action, with respect to such Event of Default in respect of the Collateral as it shall deem advisable in the best interests of the holders of the Notes. 

(g) Indemnification. To the extent Agent is not reimbursed and indemnified by the Company, each holder of the Notes will
reimburse and indemnify Agent in proportion to its respective portion of the Notes outstanding, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may be imposed on, incurred by or asserted against Agent in performing its duties hereunder, or in any way relating to or arising out of the Notes or the other Transaction Documents; provided, that, the holders
of the Notes shall not be liable for any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from Agent’s gross (not mere) negligence or willful misconduct
(as determined by a court of competent jurisdiction in a final non-appealable judgment). 
 (h) Agent in its Individual
Capacity. With respect to the rights of Agent arising under the Note purchased by it and the other Transaction Documents to which it is a party, the Agent shall have the same rights and powers hereunder as any other holder of the Notes as if it
were not performing the duties as Agent specified herein. 
 24. COLLECTION. The Company agrees to pay all reasonable costs and
expenses incurred by the Holder or the Agent, on behalf of the holders of the Notes, including reasonable attorneys’ fees (including those for appellate proceedings), incurred in connection with any Event of Default or in connection with the
collection or attempted collection or enforcement hereof, whether or not legal proceedings may have been instituted. 
 25. CERTAIN
DEFINITIONS. For purposes of this Note, the following terms shall have the following meanings: 
 (a) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed. 

(b) “Collateral” shall have the meaning assigned to that term in the Purchase Agreement. 

  
 10 








 (c) “Common Stock” means (i) the Company’s shares of
common stock, $0.001 par value per share, and (ii) any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock. 

(d) “Conversion Date” means the date upon which this Note is converted pursuant to Section 2(a). 

(e) “Conversion Price” means $0.80. 

(f) “Conversion Shares” means the shares of Preferred Stock issuable upon conversion of the Notes. 

(g) “Credit Agreement” means that certain Credit Agreement, dated as of June 14, 2013, as amended to date
and in effect from time to time, among the Company, as the Lead Borrower for the Borrowers named therein, the Guarantors named therein, Salus Capital Partners, LLC, as Administrative Agent and Collateral Agent, and the other lenders party thereto.

 (h) “Deposit Account” means the deposit account of the Company established by the Company for the purpose
of holding the proceeds of the Notes during the period provided for in the Purchase Agreement. 
 (i)
“Flatbush” means Flatbush Watermill LLC. 
 (j) “Insolvency Proceeding” means any
proceeding commenced by or against any Person under any provision of the Bankruptcy Code (Chapter 11 of Title 11 of the United States Code) or under any other bankruptcy or insolvency law, assignments for the benefit of creditors, or proceedings
seeking reorganization, arrangement, or other similar relief. 
 (k) “Interest Rate” means Seven and
Twenty-Five Hundredths percent (7.25%) per annum. The “Interest Rate” shall in all cases be subject to adjustment as set forth in Section 2. 

(l) “Material Adverse Effect” shall mean any set of circumstances or events which (i) has or could
reasonably be expected to have any material adverse effect upon the business, properties, assets, financial condition, results of operations or prospects of the Company and its subsidiaries taken as a whole, (ii) impairs or could reasonably be
expected to impair the ability of the Company to perform its obligations under the Transaction Documents, or (iii) impairs or could reasonably be expected to impair the ability of the Holder to enforce its legal remedies pursuant to the
Transaction Documents. 
 (m) “Maturity Date” means the earlier of (i) August 18, 2014 and
(ii) the Trading Day after the Stockholder Meeting (as defined in the Purchase Agreement) if Stockholder Approval is not obtained at the Stockholder Meeting. 

(n) “Obligations” means for so long as the Notes are outstanding, the payment by the Company, as and when due
and payable (by scheduled maturity, acceleration, demand or otherwise, but not including the payment of any Notes by conversion thereof into shares of Preferred Stock), of all principal and interest from time to time owing by the Company under the
Notes, including, without limitation, all interest that accrues after the commencement of any Insolvency Proceeding of the Company, whether or not the payment of such interest is unenforceable or is not allowable due to the existence of an
Insolvency Proceeding. 

  
 11 








 (o) “Person” means an individual, a limited liability company, a
partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof. 

(p) “Preferred Stock” means (i) the Company’s Series B Convertible Preferred Stock, $0.001 par value
per share, and (ii) any capital stock into which such preferred stock shall have been changed or any share capital resulting from a reclassification of such preferred stock. 

(q) “Purchase Agreement” means that certain Securities Purchase Agreement, dated as of February 18, 2014,
by and among the Company and the initial holders of the Notes pursuant to which the Company issued the Notes, as may be amended, modified or supplemented from time to time. 

(r) “Principal Market” means the Nasdaq Global Market. 

(s) “Required Holders” means the holders of Notes representing at least a majority of the aggregate principal
amount of the Notes then outstanding (which majority must include the Lead Investor and Flatbush). 
 (t) “Rights
Agreement” means that certain stockholders rights agreement, dated as of December 19, 2005, between the Company and AST, as rights agent. 

(u) “Stockholder Approval” means approval by the stockholders of the Company of an amendment to the
certificate of incorporation of the Company to increase the number of authorized and unissued shares of Common Stock by an amount not less than the maximum number of shares of Common Stock issuable upon conversion of the Conversion Shares issuable
as of the Issuance Date, including Common Stock issuable upon conversion of the Preferred Stock, pursuant to the Notes. 

(v) “Salus Liens” shall have the meaning ascribed to it in the Purchase Agreement. 

(w) “Stockholder Approval Date” the date on which the Company obtains Stockholder Approval. 

(x) “Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the
Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that “Trading Day” shall not include any day on
which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market
does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 p.m., New York City time) unless such day is otherwise designated as a Trading Day in writing by the Holder. 

(y) “Transaction Documents” means this Note, the Other Notes, the Purchase Agreement, the Certificate of
Designation, the amendment to the Rights Agreement, together with any amendments, restatements, extensions or other modification thereto. 

(page intentionally ends here) 

  
 12 








 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed as of the Issuance Date
set out above. 
  

					
	dELiA*s, Inc.
		
	By:	 	  

		 	Name:	 	David J. Dick
		 	Title:	 	Chief Financial Officer









 EXHIBIT A 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto [NAME OF ASSIGNEE] the within instrument of
dELiA*s, Inc. and does hereby irrevocably constitute and appoint [                    ] as Attorney to transfer said instrument on the books
of the within-named Company, with full power of substitution in the premises. 
 Please Insert Social Security or Other Identifying Number of Assignee:
                     
 Dated:
                 , 20     
  

			
	By:	 	  

		 	Name:
		 	Title:

 NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within instrument in
every particular, without alteration or enlargement or any change whatever. 







 Annex B 

Form of Certificate of Designation of Series B Convertible Preferred Stock 







 CERTIFICATE OF DESIGNATION OF 

SERIES B CONVERTIBLE PREFERRED STOCK, 

PAR VALUE $0.001 PER SHARE, 

OF 
 dELiA*s, Inc.

 Pursuant to Section 151 of the 

General Corporation Law of the State of Delaware 

The undersigned DOES HEREBY CERTIFY that the following resolution was duly adopted by the Board of Directors (the “Board”) of
dELiA*s, Inc., a Delaware corporation (hereinafter called the “Corporation”), with the designations, powers, preferences and relative, participating, optional or other special rights, and qualifications, limitations and restrictions
having been fixed by the Board pursuant to authority granted to it under the Corporation’s Amended and Restated Certificate of Incorporation and in accordance with the provisions of Section 151 of the General Corporation Law of the State
of Delaware: 
 WHEREAS, the Corporation’s Amended and Restated Certificate of Incorporation provides for a class of its authorized
stock known as Preferred Stock, consisting of 25,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series; 

WHEREAS, the Board is authorized by the Corporation’s Amended and Restated Certificate of Incorporation to fix the designations, powers,
preferences and relative, participating, optional or other special rights, and qualifications, limitations and restrictions of any wholly unissued series of Preferred Stock and the number of shares constituting any such series; 

NOW, THEREFORE, BE IT RESOLVED, that, pursuant to authority conferred upon the Board by the Amended and Restated Certificate of Incorporation
of the Corporation, the Board hereby authorizes the issuance of 441,000 shares of Series B Convertible Preferred Stock, par value $0.001 per share, of the Corporation and hereby fixes the designations, powers, preferences and relative,
participating, optional or other special rights, and qualifications, limitations and restrictions relating to such shares, in addition to those set forth in the Amended and Restated Certificate of Incorporation of the Corporation, as follows: 

Section 1. Designation. The shares of such series shall be designated “Series B Convertible Preferred Stock,” and the
number of shares constituting such series shall be 441,000 (the “Series B Preferred Stock”). The number of shares of Series B Preferred Stock may be increased or decreased by resolution of the Board and the approval by the holders
of a majority of the shares of the outstanding Series B Preferred Stock, voting as a separate class; provided that no decrease shall reduce the number of shares of Series B Preferred Stock to a number less than the number of shares of such
series then outstanding. 
 Section 2. Currency. All Series B Preferred Stock shall be denominated in United States currency,
and all payments and distributions thereon or with respect thereto shall be made in United States currency. All references herein to “$” or “dollars” refer to United States currency. 

Section 3. Ranking. The Series B Preferred Stock shall, with respect to dividend rights and rights upon liquidation, winding up or
dissolution, rank senior to each other class or series of shares of the Corporation that the Corporation may issue in the future the terms of which do not expressly provide that such class or series ranks equally with, or senior to, the Series B
Preferred Stock, with respect to dividend rights and/or rights upon liquidation, winding up or dissolution, including, without limitation, the common stock of the Corporation, par value $0.001 per share (the “Common Stock”) and the
Corporation’s Series A Junior Participating Preferred Stock (such junior stock being referred to hereinafter collectively as “Junior Stock”). 







 The Series B Preferred Stock shall, with respect to dividend rights and rights upon liquidation,
winding up or dissolution, rank equally with each other class or series of shares of the Corporation that the Corporation may issue in the future the terms of which expressly provide that such class or series shall rank equally with the Series B
Preferred Stock with respect to dividend rights and rights upon liquidation, winding up or dissolution (“Parity Stock”). 

The Series B Preferred Stock shall, with respect to dividend rights and rights upon liquidation, winding up or dissolution, rank junior to
each other class or series of shares of the Corporation that the Corporation may issue in the future the terms of which expressly provide that such class or series shall rank senior to the Series B Preferred Stock with respect to dividend rights and
rights upon liquidation, winding up or dissolution (“Senior Stock”). The Series B Preferred Stock shall also rank junior to the Corporation’s existing and future indebtedness. 

Section 4. Dividends. 

(a) The holders of Series B Preferred Stock shall be entitled to receive, when, as and if declared by the Board, out of any funds legally
available therefor, dividends per share of Series B Preferred Stock of an amount equal to 6.0% per annum of the Stated Value (as herein defined) of each share of such Series B Preferred Stock then in effect, before any dividends shall be
declared, set apart for or paid upon the Junior Stock (the “Dividends”). For purposes hereof, the term “Stated Value” shall mean $100 per share of Series B Preferred Stock. 

(b) Dividends shall be payable in arrears. The first date on which Dividends shall be payable shall be February 18, 2015 (the
“First Payment Date”), and, thereafter, Dividends shall be payable semi-annually in arrears only on February 18 and August 18 of each year (unless any such day is not a Business Day, in which event such Dividends shall be
payable on the next succeeding Business Day, without accrual to the actual payment date), commencing on February 18, 2015 (such First Payment Date, and each such semi-annual payment date, being a “Dividend Payment Date,” and
the period from the date of issuance of the Series B Preferred Stock to the first Dividend Payment Date and each such semi-annual period thereafter being a “Dividend Period”). The amount of Dividends payable on the Series B
Preferred Stock for any period shall be computed on the basis of a 365-day year and the actual number of days elapsed. For the avoidance of doubt, on the First Payment Date the Company shall pay both (i) the dividend otherwise due on such date,
and (ii) an additional dividend equal to the dividend which accrued in the first semi-annual period following the filing of this Certificate. 

(c) Dividends, whether or not declared, shall begin to accrue and be cumulative from the Issue Date. If the Corporation does not pay any
Dividend in full on any scheduled Dividend Payment Date, then Dividends thereafter will accrue at an annual rate of 8.0% of the Stated Value from such scheduled Dividend Payment Date to the date that all accumulated Dividends on the Series B
Preferred have been paid in cash in full. For the avoidance of doubt, Dividends shall accumulate whether or not in any Dividend Period there have been funds of the Corporation legally available for the payment of such Dividends. By way of example,
with respect to one share of Series B Preferred Stock, if the Dividend Payment Dates were February 15 and August 15, and on February 15 the Company fails to make the required $3 Dividend (i.e., 6% per annum on the $100 Stated
Value), then on August 15 the Corporation owes $3 for the prior Dividend and $4 for the current Dividend. 
 (d) Except as otherwise
provided herein, if at any time the Corporation pays less than the total amount of Dividends then accumulated with respect to the Series B Preferred Stock, such payment 

  
 2 








 
shall be distributed pro rata among the holders thereof based upon the Stated Value on all shares of Series B Preferred Stock held by each such holder. When Dividends are not paid in full upon
the shares of Series B Preferred Stock, all Dividends declared on Series B Preferred Stock and any other Parity Stock shall be paid pro rata so that the amount of Dividends so declared on the shares of Series B Preferred Stock and each such other
class or series of Parity Stock shall in all cases bear to each other the same ratio as accumulated Dividends (for the full amount of dividends that would be payable for the most recently payable dividend period if dividends were declared in full on
non-cumulative Parity Stock) on the shares of Series B Preferred Stock and such other class or series of Parity Stock bear to each other. 

(e) When and if declared, the Dividends shall be paid in cash. 

(f) From and after the time, if any, that the Corporation shall have failed to pay in full all accumulated and unpaid Dividends for all prior
Dividend Periods in accordance with this Section 4, without the consent of a majority of the holders of the Series B Preferred Stock, no dividends shall be declared or paid or set apart for payment, or other distribution declared or made, upon
any Junior Stock, nor shall any Junior Stock be redeemed, purchased or otherwise acquired for any consideration (nor shall any moneys be paid to or made available for a sinking fund for the redemption of any shares of any such Junior Stock) by the
Corporation, directly or indirectly until all such Dividends have been paid in full. 
 (g) The Board may fix a record date for the
determination of holders entitled to receive payment of the Dividends payable pursuant to this Section 4, which record date shall not be more than 60 days nor less than 10 days prior to the date on which any such Dividend is paid. 

(h) Notwithstanding anything herein to the contrary, any Dividend payments made with respect to shares of Series B Preferred Stock will be
made so long as such payments are permitted under the Credit Agreement; provided however, that for the avoidance of doubt, if Dividends are not paid on a Scheduled Payment Date because they are not permitted under the Credit Agreement, Dividends
will accrue at an annual rate of 8.0% of the Stated Value from such scheduled Dividend Payment Date to the date that all accumulated Dividends on the Series B Preferred have been paid. 

Section 5. Liquidation, Dissolution or Winding Up. 

(a) Upon any voluntary or involuntary liquidation, dissolution or winding up of the Corporation (each, a “Liquidation”),
after satisfaction of all liabilities and obligations to creditors of the Corporation and before any distribution or payment shall be made to holders of any Junior Stock, each holder of Series B Preferred Stock shall be entitled to receive, out of
the assets of the Corporation or proceeds thereof (whether capital or surplus) legally available therefor, an amount per share of Series B Preferred Stock equal to the Stated Value per share, plus, an amount equal to any Dividends accumulated but
unpaid thereon (whether or not declared) through the date of Liquidation (the “Liquidation Preference”). Subject to Section 8(i), holders of Series B Preferred Stock will not be entitled to any other amounts from the
Corporation after they have received the full amounts provided for in this Section 5(a) and will have no right or claim to any of the Corporation’s remaining assets. Notwithstanding anything herein to the contrary, any Dividend payments
made with respect to shares of Series B Preferred Stock will be made so long as such payments are permitted under the Credit Agreement; provided, however, that for the avoidance of doubt, if accrued but unpaid Dividends are not paid on any date of
Liquidation because Dividends are not permitted under the Credit Agreement, such accrued but unpaid Dividends will accrue at an annual rate of 8.0% until paid. 

(b) If, in connection with any distribution described in Section 5(a) above, the assets of the Corporation or proceeds thereof are not
sufficient to pay in full the Liquidation Preference payable on the Series B Preferred Stock and the corresponding amounts payable on the Parity Stock, then such assets, or the proceeds thereof, shall be paid pro rata in accordance with the full
respective amounts which would be payable on such shares if all amounts payable thereon were paid in full. 

  
 3 








 (c) For purposes of Section 5(a), the merger or consolidation of the Corporation with or
into any other corporation or other entity, or the sale, conveyance, license, lease or other disposition of all or substantially all of the assets of the Corporation shall constitute a Liquidation; provided however, that the holders of a majority of
the Preferred Stock may declare that an event described in this Section 5(c) does not constitute a Liquidation and the holders of the Series B Preferred will receive the Conversion Price adjustment set forth in Section 8(e). 

(d) If the Corporation does not pay any accrued but unpaid Dividends in full on any date of Liquidation, such accrued but unpaid Dividends
will bear interest at rate of 8.0% per annum until paid in full. 
 Section 6. Voting Rights. The holders of the shares of
Series B Preferred Stock shall be entitled to (i) vote with the holders of the Common Stock on all matters submitted for a vote of holders of Common Stock, (ii) a number of votes per share of Series B Preferred Stock equal to the number of
shares of whole shares of Common Stock into which each such share of Series B Preferred Stock is then convertible at the time of the related record date and (iii) notice of all stockholders’ meetings (or pursuant to any action by written
consent) in accordance with the Corporation’s Amended and Restated Certificate of Incorporation and Bylaws as if the holders of Series B Preferred Stock were holders of Common Stock. Except as provided herein or by law, holders of Series B
Preferred Stock shall vote together with the holders of Common Stock as a single class. 
 Section 7. Conversion. 

(a) Mandatory Conversion by the Corporation. If, at any time beginning on the eighteenth (18) month anniversary of the Issue Date,
the average of the Closing Price of the Common Stock equals or exceeds two times the Conversion Price (adjusted as described in Section 8) for a period of 30 Trading Days in any 45 consecutive Trading Day period (the Business Day immediately
following such 30th Trading Day, the “Mandatory Conversion Date”), then at the Corporation’s election at any time thereafter, each share of Series B Preferred Stock shall be
converted into that number of shares of Common Stock determined by dividing the Stated Value of such share of Series B Preferred Stock by the Conversion Price, plus the Corporation shall pay to the holders of the Series B Preferred Stock an amount
of cash per share of Series B Preferred Stock equal to accrued but unpaid Dividends on such share through but excluding the Mandatory Conversion Date, out of surplus and from funds legally available therefor (the “Mandatory
Conversion”); provided that the foregoing Mandatory Conversion may only be elected by the Corporation if (i) there is an effective registration statement covering all of the shares of Common Stock issuable upon such Mandatory
Conversion, and (ii) the Common Stock is then trading on the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market. If the Corporation does not pay any accrued but unpaid
Dividends in full in cash on any Mandatory Conversion Date, such accrued but unpaid Dividends will bear interest at rate of 8.0% per annum until paid in full. Notwithstanding anything herein to the contrary, any such payments made with respect
to shares of Series B Preferred Stock will be made so long as such payments are permitted under the Credit Agreement; provided, however, that for the avoidance of doubt, if accrued but unpaid Dividends are not paid on any Mandatory Conversion Date
because Dividends are not permitted under the Credit Agreement, such accrued but unpaid Dividends will accrue at an annual rate of 8.0% until paid. 

(b) Optional Conversion. At any time, each holder of Series B Preferred Stock shall have the right, at such holder’s option, to
convert any or all of such holder’s shares of Series B Preferred Stock, 

  
 4 








 
and the shares of Series B Preferred Stock to be converted shall be converted into that number of shares of Common Stock determined by dividing the Stated Value of such share of Series B
Preferred Stock by the Conversion Price, plus the Corporation shall pay to the holders of the Series B Preferred Stock an amount in cash per share of Series B Preferred Stock equal to accrued but unpaid dividends on such shares through but excluding
the applicable conversion date, out of surplus and from funds legally available therefor. If the Corporation does not pay any accrued but unpaid Dividends in cash in full on any Conversion Date (as defined below), such accrued but unpaid Dividends
will bear interest at rate of 8.0% per annum until paid in full. Notwithstanding anything herein to the contrary, any such payments made with respect to shares of Series B Preferred Stock will be made so long as such payments are permitted
under the Credit Agreement; provided, however, that for the avoidance of doubt, if accrued but unpaid Dividends are not paid on any Conversion Date because Dividends are not permitted under the Credit Agreement, such accrued but unpaid Dividends
will accrue at an annual rate of 8.0% until paid. 
 (c) Conversion Price. The Conversion Price is subject to adjustment in
accordance with Section 8. 
 (d) Conversion Procedures. A holder must do each of the following in order to convert its shares
of Series B Preferred Stock pursuant to this Section 7: 
 (1) complete and manually sign the conversion notice provided by the
Corporation, and deliver such notice to the Corporation; 
 (2) deliver to the Corporation the certificate or certificates representing the
shares of Series B Preferred Stock to be converted (or, if such certificate or certificates have been lost, stolen or destroyed, a lost certificate affidavit and indemnity in form and substance reasonably acceptable to the Corporation); 

(3) if required, furnish appropriate endorsements and transfer documents in form and substance reasonably acceptable to the Corporation; and

 (4) if required, pay any stock transfer, documentary, stamp or similar taxes not payable by the Corporation pursuant to
Section 7(h). 
 The “Conversion Date” means the date on which a holder complies in all respects with the procedures set forth in this
Section 7(d). 
 (e) Effect of Conversion. Effective immediately prior to the Close of Business on the Conversion Date
applicable to any shares of Series B Preferred Stock, dividends shall no longer accrue or be declared on any such shares of Series B Preferred Stock and such shares of Series B Preferred Stock shall cease to be outstanding. 

(f) Record Holder of Underlying Securities as of Conversion Date. The Person or Persons entitled to receive the Common Stock and, to
the extent applicable, cash, issuable upon conversion of Series B Preferred Stock on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of Common Stock and/or cash as of the Close of Business on such
Conversion Date. As promptly as practicable on or after the Conversion Date and compliance by the applicable holder with the relevant conversion procedures contained in Section 7(d) (and in any event no later than three Trading Days
thereafter), the Corporation shall issue the number of whole shares of Common Stock issuable upon conversion. Such delivery of shares of Common Stock shall be made in certificated form. Any such certificate or certificates and any cash shall be
delivered by the Corporation to the appropriate holder by mailing certificates evidencing the shares to the holders at their respective addresses as set forth in the 

  
 5 








 
conversion notice. If fewer than all of the shares of Series B Preferred Stock held by any holder are converted pursuant to Section 7(b), then a new certificate representing the unconverted
shares of Series B Preferred Stock shall be issued to such holder concurrently with the issuance of the certificates representing the applicable shares of Common Stock. In the event that a holder shall not by written notice designate the name in
which shares of Common Stock and, to the extent applicable, cash to be delivered upon conversion of shares of Series B Preferred Stock should be registered or paid, or the manner in which such shares and, if applicable, cash should be delivered, the
Corporation shall be entitled to register and deliver such shares and, if applicable, cash in the name of the holder and in the manner shown on the records of the Corporation. 

(g) Status of Converted or Acquired Shares. Shares of Series B Preferred Stock duly converted in accordance with this Certificate of
Designation, or otherwise acquired by the Corporation in any manner whatsoever, shall be retired promptly after the acquisition thereof. All such shares shall upon their retirement and any filing required by the Delaware General Corporation Law
become authorized but unissued shares of Preferred Stock, without designation as to series until such shares are once more designated as part of a particular series by the Board pursuant to the provisions of the Amended and Restated Certificate of
Incorporation. 
 (h) Taxes. (1) The Corporation and its paying agent shall be entitled to withhold taxes on all payments on the
Series B Preferred Stock or Common Stock or other securities issued upon conversion of the Series B Preferred Stock to the extent required by law. Prior to the date of any such payment, each holder of Series B Preferred Stock shall deliver to the
Corporation or its paying agent a duly executed, valid, accurate and properly completed Internal Revenue Service Form W-9 or an appropriate Internal Revenue Service Form W-8, as applicable. 

(2) The Corporation shall pay any and all documentary, stamp and similar issue or transfer tax due on (x) the issue of the Series B
Preferred Stock and (y) the issue of shares of Common Stock upon conversion of the Series B Preferred Stock. However, in the case of conversion of Series B Preferred Stock, the Corporation shall not be required to pay any tax or duty that may
be payable in respect of any transfer involved in the issue and delivery of shares of Common Stock or Series B Preferred Stock in a name other than that of the holder of the shares to be converted, and no such issue or delivery shall be made unless
and until the person requesting such issue has paid to the Corporation the amount of any such tax or duty, or has established to the satisfaction of the Corporation that such tax or duty has been paid. 

(i) Compensation for Buy-In on Failure to Timely Deliver Certificates upon Conversion. If the Corporation fails to deliver to a holder
of Series B Preferred Stock the applicable certificate or certificates, with respect to the Conversion Shares within three (3) Trading Days following each Conversion Date (the “Share Delivery Date”) (other than a failure caused
by incorrect or incomplete information provided by such holder to the Corporation), and if after such Share Delivery Date such holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the holder’s
brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a “Buy-In”), then the Corporation shall (A) pay in cash to such holder (in addition to any
other remedies available to or elected by such holder) the amount by which (x) such holder’s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased pursuant to such Buy-In exceeds
(y) the product of (1) the number of shares of Common Stock subject to such Buy-In multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed) including brokerage commissions),
and (B) at the option of such holder, either reissue (if surrendered) the shares of Series B Preferred Stock equal to the number of shares of Series B Preferred Stock submitted for conversion or deliver to such holder the number of shares of
Common Stock that would have been issued if the Corporation had timely complied 

  
 6 








 
with its delivery requirements. For example, if a holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of
shares of Series B Preferred Stock with respect to which the actual sale price (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the
Corporation shall be required to pay such holder $1,000. The holder shall provide the Corporation written notice, within five (5) Trading Days after the occurrence of Buy-In, indicating the amounts payable to such holder in respect of such
Buy-In together with applicable confirmations and other evidence reasonably requested by the Corporation. Nothing herein shall limit a holder’s right to pursue any other remedies available to it hereunder, at law, or in equity, including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation’s failure to timely deliver certificates representing shares of Common Stock upon conversion of the shares of the Series B Preferred
Stock as required pursuant to the terms hereof; provided, however, that the holder shall not be entitled to both (i) require the reissuance of the shares of Series B Preferred Stock submitted for conversion for which such
conversion was not timely honored and (ii) receive the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements set forth herein 

Section 8. Certain Adjustments. 

(a) Stock Dividends and Stock Splits. If the Corporation, at any time while the Series B Preferred Stock is outstanding: (i) pays
a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Corporation upon conversion of, or payment of a Dividend on, the Series B Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be
multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of
Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 8(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. 

(b) Subsequent Equity Sales. If the Corporation, at any time while the Series B Preferred Stock is outstanding, shall sell, grant any
option to purchase, sell or grant any right to reprice its securities, or otherwise disposes of or issue any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock, at a price per share less than the then
Conversion Price (such issuances collectively, a “Dilutive Issuance”), as adjusted hereunder (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price
adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which is issued in connection with such issuance, be entitled to receive shares of Common Stock at an
effective price per share which is less than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced by multiplying
the Conversion Price by a fraction, the numerator of which is the number of shares of Common Stock issued and outstanding immediately prior to the Dilutive Issuance plus the number of shares of Common Stock which the offering price for such Dilutive
Issuance would purchase at the then Conversion Price, and the denominator of which shall be the sum of the number of shares of Common Stock issued and outstanding immediately prior to the Dilutive Issuance plus the number of shares of Common Stock
so issued or 

  
 7 








 
issuable in connection with the Dilutive Issuance. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustment
will be made under this Section 8(b) in respect of an Exempt Issuance. Notwithstanding anything to the contrary in this Section 8(b), the Conversion Price will not be adjusted to a price that is less than $0.75 (as adjusted in accordance
with Section 8(a) and Section 8(c)-(i)). 
 (c) Subsequent Rights Offerings. In addition to any adjustments pursuant to
Section 8(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
(the “Purchase Rights”), then the holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the holder could have acquired if the holder had held the number of shares
of Common Stock acquirable upon complete conversion of such holder’s Series B Preferred Stock immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. 

(d) Pro Rata Distributions. During such time as the Series B Preferred Stock is outstanding, if the Corporation declares or makes any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of the Series B Preferred Stock,
then, in each such case, the holder shall be entitled to participate in such Distribution to the same extent that the holder would have participated therein if the holder had held the number of shares of Common Stock acquirable upon complete
conversion of the Series B Preferred Stock immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
participation in such Distribution. 
 (e) Fundamental Transaction. Subject to Section 5(c), if, at any time while
the Series B Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer,
tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted
by the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement
or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of the Series B Preferred Stock, the holder shall have the right to receive, for each share of Common Stock that would have been
issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation,


  
 8 








 
and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for
which the Series B Preferred Stock is convertible immediately prior to such Fundamental Transaction. For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the holder of
Series B Preferred Stock shall be given the same choice as to the Alternate Consideration it receives upon any conversion of the Series B Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing
provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the holders new preferred stock consistent with the
foregoing provisions and evidencing the holders’ right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the
“Successor Entity”) to assume in writing all of the obligations of the Corporation under this Certificate of Designation in accordance with the provisions of this Section 8(e) pursuant to written agreements in form and
substance reasonably satisfactory to the holder and approved by the holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of the Series B Preferred Stock, deliver to the holder in exchange
for the Series B Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Series B Preferred Stock which is convertible for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Series B Preferred Stock (without regard to any limitations on the conversion of the Series B Preferred
Stock) prior to such Fundamental Transaction, and with a conversion price which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such
Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Series B Preferred Stock immediately prior to the
consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that
from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation referring to the “Corporation” shall refer instead to the Successor Entity), and may exercise every right and power of the
Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Corporation herein. 

(f) Other Events. If any event occurs of the type contemplated by the foregoing provisions of this Section 8 but not expressly
provided for by such provisions, then the Board will make an appropriate adjustment to the Conversion Price so as to protect the rights of the holders of the Series B Preferred Stock; provided, however, that no such adjustment will increase the
Conversion Price as otherwise determined pursuant to this Section 8. 
 (g) Limitation to Conversion Price Adjustment. All
calculations under this Section 8 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 8, the number of shares of Common Stock deemed to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding. 

  
 9 








 (h) Notice to the Holders. Whenever the Conversion Price is adjusted pursuant to any
provision of this Section 8, the Corporation shall promptly deliver to each holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. 

(i) Notice to Allow Conversion by Holder. In addition to any notices required pursuant to Section 8(h), if (A) the
Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall
authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in
connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, or (F) any Liquidation not
covered by the foregoing clauses, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Series B Preferred Stock, and shall cause to be delivered to each holder at its
last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of
the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange 

Section 9. Negative Covenants. So long as the Lead Investor or Flatbush, as the case may be, beneficially owns (determined in
accordance with Rule 13D-3 under the Exchange Act) at least ten percent (10%) of the Common Stock (on an as-converted basis), the Company shall not, without the prior written consent of the Lead Investor and/or Flatbush, as the case may be,
take any of the following actions or engage in any of the following transactions: (a) if all accrued dividends on the Series B Preferred Stock shall not have been paid in full, declare or pay dividends on, or repurchase or redeem, any shares of
capital stock of the Company; except for repurchases or deemed repurchases in connection with net or cashless exercise of options and issuances under the Rights Agreement; (b) authorize, create or issue any class or series of capital stock of
the Corporation that ranks senior to or in parity with the Preferred Stock, including any additional Series B Preferred Stock; or (iii) amend, alter or repeal of any provision of the certificate of incorporation or bylaws of the Corporation
that materially and adversely affects the rights, preferences, privileges or voting powers of the Series B Preferred Stock; provided, that an amendment to the certificate of incorporation of the Corporation to increase the number of
authorized and unissued shares of Common Stock by an amount not less than the maximum number of Common Stock issuable upon conversion of the shares of Series B Preferred Stock, as well as an incremental increase in the number of authorized shares of
Common Stock to be used, inter alia, in respect of the Corporation’s present or future compensation plans, shall not require the consent of the Lead Investor or Flatbush. 

Section 10. Reservation of Shares. The Corporation shall at all times when the Series B Preferred Stock shall be outstanding
reserve and keep available, free from preemptive rights, for issuance upon the conversion of Series B Preferred Stock, such number of its authorized but unissued Common Stock as will from time to time be sufficient to permit the conversion of all
outstanding Series B Preferred Stock. Prior to the delivery of any securities which the Corporation shall be obligated to deliver upon conversion of the Series B Preferred Stock, the Corporation shall comply with all applicable laws and regulations
which require action to be taken by the Corporation. 

  
 10 








 Section 11. Fractional Shares. No fractional shares of Common Stock will be delivered
to the holders of Series B Preferred Stock upon conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Corporation shall round such fraction up to the nearest whole share. 

Section 12. Notices. Any and all notices or other communications or deliveries hereunder shall be in writing and shall be deemed
given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section prior to or at the Close of Business on a Business Day and
electronic confirmation of receipt is received by the sender, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that
is not a Business Day or later than the Close of Business on any Business Day, (iii) the Business Day following the date of mailing, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to
whom such notice is required to be given. The addresses for such communications shall be: (i) if to the Corporation, attention: General Counsel, or (ii) if to a holder of Series B Preferred Stock, to the address or facsimile number
appearing on the Corporation’s stockholder records or such other address or facsimile number as such holder may provide to the Corporation in accordance with this Section 12. 

Section 13. Certain Definitions. As used in this Certificate of Designation, the following terms shall have the following
meanings, unless the context otherwise requires: 
 “Alternate Consideration” shall have the meaning ascribed to it in
Section 8(e). 
 “Board” shall have the meaning ascribed to it in the recitals. 

“Business Day” shall mean a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking
institutions in New York, New York generally are authorized or obligated by law, regulation or executive order to close. 
 “Capital
Stock” shall mean any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) stock issued by the Corporation. 

“Certificate of Designation” shall mean this Certificate of Designation relating to the Series B Preferred Stock, as it may
be amended from time to time. 
 “Close of Business” shall mean 5:00 p.m., New York City time, on any Business Day. 

“Closing Price” shall mean (i) if the Common Stock is listed on a national securities exchange, the volume weighted
average price per share of the Common Stock on the applicable Trading Day on the principal national securities exchange on which the Common Stock is listed or admitted to trading, (ii) if the Common Stock is not listed on a national securities
exchange and if prices for the Common Stock are then quoted on the OTC Bulletin Board, the volume weighted average price per share of the Common Stock on the applicable Trading Day on the OTC Bulletin Board, or (iii) if the Common Stock is not
then listed or quoted on the OTC Bulletin Board, then a price per share of Common Stock calculated by reference to the fair market value of the Corporation as may be established by a nationally recognized third party valuation consultant mutually
acceptable to the Corporation and the holders of a majority of the Preferred Stock, the cost of which valuation will be borne by the Corporation. 

  
 11 








 “Commission” means the United States Securities and Exchange Commission. 

“Common Stock” shall have the meaning ascribed to it in Section 3. 

“Common Stock Equivalents” means any securities of the Corporation which would entitle the holder thereof to acquire at any
time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock. 
 “Conversion Date” shall have the meaning ascribed to it in Section 7(d). 

“Conversion Price” means $0.80. 

“Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series B
Preferred Stock in accordance with the terms hereof. 
 “Corporation” shall have the meaning ascribed to it in the
recitals. 
 “Credit Agreement” means that certain credit agreement, dated as of June 14, 2013, by, among others, the
Corporation, certain wholly-owned subsidiaries of the Corporation, and Salus Capital Partners, LLC, as amended and in effect from time to time. 

“Dilutive Issuance” shall have the meaning ascribed to it in Section 8(b). 

“Distribution” shall have the meaning ascribed to it in Section 8(d). 

“Dividend” shall have the meaning ascribed to it in Section 4(a). 

“Dividend Payment Date” shall have the meaning ascribed to it in Section 4(b). 

“Dividend Period” shall have the meaning ascribed to it in Section 4(b). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Exempt Issuance” shall mean, any issuances of (1) Capital Stock to employees, directors, officers or consultants of or
to the Corporation or any of its Subsidiaries pursuant to a stock option or incentive compensation or similar plan outstanding as of the date hereof or, subsequent to the date hereof, approved by the Board or a duly authorized committee of the
Board, (2) securities pursuant to any bona fide merger, joint venture, partnership, consolidation, dissolution, liquidation, tender offer, recapitalization, reorganization, share exchange, business combination or similar transaction or any
other direct or indirect acquisition by the Corporation, whereby the Corporation’s securities comprise, in whole or in part, the consideration paid by the Corporation in such transaction, (3) shares of Common Stock issued at a price equal
to or greater than the Closing Price on the Trading Day immediately preceding the earlier of (x) the date on which the sale or issuance of the Series B Preferred Stock is publicly announced and (y) the date on which the price for such sale
or issuance of the Series B Preferred Stock is agreed or fixed, and (4) securities convertible into, exercisable or exchangeable for shares of Common Stock issued with an exercise or conversion price equal to or greater than the Closing Price
on the Trading Day immediately preceding the earlier of (x) the date on which the sale or issuance is publicly announced and (y) the date on which the price for such sale or issuance is agreed or fixed. 

“Fundamental Transaction” shall have the meaning ascribed to it in Section 8(e). 

  
 12 








 “Issue Date” shall mean February 18, 2014, including, without limitation,
with respect to any shares of Series B Preferred Stock issued in connection with the conversion of Secured Convertible Notes (the “Notes”) of the Corporation issued to the holders of Series B Preferred Stock on or about the Issue
Date, without regard to when such shares of Preferred Stock are actually issued. For the avoidance of doubt, upon conversion of the Notes into shares of Series B Preferred Stock, Dividends shall be deemed to have started accruing on such shares as
of the Issue Date, even though such shares were issued after the Issue Date 
 “Junior Stock” shall have the meaning
ascribed to it in Section 3. 
 “Liquidation” shall have the meaning ascribed to it in Section 5(a). 

“Liquidation Preference” shall have the meaning ascribed to it in Section 5(a). 

“Mandatory Conversion” shall have the meaning ascribed to it in Section 7(a). 

“Mandatory Conversion Date” shall have the meaning ascribed to it in Section 7(a). 

“Parity Stock” shall have the meaning ascribed to it in Section 3. 

“Person” shall mean any individual, company, partnership, limited liability company, joint venture, association, joint stock
company, trust, unincorporated organization, government or agency or political subdivision thereof or any other entity. 

“Preferred Stock” shall mean any and all series of preferred stock of the Corporation, including the Series B Preferred
Stock. 
 “Purchase Rights” shall have the meaning ascribed to it in Section 8(c). 

“Senior Stock” shall have the meaning ascribed to it in Section 3. 

“Series B Preferred Stock” shall have the meaning ascribed to it in Section 1. 

“Stated Value” shall have the meaning ascribed to it in Section 4(a). 

“Subsidiary” means any company or corporate entity for which the Corporation owns, directly or indirectly, an amount of the
voting securities, other voting rights or voting partnership interests of which is sufficient to elect at least a majority of its board of directors or other governing body (or, if there are no such voting interests, more than 50% of the equity
interests of such company or corporate entity). 
 “Successor Entity” shall have the meaning ascribed to it in
Section 8(e). 
 “Trading Day” shall mean any Business Day on which the Common Stock is traded, or able to be traded,
on the principal national securities exchange on which the Common Stock is listed or admitted to trading. 
 Section 14.
Headings. The headings of the paragraphs of this Certificate of Designation are for convenience of reference only and shall not define, limit or affect any of the provisions hereof. 

Section 15. Record Holders. To the fullest extent permitted by applicable law, the Corporation may deem and treat the record
holder of any share of the Series B Preferred Stock as the true and lawful owner thereof for all purposes, and the Corporation shall not be affected by any notice to the contrary. 

  
 13 








 Section 16. Replacement Certificates. The Corporation shall replace any mutilated
certificate at the holder’s expense upon surrender of that certificate to the Corporation. The Corporation shall replace certificates that become destroyed, stolen or lost at the holder’s expense upon delivery to the Corporation of
reasonably satisfactory evidence that the certificate has been destroyed, stolen or lost, together with any indemnity that may be required by the Corporation. 

Section 17. Transfer Agent, Conversion Agent, Registrar and Paying Agent. The duly appointed Transfer Agent, Conversion Agent,
Registrar and Paying Agent for the Series B Preferred Stock shall be the Corporation. The Corporation may, in its sole discretion, cease to act as Transfer Agent, Conversion Agent, Registrar and Paying Agent for the Series B Preferred Stock;
provided that the Corporation shall appoint a successor transfer agent who shall accept such appointment prior to the effectiveness of such cessation. Upon any such cessation or appointment, the Corporation shall send notice thereof to the
holders of the Series B Preferred Stock. 
 Section 18. Waiver. Any waiver by the Corporation or a holder of a breach of any
provision of this Certificate of Designation shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other holders. The
failure of the Corporation or a holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other holder) of the right thereafter to
insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a holder must be in writing. 

Section 19. Severability. If any term of the Series B Preferred Stock set forth herein is invalid, unlawful or incapable of being
enforced by reason of any rule of law or public policy, all other terms set forth herein which can be given effect without the invalid, unlawful or unenforceable term will, nevertheless, remain in full force and effect, and no term herein set forth
will be deemed dependent upon any other such term unless so expressed herein. 
 Section 20. Other Rights. The shares of Series
B Preferred Stock shall not have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the
Amended and Restated Certificate of Incorporation or as provided by applicable law and regulation. 
 RESOLVED, FURTHER, that the Chief Executive Officer or
Secretary of the Corporation be and they hereby are authorized and directed to prepare and file this Certificate of Designation in accordance with the foregoing resolution and the provisions of Delaware law. 

  
 14 








 IN WITNESS WHEREOF, dELiA*s, Inc. has caused this Certificate of Designation to be duly executed
by its authorized corporate officer this 18th day of February, 2014. 
  

			
	dELiA*s, Inc.
		
	By:	 	  

		 	Name:
		 	Title:



  
 15 








 Exhibit A 

INSTRUCTION SHEET FOR INVESTOR 

(to be read in conjunction with the entire Securities Purchase Agreement) 

 

	A.	Complete the following items in the Securities Purchase Agreement: 

  

	 	1.	Complete and execute the Investor Signature Page. The Agreement must be executed by an individual authorized to bind the Investor. 


Provide the information requested by the Investor Questionnaire: 

 

	 	2.	Exhibit A-1 - Investor Questionnaire. 

 Provide the information requested by the
Registration Statement Questionnaire: 
  

	 	3.	Exhibit A-2 - Registration Statement Questionnaire. 

 Provide the information requested by
the Investor Certificate: 
  

	 	4.	Exhibit A-3 - Investor Certificate. Please provide Certificate 1 or Certificate 2, as applicable. 


Return Documents to the Company. 
  

	 	5.	Return, via facsimile, the signed Securities Purchase Agreement including the properly completed Exhibits A-1 through A-3, to: 


Facsimile: 
 Telephone: 

Attn: 
  

	 	6.	After completing instruction number five (5) above, deliver the original signed Securities Purchase Agreement including the properly completed Exhibits A-1 through A-3 to: 


Address: 
  

	B.	Instructions regarding the wire transfer of funds for the purchase of the Securities will be telecopied to the Investor by the Company at a later date. 


  
 -2- 








 Exhibit A-1 

dELiA*s, Inc. 

INVESTOR QUESTIONNAIRE 

Please provide us with the following information: 
  

					
	1.	 	The exact name that the certificates representing shares of Preferred Stock and the Note are to be registered in (this is also the name that will appear on the stock certificate(s) for the Conversion Shares). You may use a nominee
name if appropriate:	  	  

			
	2.	 	The relationship between the Investor of the Securities and the Registered Holder listed in response to item 1 above:	  	  

			
	3.	 	The mailing address, telephone and telecopy number and email address of the Registered Holder listed in response to item 1 above:	  	  

			
		 		  	  

			
		 		  	  

			
		 		  	  

			
		 		  	  

			
	4.	 	The Tax Identification Number of the Registered Holder listed in response to item 1 above:	  	  









 Exhibit A-2 

dELiA*s, Inc. 

REGISTRATION STATEMENT QUESTIONNAIRE 

In connection with the Registration Statement, please provide us with the following information regarding the Investor. 

 

	1.	Please state your organization’s name exactly as it should appear in the Registration Statement: 

  

	
	  


 Except as set forth below, your organization does not hold any equity securities of the Company on behalf of
another person or entity. 
 State any exceptions here: 
  

	
	  


 If the Investor is not a natural person, please identify the natural person or persons who will have voting
and investment control over the shares of Preferred Stock and Conversion Shares owned by the Investor: 
  

	
	  


 2. Address of your organization: 
  

			
	  

	
	  

		
	Telephone:	  	  

		
	Fax:	  	  

		
	Contact Person:	  	  


 3. Have you or your organization had any position, office or other material relationship within the past three years with the
Company or its affiliates? (Include any relationships involving you or any of your affiliates, officers, directors, or principal equity holders (5% or more) that has held any position or office or has had any other material relationship with the
Company (or its predecessors or affiliates) during the past three years.) 

                      
  Yes                                      
                  No 







 If yes, please indicate the nature of any such relationship below: 

4. Are you the beneficial owner of any other securities of the Company? (Include any equity securities that you beneficially own or have a right to acquire
within 60 days after the date hereof, and as to which you have sole voting power, shared voting power, sole investment power or shared investment power.) 

                      
  Yes                                      
                  No 
 If yes, please describe
the nature and amount of such ownership as of a recent date. 
 5. Except as set forth below, you wish that all the shares of the Company’s common
stock beneficially owned by you or that you have the right to acquire from the Company be offered for your account in the Registration Statement. 

State any exceptions here: 
 6. Have you made or
are you aware of any arrangements relating to the distribution of the shares of the Company pursuant to the Registration Statement? 

                      
  Yes                                      
                  No 
 If yes, please describe
the nature and amount of such arrangements. 
 7. FINRA Matters 

(a) State below whether (i) you or any associate or affiliate of yours are a member of the FINRA, a
controlling shareholder of an FINRA member, a person associated with a member, a direct or indirect affiliate of a member, or an underwriter or related person with respect to the proposed offering;
(ii) you or any associate or affiliate of yours owns any stock or other securities of any FINRA member not purchased in the open market; or (iii) you or any associate or affiliate of yours has made any
outstanding subordinated loans to any FINRA member. If you are a general or limited partnership, a no answer asserts that no such relationship exists for you as well as for each of your general or limited partners. 

 

															
		 		 		 	Yes:	  	No:	  		  		  	
		 		 		 	______	  	______	  		  		  	


  
 -2- 








 If “yes,” please identify the FINRA member and describe your relationship,
including, in the case of a general or limited partner, the name of the partner: 
 If you answer “no” to Question 7(a), you need
not respond to Question 7(b). 
 (b) State below whether you or any associate or affiliate of yours has been an
underwriter, or a controlling person or member of any investment banking or brokerage firm which has been or might be an underwriter for securities of the Corporation or any affiliate thereof including, but not limited to, the common
stock now being registered. 
  

															
		 		 		 	Yes:	  	No:	  		  		  	
		 		 		 	______	  	______	  		  		  	

 If “yes,” please identify the FINRA member and describe your relationship, including, in the
case of a general or limited partner, the name of the partner. 

  
 -3- 








 ACKNOWLEDGEMENT 

The undersigned hereby agrees to notify the Company promptly of any changes in the foregoing information which should be made as a result of
any developments, including the passage of time. The undersigned also agrees to provide the Company and the Company’s counsel any and all such further information regarding the undersigned promptly upon request in connection with the
preparation, filing, amending, and supplementing of the Registration Statement (or any prospectus contained therein). The undersigned hereby consents to the use of all such information in the Registration Statement. 

The undersigned understands and acknowledges that the Company will rely on the information set forth herein for purposes of the preparation
and filing of the Registration Statement. 
 The undersigned understands that the undersigned may be subject to serious civil and criminal
liabilities if the Registration Statement, when it becomes effective, either contains an untrue statement of a material fact or omits to state a material fact required to be stated in the Registration Statement or necessary to make the statements in
the Registration Statement not misleading. The undersigned represents and warrants that all information it provides to the Company and its counsel is currently accurate and complete and will be accurate and complete at the time the Registration
Statement becomes effective and at all times subsequent thereto, and agrees during the Effectiveness Period and any additional period in which the undersigned is making sales of Shares under and pursuant to the Registration Statement, and agrees
during such periods to notify the Company immediately of any misstatement of a material fact in the Registration Statement, and of the omission of any material fact necessary to make the statements contained therein not misleading. 

 

									
		 	Dated:	 	  
	 		 	
					
		 		 		 		 	  

		 		 		 		 	Name
					
		 		 		 		 	  

		 		 		 		 	Signature
					
		 		 		 		 	  

		 		 		 		 	Name and Title of Signatory


  
 -4- 








 Exhibit A-3 

dELiA*s, Inc. 

INVESTOR CERTIFICATE 

If the Investor is a corporation, partnership, limited liability company, trust, pension plan, foundation, joint Investor (other than a
married couple) or other entity, an authorized officer, partner, or trustee must complete, date and sign this Certificate 1. If the Investor is an individual, such individual must complete, date and sign Certificate 2. 

CERTIFICATE 1 

CERTIFICATE FOR CORPORATE, PARTNERSHIP, LIMITED LIABILITY COMPANY, 

TRUST, FOUNDATION AND JOINT INVESTORS 

The undersigned certifies that the representations and responses below are true and accurate: 

(a) The Investor has been duly formed and is validly existing and has full power and authority to invest in the Company. The person signing on
behalf of the undersigned has the authority to execute and deliver the Securities Purchase Agreement on behalf of the Investor and to take other actions with respect thereto. 

(b) Indicate the form of entity of the undersigned: 
  

					
		 	  
	  	Limited Partnership
			
		 	  
	  	General Partnership
			
		 	  
	  	Limited Liability Company
			
		 	  
	  	Corporation
			
		 	  
	  	Revocable Trust (identify each grantor and indicate under what circumstances the trust is revocable by


			
	the grantor):	  	  

	  


 (Continue on a separate piece of paper, if necessary.) 

 

					
		 	  
	  	Other type of Trust (indicate type of trust and, for trusts other than pension trusts, name the grantors and


			
	beneficiaries):	  	  

	  



(Continue on a separate piece of paper, if necessary.) 
  

							
		 	  
	  	Other form of organization (indicate form of organization (	 	  



									
	  
	 	).

  

							
		 	(c) Indicate the approximate date the undersigned entity was formed:	  	  
	 	.


  
 -5- 








 (d) In order for the Company to offer and sell the Securities in conformance with state and
federal securities laws, the following information must be obtained regarding your investor status. Please initial each category applicable to you as an investor in the Company. 

 

					
		 	              
	  	1. A bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary
capacity;
			
		 	  
	  	2. A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934;
			
		 	  
	  	3. An insurance company as defined in Section 2(13) of the Securities Act;
			
		 	  
	  	4. An investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act;
			
		 	  
	  	5. A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;
			
		 	  
	  	6. A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of
$5,000,000;
			
		 	  
	  	7. An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank,
savings and loan association, insurance company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are
accredited investors;
			
		 	  
	  	8. A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;
			
		 	  
	  	9. Any partnership or corporation or any organization described in Section 501(c)(3) of the Internal Revenue Code or similar business trust, not formed for the specific purpose of acquiring the Shares, with total assets in
excess of $5,000,000;
			
		 	  
	  	10. A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of the Exchange
Act;


  
 -6- 









					
			
		 	              
	  	11. An entity in which all of the equity owners qualify under any of the above or below subparagraphs. If the undersigned belongs to this investor category only, list the equity owners of the undersigned, and the investor category
which each such equity owner satisfies:

  

					
		 	  

		 	(Continue on a separate piece of paper, if necessary.)
			
		 	a.	  	Any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of the purchase exceeds $1,000,0001 ; and/or
			
		 	b.	  	Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of the two most recent years and who reasonably
expects to reach the same income level in the current year; and/or
			
		 	c.	  	Any director or executive officer of the Company.

 Please set forth in the space provided below the (i) states, if any, in the U.S. in which you maintained
your principal office during the past two years and the dates during which you maintained your office in each state, (ii) state(s), if any, in which you are incorporated or otherwise organized and (iii) state(s), if any, in which you pay
income taxes. 
  

			
		 	  

		
		 	  


  

					
	Dated:	 	  
	 	, 2014
	
	  

	Print Name of Investor
	
	  

	Name:	 		 	
	Title:	 		 	
	(Signature and title of authorized officer, partner or trustee)

  

	1 	“Net worth” means the excess of total assets at fair market value (including personal and real property, but excluding the estimated fair market value of a person’s primary home) over total liabilities.
Total liabilities excludes any mortgage on the primary home in an amount of up to the home’s estimated fair market value as long as the mortgage was incurred more than 60 days before the securities are purchased or acquired, but includes
(i) any mortgage amount in excess of the home’s fair market value and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of securities for the purpose of investing in the
securities. 


  
 -7- 








 CERTIFICATE 2 

CERTIFICATE FOR INDIVIDUALS 

The undersigned certifies that the representations and responses below are true and accurate: 

(a) The Investor has the authority and capacity to invest in the Company. 

(b) In order for the Company to offer and sell the securities in conformance with state and federal securities laws, the following information
must be obtained regarding your investor status. Please initial each category applicable to you as an investor in the Company. 
  

							
		 	  
	 	1.	  	Any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of the purchase exceeds $1,000,0002; and/or
				
		 	  
	 	2.	  	Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of the two most recent years and who reasonably
expects to reach the same income level in the current year; and/or
				
		 	  
	 	3.	  	Any director or executive officer of the Company.

 (Please note that “income” does not refer simply to gross income or total revenues.
For instance, if appropriate, your operating expenses or costs of revenues should be deducted from your total income, if those amounts are material. Your “income” for a particular year may be calculated by adding to your adjusted gross
income as calculated for federal income tax purposes any deduction for long term capital gains, any deduction for depletion allowance, any exclusion for tax exempt interest and any losses of a partnership allocated to you as a partner.) 

 

	2 	“Net worth” means the excess of total assets at fair market value (including personal and real property, but excluding the estimated fair market value of a person’s primary home) over total liabilities.
Total liabilities excludes any mortgage on the primary home in an amount of up to the home’s estimated fair market value as long as the mortgage was incurred more than 60 days before the securities are purchased or otherwise acquired, but
includes (i) any mortgage amount in excess of the home’s fair market value and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of securities for the purpose of investing in the
securities. 


  
 -8- 








 Please set forth in the space provided below the (i) states, if any, in the U.S. in which
you maintained your principal residence during the past two years and the dates during which you maintained your principal residence in each state, (ii) state(s), if any, in which you are registered to vote; (iii) states, if any, in which
you hold a driver’s license, and (iv) state(s), if any, in which you pay income taxes. 
  

			
		  	  

	
	  


 Please set forth in the space provided below the name, address and title/capacity (e.g., parent, legal
guardian, joint owners (if securities are held jointly), executor, etc.) of each person, if any, that has the sole or shared power to vote or to direct the vote the Securities. 

 

			
	  

	
	  


  

					
	Dated:	 	  
	 	, 2014
	
	  

	Print Name of Investor
	
	  

	Signature of Investor
		
		 	  

	Print Name of Joint Investor
		
		 	  

	Signature of Joint Investor








 Exhibit B 

AMENDMENT TO RIGHTS AGREEMENT 







 FIRST AMENDMENT TO RIGHTS AGREEMENT 

This FIRST AMENDMENT TO RIGHTS AGREEMENT (the “Amendment”) is dated as of February 18, 2014 and amends that certain
Rights Agreement, dated as of December 19, 2005 (the “Rights Agreement”), by and between dELiA*s, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company LLC, a New
York limited liability trust company (the “Rights Agent”). Capitalized terms used but not otherwise defined in this Amendment have the respective meanings set forth in the Rights Agreement. 

RECITALS: 
 WHEREAS, the
board of directors of the Company determined it is in the best interests of the Company and its stockholders to amend the Rights Agreement on the terms set forth herein; 

WHEREAS, in accordance with Section 27 of the Rights Agreement and subject to certain provisions of that section, for so long as the
Rights are then redeemable, the Company may in its sole and absolute discretion, and the Rights Agent shall if the Company so directs, supplement or amend any provision of the Rights Agreement in any respect without the approval of any holders of
the Rights; 
 WHEREAS, the Rights Agent is hereby directed to join in the amendment to the Rights Agreement as set forth herein. 

AGREEMENT: 
 NOW,
THEREFORE, in consideration of the promises and the mutual agreements herein set forth, the parties hereby agree as follows: 
 1. Amendment of the
Rights Agreement. 
  

	 	(a)	Section 1 of the Rights Agreement is hereby amended as follows: 

 (i) The
definition of “Acquiring Person” is hereby amended and restated to read as follows: 
 “(a) “Acquiring
Person” shall mean any Person who or which, together with all Affiliates and Associates of such Person, shall become the Beneficial Owner of fifteen percent (15%) or more (or more than 30% with respect to an Excluded Shareholder or
19.99% with respect to a Valinor Shareholder or a Flatbush Shareholder) of the shares of Common Stock then outstanding, but shall not include the Company, any Subsidiary of the Company, any employee benefit plan of the Company or of any Subsidiary
of the Company, or any Person or entity organized, appointed or established by the Company for or pursuant to the terms of any such plan; provided, however, that (i) if the Board of Directors of the Company determines in good
faith that a Person who would otherwise be an “Acquiring Person” inadvertently became the Beneficial Owner of a number of shares 







 
of Common Stock such that the Person would otherwise qualify as an “Acquiring Person” (including, without limitation, because (A) such Person was unaware that it beneficially owned
a percentage of Common Stock that would otherwise cause such Person to be an “Acquiring Person” or (B) such Person was aware of the extent of its Beneficial Ownership of Common Stock but had no actual knowledge of the consequences of
such Beneficial Ownership under this Agreement), without any intention of changing or influencing control of the Company, then the Board may determine that such Person shall not be deemed to be or to have become an “Acquiring Person” for
any purposes of this Agreement unless and until such Person shall have failed to divest itself, as soon as practicable (as determined, in good faith, by the Board of Directors of the Company), of Beneficial Ownership of a sufficient number of shares
of Common Stock so that such Person would no longer otherwise qualify as an “Acquiring Person”; (ii) if, as of the date of the first public announcement of the adoption of this Agreement, any Person is the Beneficial Owner of fifteen
percent (15%) or more of the shares of Common Stock outstanding, such Person shall not be deemed to be or to become an “Acquiring Person” unless and until such time as such Person shall, after the first public announcement of the
adoption of this Agreement, become the Beneficial Owner of an additional 1% or more of the shares of Common Stock outstanding (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock or pursuant
to a split or subdivision of the outstanding Common Stock), unless, upon becoming the Beneficial Owner of such additional shares of Common Stock, such Person is not then the Beneficial Owner of fifteen percent (15%) or more (or more than 30%
with respect to an Excluded Shareholder or 19.99% with respect to a Valinor Shareholder or a Flatbush Shareholder) of the shares of Common Stock then outstanding; and (iii) no Person shall become an “Acquiring Person” as a result of
an acquisition of shares of Common Stock by the Company which, by reducing the number of shares outstanding, increases the proportionate number of shares of Common Stock beneficially owned by such Person to fifteen percent (15%) or more (or
more than 30% with respect to an Excluded Shareholder or 19.99% with respect to a Valinor Shareholder) of the shares of Common Stock then outstanding; provided, however, that if a Person shall become the Beneficial Owner of fifteen
percent (15%) or more (or more than 30% with respect to an Excluded Shareholder or 19.99% with respect to a Valinor Shareholder or a Flatbush Shareholder) of the shares of Common Stock then outstanding by reason of such share acquisitions by
the Company and shall thereafter become the Beneficial Owner of an additional 1% or more of the shares of Common Stock outstanding (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock or
pursuant to a split or subdivision of the outstanding Common Stock), then such Person shall be deemed to be an “Acquiring Person” unless upon becoming the Beneficial Owner of such additional shares of Common Stock such Person does not
beneficially own fifteen percent (15%) or more (or more than 30% with respect to a Excluded Shareholder or 19.99% with respect to a Valinor Shareholder or a Flatbush Shareholder) of the shares of Common Stock then outstanding. For all purposes
of this Agreement, any calculation of the number of shares of Common Stock outstanding at any particular time, including for purposes of determining the particular percentage of such outstanding shares of Common Stock of which any Person is the
Beneficial Owner, shall be made in accordance with the last sentence of Rule 13d-3(d)(1)(i) of the General Rules and Regulations under the Exchange Act (as such term is hereinafter defined).” 

  
 2 








 (ii) Two new defined terms are hereby added at the end of Section 1 of the Rights Agreement
as follows: 
 “(rr) “Flatbush Shareholders” shall mean, collectively, Flatbush Watermill, LLC and its
Affiliates and Associates. 
 (ss) “Valinor Shareholders” shall mean, collectively, Valinor Management, LLC
and its Affiliates and Associates.” 
 (iii) Subparagraph (iii) of Section 1(e) of the Rights Agreement is hereby amended to
add the following before the period at the end of that Section: 
 “; and provided, further, that the voting agreement of
the Flatbush Shareholders and the Valinor Shareholders contained in Section 4.11(a) of that certain Securities Purchase Agreement entered into by and among the Company and the investors listed on the signature pages thereof shall not be
considered to be an agreement for the purpose of purpose of acquiring, holding, voting or disposing of securities of the Company for purposes of this subparagraph (iii)”. 

2. Outside Date for Closing of Transactions under Securities Purchase Agreement. If the sale by the Company of its securities to, and the purchase of
securities from the Company by, the Valinor Shareholders pursuant to that certain Securities Purchase Agreement proposed to be entered into by and among the Company and the investors listed on the signature pages thereof shall not have been
consummated by February 28, 2014, then this Amendment shall be of no further force and effect, and the Rights Agreement shall remain exactly the same as it existed immediately prior to execution of this Amendment. The Company shall notify the
Rights Agent promptly if such sale and purchase of securities shall not have been so consummated. 
 3. No Other Amendment; Effect of Amendment.
Except as and to the extent expressly modified by this Amendment, the Rights Agreement and the exhibits thereto shall remain in full force and effect in all respects without any modification. By executing this Amendment below, the Company certifies
that this Amendment has been executed and delivered in compliance with the terms of Section 27 of the Rights Agreement. In the event of a conflict or inconsistency between this Amendment and the Rights Agreement and the exhibits thereto, the
provisions of this Amendment shall govern. 
 4. Counterparts. This Amendment may be executed in any number of counterparts and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Amendment transmitted electronically shall have the same authority, effect and
enforceability as an original signature. 
 5. Severability. If any term, provision, covenant or restriction of this Amendment is held by a court of
competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or
invalidated. 

  
 3 








 6. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of
Delaware and for all purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts made and to be performed entirely within such State. 

[Remainder of Page Intentionally Left Blank] 

  
 4 








 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the
day and year first above written. 
  

			
	dELiA*s, INC.
		
	By:	 	 /s/ David J. Dick

	Name:	 	 David J. Dick

	Title:	 	 Chief Financial Officer and Treasurer

	
	AMERICAN STOCK TRANSFER & TRUST COMPANY LLC, as Rights Agent
		
	By:	 	 /s/ Paula Caroppoli

	Name:	 	 Paula Caroppoli

	Title:	 	 Senior Vice President




  
 5 








 Exhibit C 

OPINION OF COMPANY COUNSEL 







 Exhibit D 

PLAN OF DISTRIBUTION 
 The selling
stockholders may, from time to time, sell any or all of their shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. The
selling stockholders may use any one or more of the following methods when selling shares: 
  

	 	•	 	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; 

  

	 	•	 	block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; 


 

	 	•	 	purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

  

	 	•	 	an exchange distribution in accordance with the rules of the applicable exchange; 

  

	 	•	 	privately negotiated transactions; 

  

	 	•	 	short sales; 

  

	 	•	 	broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share; 

  

	 	•	 	a combination of any such methods of sale; and 

  

	 	•	 	any other method permitted pursuant to applicable law. 

 The selling stockholders may also sell
shares under Rule 144 under the Securities Act, if available, rather than under this prospectus. 
 Broker-dealers engaged by the selling
stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in
amounts to be negotiated. The selling stockholders do not expect these commissions and discounts to exceed what is customary in the types of transactions involved. Any profits on the resale of shares of common stock by a broker-dealer acting as
principal might be deemed to be underwriting discounts or commissions under the Securities Act. Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by a selling stockholder. The
selling stockholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act. 

The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them
and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under
Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.








 The selling stockholders also may transfer the shares of common stock in other circumstances, in
which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common stock from time to time under this prospectus after we have filed a
supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. 
 The selling stockholders and any broker-dealers or agents that are involved in selling the shares of
common stock may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares of
common stock purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. 
 We are required to pay
all fees and expenses incident to the registration of the shares of common stock. We have agreed to indemnify the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. 

The selling stockholders have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters
or broker-dealers regarding the sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed sale of shares of common stock by any selling stockholder. If we are notified by any
selling stockholder that any material arrangement has been entered into with a broker-dealer for the sale of shares of common stock, if required, we will file a supplement to this prospectus. If the selling stockholders use this prospectus for any
sale of the shares of common stock, they will be subject to the prospectus delivery requirements of the Securities Act. 
 The
anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934 may apply to sales of our common stock and activities of the selling stockholders. 

  
 -2- 








 Exhibit E 

COMPANY TRANSFER AGENT INSTRUCTIONS 

[TRANSFER AGENT] 

[                    ] 

[                    ] 

Attention: [                    ] Representative

 Ladies and Gentlemen: 
 Reference is made
to that certain Securities Purchase Agreement, dated as of February 18, 2014 (the “Agreement”), by and among dELiA*s, Inc., a Delaware corporation (the “Company”), and the investors named on the Schedule of
Investors attached thereto (collectively, the “Holders”), pursuant to which the Company is issuing shares of Series B Convertible Preferred Stock (the “Preferred Shares”) which are convertible into shares of common
stock, par value $0.001 per share (the “Common Stock”), of the Company (“Conversion Shares”), and notes which are convertible into Preferred Shares. 

In connection with the consummation of the transactions contemplated by the Agreement, this letter shall serve as our irrevocable
authorization and direction to you: 
 (i) to issue (provided that you are the transfer agent of the Company at such time) upon further
written direction of the Company to be provided after the Company obtains the approval of its stockholders to issue the Conversion Shares, an aggregate of 55,125,000 shares of our Common Stock in the names and denominations set forth on Annex I
attached hereto. The certificates should bear the legend set forth on Annex II attached hereto and “stop transfer” instructions should be placed against their subsequent transfer. Kindly deliver the certificates to the respective
delivery addresses set forth on Annex I via hand delivery or overnight courier. We confirm that these shares will be validly issued, fully paid and non-assessable upon issuance; and 

(ii) to issue (provided that you are the transfer agent of the Company at such time) certificates for the Conversion Shares upon transfer or
resale of the Conversion Shares and receipt by you of certificate(s) for the Conversion Shares so transferred or sold (duly endorsed or accompanied by stock powers duly endorsed, in each case with signatures guaranteed and otherwise in form eligible
for transfer). 
 You acknowledge and agree that so long as you have previously received written confirmation from the Company’s legal
counsel that the Conversion Shares are eligible for sale in conformity with Rule 144(c)(i) under the Securities Act of 1933, as amended, then, unless otherwise required by law, within three (3) business days of your receipt of certificates
representing the Conversion Shares, you shall issue the certificates representing the Conversion Shares to the Holders or their transferees, as the case may be, registered in the names of such Holders or transferees, as the case may be, and such
certificates shall not bear any legend restricting transfer of the Conversion Shares thereby and should not be subject to any stop-transfer restriction. 

A form of written confirmation from the Company’s outside legal counsel that a registration statement covering resales of the Conversion
Shares has been declared effective by the SEC under the Securities Act is attached hereto as Annex III. 







 Please be advised that the Holders are relying upon this letter as an inducement to enter into
the Agreement and, accordingly, each Holder is a third party beneficiary to these instructions. 
 Please execute this letter in the space
indicated to acknowledge your agreement to act in accordance with these instructions. Should you have any questions concerning this matter, please contact our counsel, William D. Freedman, Esq., at (212) 704-6000. 

 

			
	Very truly yours,
	
	dELiA*s, Inc.
		
	By:	 	  

		 	Name:
		 	Title:


  
  

					
	 THE FOREGOING INSTRUCTIONS ARE

ACKNOWLEDGED AND AGREED TO
 this      day of
February, 2014

	
	[TRANSFER AGENT]
		
	By:	 	  

		 	Name:	 	  

		 	Title:	 	  


 Enclosures 

  
 -2- 








 ANNEX I 

SCHEDULE OF INVESTORS 

  
 -3- 








 ANNEX II 

LEGEND 
 THESE SECURITIES HAVE NOT BEEN
REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE
STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. 

  
 -4- 








 ANNEX III 

FORM OF NOTICE OF EFFECTIVENESS OF REGISTRATION STATEMENT 

[TRANSFER AGENT] 

[                    ] 

[                    ] 

Attention: [                    ] Representative

  

	 	Re:	dELiA*s, Inc. 

 Ladies and Gentlemen: 

We are counsel to dELiA*s, Inc., a Delaware corporation (the “Company”), and have represented the Company in connection with
that certain Securities Purchase Agreement, dated as of February 18, 2014 (the “Securities Purchase Agreement”), entered into by and among the Company and the buyers named therein (collectively, the
“Purchasers”) pursuant to which the Company issued to the Purchasers shares of Series B Convertible Preferred Stock (the “Preferred Shares”) which are convertible into shares of common stock, par value $0.001 per
share (“Common Stock”), of the Company (the “Conversion Shares”) and notes which are convertible into Preferred Shares. Pursuant to the Securities Purchase Agreement, the Company agreed to register the resale of the
Conversion Shares (collectively, the “Registrable Securities”) under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Company’s obligations under the Securities Purchase
Agreement, on [Month]     ], 20[    ], the Company filed a Registration Statement on Form S-3 (File No. 333-[            ] ) (the
“Registration Statement”) with the Securities and Exchange Commission (the “Commission”) relating to the Registrable Securities which names each of the Purchasers as a selling shareholder thereunder. 

In connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered an
order declaring the Registration Statement effective under the Securities Act at [            ] [a.m.][p.m.] on [            ],
20[    ], and we have no Knowledge, after telephonic inquiry of a member of the staff, that any stop order suspending its effectiveness has been issued or that any proceedings for that purpose are pending before, or threatened
by, the Commission and the Registrable Securities are available for resale under the Securities Act pursuant to the Registration Statement. 

  
 -5- 








 Schedule 3.1(a) 
  

	1.	Alloy Merchandise, LLC – 100% owned by dELiA*s, Inc. 

  

	2.	dELiA*s Assets Corp. – 100% owned by dELiA*s, Inc. 

  

	3.	DACCS, Inc. – 100% owned by dELiA*s, Inc. 

  

	4.	dELiA*s Group Inc. – 100% owned by dELiA*s, Inc. 

  

	5.	dELiA*s Brand LLC – 100% owned by dELiA*s, Inc. 

  

	6.	dELiA*s Operating Company – 100% owned by dELiA*s, Inc. 

  

	7.	AMG Direct, LLC – 100% owned by dELiA*s, Inc. 

  

	8.	dELiA*s Distribution Company, Inc. – 100% owned by dELiA*s, Inc. 

  

	9.	dELiA*s Retail Company – 100% owned by dELiA*s, Inc. 








 Schedule 3.1(g) 

1. Preferred Stock: $.001 par value, 25,000,000 shares authorized, none issued. 

2. Common Stock, $.001 par value, 100,000,000 shares authorized, 69,415,415 shares issued and outstanding. 

3. 3,336,913 shares of common stock, $0.001 par value, are issuable pursuant to options granted under the Company’s 2005 Stock Incentive
Plan. 
 4. 215,343 shares of common stock, $0.001 par value, are issuable pursuant to the exercise of warrants issued by the Company. 

  
 -2- 








 Schedule 3.1(i) 

None 

  
 -3- 








 Schedule 3.1(n) 

On January 31, 2014, the Company received a letter from the Nasdaq Stock market indicating that the Listing Rules of the Nasdaq Stock
market required that listed securities maintain a minimum bid price of $1 per shares and based on the closing bid price for the last 30 consecutive business dates, the Company no longer met this requirement. 

  
 -4- 








 Schedule 3.1(o) 

3. At any time following July 31, 2015, officers and directors who purchased common stock and convertible notes in a private placement
transaction that was completed on July 31, 2013 and who hold 50% of the shares of common stock of the Company issued in the private placement and upon conversion of the convertible notes may demand for registration under the Securities Act of
an underwritten offering of all or part of their shares. 
 2. The Company has granted piggy-back registration rights to the investors who
purchased common stock and convertible notes in a private placement transaction that was completed on July 31, 2013. 

  
 -5- 








 Schedule 3.1(z) 

None 

  
 -6-